Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
TG	"AITD3, TGN"	ENSG00000042832	Thyroglobulin	P01266	8	132866958-133134903	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	247	"thyroid gland: 994.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.5;HSkMC: 4.2;Karpas-707: 9.7;PC-3: 4.8;U-266/70: 3.5"	"Cancer enriched"	"Detected in some"	1672	"thyroid cancer: 3072.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.0"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"cerebellum: 1.3"	"Low region specificity"	"Detected in many"			"CAB000077, HPA002740, CAB056155"	Enhanced				"Secreted in other tissues"	1000000	1000000			"CAB000077: , CAB056155: AB_2665573, HPA002740: AB_1080277"	"unprognostic (1.18e-1)"	"unprognostic (6.86e-2)"	"unprognostic (7.40e-4)"	"unprognostic (1.20e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.77e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.64e-2)"	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.4	0.6	0.1	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.3	0.3	0.1	0.1	0.1	0.1	0.0	0.1	3.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	994.3	0.1	0.1	0.1	0.1	0.3	1.2	4.0	0.6	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.9	1.4	0.6	0.0	1.7	0.0	0.1	0.9	0.0	0.0	0.2	0.4	0.5	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.2	2.9	1.1	0.0	0.0	0.0	9.7	0.2	0.0	0.1	0.0	0.0	4.8	0.1	0.0	0.3	0.2	2.8	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.6	0.0	3.5	2.9	0.0	0.2	1.2	0.0	0.0	0.6	0.7	0.2	0.0	0.9	0.0	0.4	0.0	0.0	0.3	0.3	0.2	4.0	0.0	0.3	1.2	0.4	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TPO	TPX	ENSG00000115705	"Thyroid peroxidase"	P07202	2	1374223-1543711	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	58	"thyroid gland: 411.3"	"Group enriched"	"Detected in some"	5	"Karpas-707: 14.0;RPMI-8226: 5.9"	"Cancer enriched"	"Detected in some"	364	"thyroid cancer: 188.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"memory CD4 T-cell: 5.1;T-reg: 3.0"	"Lineage enriched"	"Detected in single"	21	"T-cells: 5.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA007987, CAB009587"	Enhanced				"Intracellular and membrane"					"CAB009587: , HPA007987: AB_1080270"	"unprognostic (1.55e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.56e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.19e-4)"	"unprognostic (2.61e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.44e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.98e-3)"	"unprognostic (7.10e-3)"	1.1	0.0	0.1	0.1	0.1	0.0	0.9	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.4	1.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.2	0.1	0.5	0.0	0.2	0.1	0.1	7.1	0.2	0.1	0.1	0.1	411.3	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	5.1	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	1.4	0.0	0.0	0.1	0.2	0.0	0.0	5.9	0.0	0.0	0.0	0.1	0.0	2.0	0.0	1.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.3	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	3.0	0.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
DIO1	TXDI1	ENSG00000211452	"Iodothyronine deiodinase 1"	P49895	1	53891239-53911086	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"kidney: 36.1;liver: 50.8;thyroid gland: 67.7"	"Group enriched"	"Detected in some"	26	"Hep G2: 16.6;SK-BR-3: 40.3"	"Group enriched"	"Detected in many"	8	"liver cancer: 44.7;thyroid cancer: 43.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (4.89e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.91e-3)"	"unprognostic (6.96e-4)"	"unprognostic (6.94e-2)"	"unprognostic (4.83e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.50e-3)"	"unprognostic (9.99e-3)"	"unprognostic (3.78e-2)"	"prognostic unfavourable (5.44e-4)"	"unprognostic (3.59e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	1.0	0.1	0.1	0.1	0.0	36.1	50.8	0.4	0.1	0.2	0.1	0.4	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	67.7	0.1	0.1	0.1	0.1	0.0	1.5	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.1	0.0	16.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	40.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.1
TBX22	"CLPA, CPX"	ENSG00000122145	"T-box 22"	Q9Y458	X	80014756-80031769	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	27	"testis: 25.6;thyroid gland: 6.6"	"Cell line enriched"	"Detected in some"	4	"HDLM-2: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 0.4"	"Low region specificity"	"Detected in many"																						"unprognostic (6.58e-2)"						"unprognostic (6.31e-2)"	"unprognostic (1.18e-1)"		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0
SLC26A4	"DFNB4, PDS"	ENSG00000091137	"Solute carrier family 26 member 4"	O43511	7	107660635-107717809	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"thyroid gland: 79.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.2;LHCN-M2: 5.5;U-251 MG: 3.3"	"Cancer enriched"	"Detected in some"	8	"thyroid cancer: 37.6"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"naive B-cell: 3.1"	"Lineage enriched"	"Detected in single"	5	"B-cells: 3.1"	"Region enriched"	"Detected in some"	4	"hippocampal formation: 10.6"	"Low region specificity"	"Detected in all"			HPA042860	Approved									"HPA042860: AB_10796680"	"unprognostic (1.19e-2)"	"unprognostic (4.84e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.39e-1)"	0.1	0.0	0.8	0.2	0.5	0.0	0.2	0.0	2.9	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.2	3.3	0.0	0.2	0.0	0.1	0.6	0.1	0.1	0.1	0.1	0.0	0.0	1.8	0.0	1.4	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	79.2	0.0	0.1	0.8	0.1	3.1	0.1	0.1	0.2	0.1	0.5	0.3	0.8	0.4	0.6	0.1	0.8	1.8	0.5	0.4	0.2	0.3	0.1	0.0	0.2	0.1	3.0	0.3	0.2	0.6	0.2	0.1	4.2	1.0	0.0	0.3	0.2	0.5	0.5	1.3	0.1	1.1	0.5	0.0	0.1	0.0	0.4	5.5	0.8	0.1	0.5	0.0	1.0	0.2	1.5	0.0	0.0	0.1	3.0	0.2	0.0	0.0	2.1	0.0	0.5	0.8	0.8	0.6	0.3	3.3	0.8	0.8	0.3	1.0	0.5	2.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	3.1	0.0	0.1	0.1	0.1	0.2	0.1	0.5	0.3	0.8	0.5	0.0	1.4	0.5	0.2	0.1	0.6	0.0	0.0
NKX2-1	"BCH, NKX2A, TITF1, TTF-1, TTF1"	ENSG00000136352	"NK2 homeobox 1"	P43699	14	36516392-36521149	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"lung: 51.5;thyroid gland: 122.8"	"Cell line enriched"	"Detected in some"	28	"SCLC-21H: 47.6"	"Group enriched"	"Detected in some"	39	"lung cancer: 30.9;thyroid cancer: 103.2"	"Group enriched"	"Detected in some"	6	"basal ganglia: 2.4;hypothalamus: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 3.4;hypothalamus: 12.0"	"Group enriched"	"Detected in some"	13	"basal ganglia: 6.4;hypothalamus: 16.1"	"CAB000078, CAB053633, HPA074316"	Enhanced		Uncertain	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"CAB000078: , CAB053633: AB_442138, HPA074316: "		"unprognostic (3.79e-1)"		"unprognostic (4.25e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-2)"		"unprognostic (1.26e-2)"				"unprognostic (2.23e-1)"		"unprognostic (1.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.18e-1)"	0.1	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.5	0.0	0.0	51.5	0.1	0.0	0.1	0.0	0.0	0.0	4.9	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.4	0.0	122.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	47.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.4	0.0	0.1	0.2	2.5	0.0	0.1	0.1	0.4
IYD	"C6orf71, DEHAL1, dJ422F24.1"	ENSG00000009765	"Iodotyrosine deiodinase"	Q6PHW0	6	150368892-150405969	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"thyroid gland: 212.3"	"Group enriched"	"Detected in some"	6	"CACO-2: 3.3;SK-BR-3: 8.2"	"Cancer enriched"	"Detected in many"	20	"thyroid cancer: 80.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"hippocampal formation: 8.1;thalamus: 2.6"	"Low region specificity"	"Detected in all"			HPA059627	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA059627: AB_2684086"	"unprognostic (3.73e-4)"	"unprognostic (2.93e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-2)"	"prognostic favourable (6.22e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.07e-9)"	"unprognostic (9.79e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.18e-2)"	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	8.2	0.1	0.1	3.6	0.1	0.3	0.1	0.1	6.7	0.1	0.1	0.1	5.4	6.8	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.5	0.1	1.2	0.0	0.3	0.0	0.1	0.2	13.5	0.0	0.1	0.1	0.3	0.1	0.0	0.0	212.3	0.0	0.1	0.1	0.1	1.4	1.0	5.9	1.3	2.3	0.7	2.3	0.2	0.0	0.2	0.3	0.1	0.9	0.5	0.0	0.0	0.1	0.0	3.3	0.6	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.3	0.5	0.8	0.3	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.5	0.0	0.4	0.3	0.2	0.3	0.2	0.2	0.0	0.8	0.4	0.2	0.0	8.2	0.0	0.8	0.1	0.2	0.2	0.2	0.3	0.0	0.3	0.1	0.1	0.5	0.3	0.2	3.3	1.3	0.7	0.7	1.1	0.5	0.6	0.6	0.5	0.1	1.4	0.6	0.7	5.9	2.3	0.5	1.0	0.5	2.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.0
SFTA3	"NANCI, SFTPH"	ENSG00000229415	"Surfactant associated 3"	P0C7M3	14	36473288-36513829	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	16	"lung: 45.2;thyroid gland: 55.4"	"Cell line enriched"	"Detected in single"	195	"SCLC-21H: 21.0"	"Group enriched"	"Detected in some"	238	"lung cancer: 18.4;thyroid cancer: 52.8"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"													"prognostic favourable (8.29e-4)"				"unprognostic (3.95e-1)"				"unprognostic (3.21e-3)"		0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	45.2	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	55.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.1
SLC26A7	SUT2	ENSG00000147606	"Solute carrier family 26 member 7"	Q8TE54	8	91209494-91398152	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"thyroid gland: 194.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.7;EFO-21: 1.3;HAP1: 2.9;HEK 293: 1.6;U-266/70: 3.1"	"Group enriched"	"Detected in some"	11	"renal cancer: 8.7;thyroid cancer: 32.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.84e-2)"	"unprognostic (8.04e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.39e-3)"	"unprognostic (2.94e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.26e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.19e-3)"	"unprognostic (6.83e-3)"	0.3	0.1	0.1	0.4	0.1	0.0	0.2	0.1	0.2	1.6	0.2	0.0	0.2	0.0	1.4	0.2	0.3	0.1	0.1	0.3	0.1	0.1	13.0	0.1	0.1	1.7	0.1	0.0	0.1	0.3	0.1	0.3	4.4	0.7	0.1	0.0	8.6	0.8	0.1	0.2	0.2	0.1	0.0	0.3	0.1	1.5	0.2	0.0	0.0	194.5	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	1.3	0.0	0.0	2.9	0.1	0.2	0.0	1.6	0.3	0.1	0.0	0.0	0.0	1.1	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.6	3.1	0.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.7	0.0
AC026461.4		ENSG00000275691			16	56676132-56677763	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	10	"blood: 1.1;intestine: 2.7;kidney: 1.0;thyroid gland: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"gdTCR: 1.1;naive CD4 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"																															"unprognostic (1.03e-1)"					"unprognostic (2.92e-2)"	"unprognostic (2.63e-4)"		0.0	0.0		0.0		0.0	0.0		0.0	0.0	1.8			2.4	0.0	0.0	0.0	0.1	0.0	0.0			1.0	0.1	0.0	0.0			0.0	0.0	0.0		0.0		0.0	2.7		0.0	0.0	0.0	0.0	1.4	0.0		0.0	0.1	0.0			2.7		0.1	0.0		0.3	0.0	0.0	0.6	0.1	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.5	0.0	0.3	0.2	0.1	0.0	0.1	1.1	0.0	0.0	0.1	0.6	0.0	0.2	0.2										
ZNF804B	FLJ32110	ENSG00000182348	"Zinc finger protein 804B"	A4D1E1	7	88759368-89337057	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	9	"thyroid gland: 31.4"	"Cell line enriched"	"Detected in single"	5	"AF22: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA026702	Uncertain									"HPA026702: AB_1859459"					"unprognostic (1.10e-1)"							"unprognostic (5.00e-2)"			"unprognostic (1.29e-1)"	"unprognostic (1.99e-1)"		0.2	0.2	0.6	0.7	1.3	0.1	0.4	0.2	2.0	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.6	0.2	0.4	2.5	0.2	0.2	3.3	0.2	0.5	0.5	1.3	0.1	0.4	0.6	1.6	0.6	0.1	1.3	1.2	0.1	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.3	0.0	0.0	31.4	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.3	0.2	2.0	0.2	0.4	0.2	0.5	1.6	0.0
GRIN2C	"GluN2C, NMDAR2C"	ENSG00000161509	"Glutamate ionotropic receptor NMDA type subunit 2C"	Q14957	17	74842023-74861504	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"brain: 43.6;heart muscle: 13.2;salivary gland: 14.2;thyroid gland: 12.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.1;RPMI-8226: 3.9;SCLC-21H: 5.0"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.3"	"Region enriched"	"Detected in many"	5	"cerebellum: 43.6"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in some"	13	"cerebellum: 65.6"												"unprognostic (7.21e-3)"	"unprognostic (4.68e-2)"	"unprognostic (9.38e-3)"	"unprognostic (2.24e-5)"	"unprognostic (3.42e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.14e-1)"	1.0	1.4	7.8	0.5	9.1	1.0	0.5	43.6	8.9	0.5	0.5	2.4	0.0	0.5	0.5	0.5	0.4	0.6	0.6	13.2	4.5	1.4	0.3	0.2	0.3	0.3	3.2	4.5	0.4	0.2	0.5	0.0	2.7	4.2	0.3	0.4	0.3	14.2	0.5	0.6	0.4	0.6	0.5	1.0	0.4	0.3	2.7	0.9	0.0	12.4	0.0	0.3	0.4	0.0	0.2	1.3	0.3	0.1	0.2	0.7	0.0	0.0	0.4	0.4	0.1	0.1	0.0	11.1	0.0	0.0	0.0	0.0	1.3	0.2	0.5	0.1	0.0	0.4	0.1	0.0	0.0	1.0	0.3	0.2	0.2	0.3	0.0	0.8	0.9	0.0	0.0	0.3	0.0	0.0	0.4	0.3	0.0	1.7	0.1	0.1	0.1	0.1	0.3	0.9	3.9	0.0	0.3	5.0	0.3	2.1	0.2	0.8	0.7	0.1	0.2	0.4	2.0	0.4	0.1	1.1	0.1	0.2	0.4	0.6	0.2	0.1	0.1	0.3	0.7	0.1	0.1	0.0	0.1	0.3	0.1	0.2	0.3	0.2	0.3	0.2	0.0	1.3	0.2	0.0	7.8	9.1	43.6	6.3	4.5	1.4	3.2	4.5	4.2	0.9
IPCEF1	"KIAA0403, PIP3-E"	ENSG00000074706	"Interaction protein for cytohesin exchange factors 1"	Q8WWN9	6	154154496-154356792	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	7	"blood: 30.1;bone marrow: 15.2;brain: 26.4;lymphoid tissue: 12.4;thyroid gland: 36.9"	"Group enriched"	"Detected in some"	5	"HMC-1: 19.3;THP-1: 9.8;U-937: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA028708, HPA028710"	Enhanced		Approved	"Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies"				"Nuclear speckles, Plasma membrane"	"Nuclear speckles, Plasma membrane"	"HPA028708: AB_10601916, HPA028710: AB_2732442"	"unprognostic (1.23e-2)"	"unprognostic (8.93e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.87e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.51e-4)"	1.3	0.7	5.3	6.9	12.9	15.2	1.9	20.0	26.4	3.4	1.6	5.5	0.0	1.1	1.7	1.8	1.9	2.5	3.2	1.0	3.8	4.6	3.4	2.4	2.0	12.4	3.9	14.1	1.3	1.4	0.4	1.3	2.0	5.5	1.3	1.6	0.0	1.4	0.8	0.7	1.2	2.9	1.3	4.2	6.4	2.6	1.5	4.9	10.0	36.9	0.0	11.7	2.4	1.1	0.0	7.1	30.1	6.3	6.0	13.5	5.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.1	19.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.1	1.0	0.4	0.2	0.2	0.5	0.9	2.1	0.3	0.3	0.0	0.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.2	0.0	1.4	6.3	30.1	6.1	2.8	13.1	0.0	7.7	5.8	7.1	0.0	13.5	7.9	19.3	6.0	3.4	0.2	9.9	5.3	5.3	12.9	20.0	26.4	3.8	4.6	3.9	14.1	5.5	4.9
OTOS	OTOSP	ENSG00000178602	Otospiralin	Q8NHW6	2	240139026-240144562	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"pituitary gland: 39.1;thyroid gland: 41.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.0;hTEC/SVTERT24-B: 1.8;U-138 MG: 2.2"	"Group enriched"	"Detected in some"	13	"glioma: 6.5;thyroid cancer: 28.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"hippocampal formation: 1.8"	"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (8.52e-2)"			"unprognostic (1.73e-1)"	"unprognostic (9.01e-3)"					"unprognostic (1.35e-1)"					"unprognostic (2.72e-1)"	"unprognostic (3.27e-3)"		0.3	0.3	4.5	0.3	4.6	0.3	0.4	0.3	3.8	0.5	0.3	0.7	0.0	0.3	0.4	0.7	0.3	0.4	0.3	0.3	2.4	1.1	0.3	0.3	0.3	0.3	0.6	2.0	0.3	0.3	0.3	39.1	0.3	5.5	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.8	0.3	0.3	0.4	0.8	0.0	41.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.0	2.2	0.7	0.0	0.5	0.0	0.1	0.0	0.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	4.6	0.3	3.8	2.4	1.1	0.6	2.0	5.5	0.8
RTN4RL2	"NgR2, NGRH1"	ENSG00000186907	"Reticulon 4 receptor like 2"	Q86UN3	11	57460549-57477534	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 44.3;liver: 38.1;thyroid gland: 24.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 16.9;Karpas-707: 25.6;REH: 15.4;RPMI-8226: 49.3"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"amygdala: 17.7;basal ganglia: 17.9;cerebral cortex: 44.3;hippocampal formation: 12.4;olfactory region: 17.6"	"Group enriched"	"Detected in some"	4	"classical monocyte: 1.0;intermediate monocyte: 2.5;MAIT T-cell: 1.1;myeloid DC: 3.4"	"Group enriched"	"Detected in many"	24	"dendritic cells: 3.4;monocytes: 2.5;T-cells: 1.1"	"Group enriched"	"Detected in many"	4	"amygdala: 23.2;basal ganglia: 10.6;cerebral cortex: 29.8;hippocampal formation: 23.6"	"Low region specificity"	"Detected in many"								"Intracellular and membrane"	25000000	25000000				"unprognostic (6.27e-3)"	"unprognostic (2.02e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.40e-2)"	"unprognostic (8.51e-2)"	"unprognostic (7.64e-2)"	"unprognostic (6.83e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.28e-1)"	"prognostic unfavourable (3.05e-7)"	"unprognostic (3.53e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.16e-3)"	"unprognostic (2.18e-2)"	2.7	0.9	17.7	0.9	17.9	1.4	2.4	1.6	44.3	1.5	1.0	1.0	0.0	1.8	1.5	0.8	1.2	1.2	3.8	2.1	12.4	1.5	2.0	38.1	1.9	1.0	2.0	17.6	1.0	2.8	5.4	2.5	2.7	1.0	1.9	0.7	1.9	2.8	1.0	2.3	5.3	1.2	1.4	0.7	1.3	1.9	1.5	0.1	1.0	24.9	0.5	1.0	1.3	1.2	0.0	3.4	0.0	2.5	0.0	1.1	0.0	2.6	3.8	2.9	4.9	1.2	1.7	0.3	0.0	1.0	0.1	1.0	0.5	0.5	0.1	0.1	0.1	0.0	4.5	0.0	0.0	0.6	1.8	0.7	0.3	2.6	1.7	0.6	16.9	4.6	0.5	0.4	0.4	0.0	0.6	25.6	0.0	0.5	0.1	1.9	5.0	2.9	15.4	2.0	49.3	0.0	0.0	5.4	0.4	0.4	0.2	2.8	3.2	0.7	0.0	0.2	8.9	1.2	0.9	1.5	3.2	0.5	6.4	2.7	2.1	0.0	1.0	0.0	0.2	2.5	1.1	0.0	0.3	0.0	3.4	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	17.7	17.9	1.6	44.3	12.4	1.5	2.0	17.6	1.0	0.1
CALCB	"CALC2, CGRP-II, FLJ30166"	ENSG00000175868	"Calcitonin related polypeptide beta"	P10092	11	14904997-15082342	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 14.3;pancreas: 7.9;thyroid gland: 26.0"	"Cell line enhanced"	"Detected in some"		"HEK 293: 6.2;Karpas-707: 11.0;SH-SY5Y: 3.8;U-266/70: 16.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.4"	"Group enriched"	"Detected in many"	8	"hypothalamus: 13.5;pons and medulla: 14.3"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	7	"pons and medulla: 10.1"					HPA059886		Supported			"Secreted to blood"					"HPA059886: "	"unprognostic (7.84e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.92e-1)"	"prognostic unfavourable (3.42e-5)"	"unprognostic (2.02e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.21e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.33e-1)"	0.5	0.2	0.0	1.6	1.6	0.3	1.5	1.5	0.8	0.3	1.5	0.0	0.0	0.9	0.4	0.3	0.3	0.2	0.3	0.9	0.0	13.5	0.4	1.1	1.3	1.0	0.7	0.2	0.2	7.9	0.3	2.7	0.4	14.3	0.4	0.5	1.8	0.7	0.2	1.2	0.3	0.8	0.4	3.9	0.9	0.3	1.4	0.3	0.6	26.0	0.0	0.3	0.3	0.0	0.2	0.3	1.1	0.2	1.8	1.2	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.3	6.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	2.0	0.4	0.0	11.0	0.0	0.0	0.0	0.6	3.0	0.1	0.5	0.0	0.2	0.0	0.0	1.2	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	16.6	0.6	0.4	2.2	0.0	0.0	0.0	0.2	1.1	0.8	0.1	1.2	0.0	0.5	0.7	0.3	0.2	1.2	1.1	0.6	1.8	0.0	0.0	0.1	0.4	0.0	1.6	1.5	0.8	0.0	13.5	0.7	0.2	14.3	0.3
FOXE1	"FKHL15, FOXE2, HFKH4, TITF2, TTF-2"	ENSG00000178919	"Forkhead box E1"	O00358	9	97853254-97856715	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"thyroid gland: 115.1"	"Cell line enhanced"	"Detected in some"		"A-431: 10.7;BJ hTERT+: 6.7;HaCaT: 6.2;HeLa: 15.9;RPTEC TERT1: 15.8;SiHa: 11.6"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 84.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"basal ganglia: 0.4"												"unprognostic (8.78e-3)"	"unprognostic (9.18e-3)"		"unprognostic (3.79e-5)"	"unprognostic (2.19e-4)"	"unprognostic (8.29e-3)"		"unprognostic (1.04e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.86e-1)"	"unprognostic (6.05e-5)"	"unprognostic (8.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.45e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	115.1	4.7	20.4	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.2	0.0	10.7	3.6	0.0	0.0	0.0	0.0	0.0	1.0	6.7	0.8	1.1	0.0	0.9	0.0	0.4	0.0	6.2	0.7	0.1	3.3	0.0	0.5	0.0	15.9	0.0	0.0	0.0	1.1	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	15.8	1.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAX8		ENSG00000125618	"Paired box 8"	Q06710	2	113215997-113278950	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 69.3;thyroid gland: 120.5"	"Group enriched"	"Detected in some"	10	"EFO-21: 26.7;RPTEC TERT1: 63.0"	"Group enriched"	"Detected in many"	12	"endometrial cancer: 60.6;ovarian cancer: 63.5;renal cancer: 33.2;thyroid cancer: 122.2"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in some"	4	"pons and medulla: 5.8"					"HPA030062, CAB055097, CAB061888, HPA064554"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB055097: AB_2236705, CAB061888: AB_10895719, HPA030062: AB_10603982, HPA064554: "	"unprognostic (2.63e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (1.75e-5)"	"unprognostic (7.24e-2)"	"unprognostic (5.16e-5)"	"unprognostic (1.56e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.02e-1)"	0.9	1.4	1.1	0.5	0.4	0.0	0.6	0.2	0.8	3.8	0.4	0.2	11.7	0.1	2.2	15.2	0.6	9.6	0.8	0.6	0.5	0.5	69.3	0.4	0.5	0.7	0.4	0.3	3.8	0.6	0.1	0.7	0.8	1.5	1.1	0.1	0.5	0.5	10.0	0.3	0.5	0.6	0.4	0.8	0.3	0.4	1.9	0.2	0.4	120.5	0.0	0.2	0.8	1.9	4.4	2.8	1.5	3.4	1.9	2.5	1.1	2.9	0.2	0.1	0.0	0.1	0.0	1.0	0.8	2.6	0.2	0.4	1.8	0.5	0.5	26.7	0.2	0.0	0.5	0.8	0.2	1.2	0.0	0.4	0.2	1.0	0.3	0.0	0.0	0.7	0.1	0.2	0.6	0.0	0.4	2.0	0.8	0.6	0.3	1.2	0.1	1.8	0.0	0.2	0.6	63.0	4.6	0.5	0.0	3.3	0.0	1.8	0.0	1.1	0.9	4.6	0.1	0.8	2.3	0.4	1.3	0.1	4.0	0.6	0.0	1.5	3.4	0.0	0.6	1.8	1.5	4.4	1.5	1.1	2.8	1.9	2.5	1.5	0.5	1.9	1.3	1.1	0.8	1.1	1.1	0.4	0.2	0.8	0.5	0.5	0.4	0.3	1.5	0.2
SYT14	"FLJ34198, sytXIV"	ENSG00000143469	"Synaptotagmin 14"	Q8NB59	1	209938174-210171389	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"brain: 17.4;pituitary gland: 31.1;testis: 9.5;thyroid gland: 15.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 13.1;SCLC-21H: 6.8;TIME: 10.9;U-138 MG: 8.3"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036963			Supported	Vesicles				Vesicles	Vesicles	"HPA036963: "	"unprognostic (1.38e-4)"	"unprognostic (8.62e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.90e-4)"	"unprognostic (1.97e-1)"	"unprognostic (4.43e-5)"		"unprognostic (1.92e-1)"	"unprognostic (1.88e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.81e-1)"	"unprognostic (4.85e-3)"	"unprognostic (2.30e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.33e-3)"	0.7	3.2	5.9	0.8	7.4	0.8	0.6	17.4	10.2	0.6	0.7	3.8	0.0	0.7	1.4	0.8	0.6	0.6	0.6	0.6	4.5	2.6	0.9	0.6	0.7	0.7	3.3	5.9	0.8	1.2	0.6	31.1	0.6	5.0	0.8	0.8	1.1	0.6	0.6	0.7	0.7	0.7	0.7	2.4	0.7	0.9	9.5	3.0	0.0	15.9	0.0	0.6	0.6	0.4	2.0	0.8	2.1	0.5	1.1	0.8	0.1	3.3	0.1	0.0	0.0	0.3	0.0	0.0	2.7	13.1	2.8	1.5	0.0	0.2	0.0	0.1	0.3	4.2	0.0	0.0	3.3	0.6	0.3	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	1.9	5.8	0.5	0.0	0.0	5.0	0.0	0.0	0.0	4.5	1.8	0.0	0.1	0.1	0.2	3.0	6.8	3.1	0.0	0.0	5.6	0.0	0.1	10.9	8.3	4.0	0.7	1.4	0.1	0.1	0.0	0.7	0.0	1.9	2.1	0.4	0.6	0.8	0.2	0.4	0.6	0.5	0.4	0.3	2.0	0.4	0.6	1.8	1.1	0.5	0.8	0.4	0.1	5.9	7.4	17.4	10.2	4.5	2.6	3.3	5.9	5.0	3.0
TRMT9B	"C8orf79, FLJ36980, hTRM9L, KIAA1456, TRM9L"	ENSG00000250305	"TRNA methyltransferase 9B (putative)"	Q9P272	8	12945642-13031503	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 64.7;thyroid gland: 26.5"	"Cell line enhanced"	"Detected in some"		"AF22: 7.0;BJ: 10.0;fHDF/TERT166: 13.4;RPTEC TERT1: 4.7;SCLC-21H: 5.1;U-266/84: 4.8"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 3.2"	"Group enriched"	"Detected in all"	7	"cerebellum: 64.7;pons and medulla: 31.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 77.4"	HPA024673	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA024673: AB_1845788"	"unprognostic (9.85e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.54e-4)"	"unprognostic (1.06e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.88e-1)"	"prognostic favourable (2.77e-7)"	"unprognostic (2.22e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.27e-3)"	"unprognostic (3.34e-2)"	2.1	0.9	2.0	1.1	4.1	1.2	3.5	64.7	6.0	2.0	1.8	6.6	0.8	1.4	1.9	2.5	1.3	2.4	2.7	6.0	6.7	2.9	2.7	1.7	1.7	1.0	2.0	2.8	0.6	1.7	2.3	1.2	7.1	31.5	1.2	2.1	5.8	2.3	1.9	4.4	5.1	1.5	0.9	1.9	1.6	1.5	1.8	1.0	0.0	26.5	1.3	0.7	1.3	0.9	1.0	0.6	2.8	0.6	1.9	0.6	0.0	0.1	0.2	7.0	0.0	0.0	0.0	1.7	10.0	2.3	1.4	0.7	0.1	0.3	0.2	0.5	13.4	0.3	0.1	0.3	1.5	0.1	0.4	0.4	0.4	0.1	0.0	0.2	0.7	0.2	3.5	0.0	0.1	0.0	0.1	0.2	0.3	0.3	0.1	0.2	0.8	0.0	1.1	0.1	0.1	4.7	0.2	5.1	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.2	0.9	1.0	0.1	0.4	4.8	0.1	0.1	0.2	1.8	2.6	0.6	0.4	0.5	0.4	0.4	0.5	0.4	0.5	0.2	1.0	0.5	0.6	2.8	1.9	0.3	0.6	0.2	0.0	2.0	4.1	64.7	5.0	6.7	2.9	2.0	2.8	31.5	1.0
TSHR	LGR3	ENSG00000165409	"Thyroid stimulating hormone receptor"	P16473	14	80954989-81146302	"Cancer-related genes, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"thyroid gland: 158.0"	"Group enriched"	"Detected in some"	17	"MOLT-4: 18.1;SCLC-21H: 18.7;U-266/70: 9.2;U-266/84: 4.7"	"Cancer enriched"	"Detected in some"	116	"thyroid cancer: 100.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"T-reg: 9.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 9.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			CAB000473	Approved				"Intracellular and membrane"					"CAB000473: AB_2303782"	"unprognostic (3.36e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.02e-2)"	"unprognostic (4.17e-6)"	"unprognostic (3.01e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.11e-3)"	"unprognostic (5.08e-7)"	"unprognostic (1.32e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.66e-1)"	0.1	0.2	0.1	0.2	0.4	0.3	0.2	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.3	0.3	0.5	0.1	0.0	0.8	0.2	0.0	0.1	0.3	0.1	0.0	0.2	0.2	0.1	0.1	0.1	27.3	158.0	0.2	0.4	0.1	0.1	1.8	0.8	1.3	0.3	0.1	9.9	0.1	0.3	0.2	0.6	0.4	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.3	0.4	0.6	0.2	0.1	0.2	0.7	0.0	0.1	0.2	0.1	0.3	0.6	0.3	0.0	0.2	0.3	0.3	0.1	0.1	0.2	0.1	0.3	0.6	0.1	0.4	18.1	0.4	0.4	0.2	0.6	0.2	0.7	0.0	0.4	18.7	0.3	0.1	0.2	0.2	0.3	0.0	0.2	0.5	0.4	0.5	0.2	9.2	4.7	0.4	0.2	0.2	0.3	0.6	0.2	0.2	0.2	0.1	0.2	1.0	0.8	0.5	0.1	1.8	0.3	0.2	1.3	0.1	0.3	0.8	9.9	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.1
BMP8A		ENSG00000183682	"Bone morphogenetic protein 8a"	Q7Z5Y6	1	39491646-39525935	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"thyroid gland: 45.6"	"Cell line enhanced"	"Detected in some"		"U-2197: 15.9;U-266/70: 7.7;U-266/84: 7.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"						"unprognostic (9.62e-3)"	"unprognostic (2.11e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.95e-9)"	"unprognostic (2.62e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.28e-3)"	"unprognostic (2.55e-2)"	0.7	1.0	1.7	1.2	2.0	0.9	0.5	0.8	3.6	3.3	1.0	8.5	0.0	1.4	3.7	1.2	0.7	2.0	2.6	1.2	1.9	1.3	0.6	0.5	0.7	5.6	4.6	1.1	8.9	3.8	0.5	0.9	1.0	4.8	1.0	0.6	0.4	1.3	1.8	1.4	1.6	2.2	1.9	8.3	1.4	1.0	4.0	2.3	1.7	45.6	0.0	0.6	0.9	0.9	0.7	0.0	0.0	0.6	0.0	0.1	0.4	0.4	0.8	0.4	0.3	0.0	0.0	0.5	0.2	0.0	0.0	0.0	1.3	0.0	0.1	0.3	0.2	0.6	0.0	0.0	0.0	0.4	1.8	0.0	1.6	0.3	3.8	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.9	0.0	1.6	0.0	2.1	1.1	0.1	0.5	0.3	2.4	0.1	0.1	1.4	0.4	0.1	0.2	1.1	0.7	2.9	0.1	0.0	0.7	15.9	0.0	7.7	7.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	2.0	0.8	3.6	1.9	1.3	4.6	1.1	4.8	2.3
CNTN6	NB-3	ENSG00000134115	"Contactin 6"	Q9UQ52	3	1092576-1404217	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 41.4;thyroid gland: 18.9"	"Group enriched"	"Detected in some"	59	"AF22: 5.4;SH-SY5Y: 6.3"	"Group enriched"	"Detected in some"	15	"renal cancer: 2.7;thyroid cancer: 3.2"	"Region enriched"	"Detected in many"	5	"cerebellum: 41.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA016645	Uncertain					2100000	2100000			"HPA016645: AB_1847149"	"unprognostic (1.09e-1)"	"unprognostic (3.70e-1)"		"unprognostic (2.27e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.05e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.26e-3)"	"unprognostic (5.45e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.46e-2)"	0.2	4.7	1.6	0.2	2.2	0.2	0.4	41.4	6.3	0.3	0.3	0.1	0.0	0.2	0.3	0.8	0.3	0.4	0.2	0.4	1.5	3.0	0.5	0.2	5.6	0.2	2.4	2.6	0.2	0.3	0.2	0.5	3.4	7.8	0.2	0.3	0.4	0.3	0.3	0.2	0.2	0.2	0.3	1.7	0.2	0.2	0.4	0.3	0.0	18.9	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.2	41.4	6.3	1.5	3.0	2.4	2.6	7.8	0.3
COL9A3	"DJ885L7.4.1, EDM3, FLJ90759, IDD, MED"	ENSG00000092758	"Collagen type IX alpha 3 chain"	Q14050	20	62816244-62841159	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 26.4;retina: 37.2;salivary gland: 38.9;thyroid gland: 18.1"	"Group enriched"	"Detected in some"	6	"BEWO: 52.5;Hep G2: 20.7;SK-MEL-30: 17.2;WM-115: 20.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA040125, HPA058323"	Supported		Approved	"Nucleoplasm,Intermediate filaments"	"Secreted to extracellular matrix"			Nucleoplasm	Nucleoplasm	"HPA040125: AB_10805604, HPA058323: AB_2683679"	"unprognostic (1.14e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.21e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.67e-1)"	2.2	2.0	11.2	2.3	16.3	1.2	1.5	1.5	8.9	1.7	3.4	26.4	1.6	2.3	1.8	1.5	1.6	1.2	1.4	2.1	14.9	9.8	1.4	1.3	1.3	1.4	18.4	8.1	1.6	5.4	1.1	5.3	1.9	12.4	1.7	1.3	37.2	38.9	3.4	1.5	1.8	2.5	1.4	25.0	1.2	1.8	6.4	15.2	0.0	18.1	1.4	1.2	1.3	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.3	52.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	2.4	20.7	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	2.3	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	17.2	0.0	1.9	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	16.3	1.5	8.0	14.9	9.8	18.4	8.1	12.4	15.2
FCGBP	FC(GAMMA)BP	ENSG00000275395	"Fc fragment of IgG binding protein"		19	39863323-39934626	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in many"	5	"cervix, uterine: 13.9;gallbladder: 46.6;intestine: 43.3;stomach 1: 17.0;thyroid gland: 20.9"	"Cell line enhanced"	"Detected in some"		"A549: 9.7;Daudi: 3.0;RH-30: 10.9;RPMI-8226: 3.8;U-266/70: 3.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA003517, HPA003564"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytokinetic bridge"				"Plasma membrane"	"Plasma membrane"	"HPA003517: AB_1078838, HPA003564: AB_2231648"	"unprognostic (1.65e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.04e-2)"	"prognostic favourable (1.28e-5)"	"prognostic unfavourable (4.74e-5)"	"unprognostic (1.36e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavourable (9.70e-6)"	"unprognostic (9.44e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.92e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (4.27e-4)"	"unprognostic (2.08e-1)"	1.7	0.6	1.7	5.9	1.8	0.0	2.7	0.2	1.6	13.9	43.3	0.8	0.7	15.2	0.2	0.4	0.2	0.0	46.6	0.7	0.6		0.6	0.2	0.6	0.2	0.9	0.6	0.6	0.2	0.0	1.2	1.5	1.1	0.4	16.7	0.3	1.3	1.2	0.2	2.8	16.9	0.2	2.1	0.2	17.0	0.4	0.9	0.5	20.9	0.2	0.5	0.2	0.2	0.6	2.3	0.0	0.9	1.3	3.2	0.6	0.0	9.7	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.3	0.1	0.3	1.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.4	2.8	1.2	0.3	0.7	0.2	10.9	3.8	0.2	1.3	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	3.6	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.9	0.3	0.0	0.7	1.4	2.3	0.6	0.9	3.2	0.0	1.3	0.5	0.0	0.2	0.6										
GOLGA8Q		ENSG00000178115	"Golgin A8 family member Q"		15	30552078-30562501	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	5	"thyroid gland: 18.7"	"Group enriched"	"Detected in some"	7	"THP-1: 9.2;U-937: 12.5"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	8	"NK-cell: 2.0"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 2.0"																				"unprognostic (2.65e-2)"				"unprognostic (6.48e-2)"			"unprognostic (2.24e-1)"			"unprognostic (5.52e-4)"	"unprognostic (9.86e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.31e-1)"		1.3	0.4	0.0	0.2	0.1	2.9	0.9	0.0	0.1	1.4	0.7			0.1	1.7	3.0	0.3	1.3	0.2	1.1	0.1	0.0	0.5	0.5	1.1	0.1	0.2		2.7	2.1	2.7	2.3	0.1		0.8	0.5		0.8	0.4	0.4	0.6	0.6	1.0	0.5	0.3	0.7	4.1			18.7		0.2	1.2	0.9	0.0	0.0	0.0	0.0	2.0	0.2	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.5	0.6	0.0	1.5	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	1.1	0.0	0.0	0.4	9.2	0.1	1.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	12.5	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1										
GPR83	GPR72	ENSG00000123901	"G protein-coupled receptor 83"	Q9NYM4	11	94377311-94401419	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"brain: 20.0;thyroid gland: 9.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 61.1"	"Low region specificity"	"Detected in all"														"unprognostic (6.74e-2)"	"unprognostic (7.78e-3)"	"unprognostic (8.58e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.88e-1)"	"unprognostic (6.36e-3)"	"unprognostic (6.89e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.86e-3)"	"unprognostic (6.17e-2)"	"unprognostic (1.47e-12)"	"unprognostic (3.16e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.33e-2)"	"unprognostic (8.28e-3)"	0.6	2.6	3.3	0.8	6.1	2.0	0.6	20.0	11.7	0.8	0.7	0.9	0.0	0.7	0.8	1.2	0.5	0.8	0.8	1.2	19.8	6.7	1.2	1.2	0.7	1.1	1.0	3.7	0.7	0.7	0.5	0.6	0.5	1.7	0.5	0.6	0.3	0.6	0.6	1.3	1.4	0.8	0.6	1.8	1.1	0.8	1.1	1.0	0.0	9.3	0.0	0.7	0.5	0.3	0.7	0.5	2.6	0.6	1.6	0.6	0.2	0.3	0.4	0.8	1.1	0.0	0.2	0.9	0.7	0.1	0.1	0.2	5.6	1.0	1.1	0.5	0.1	1.2	0.3	0.2	0.1	0.8	0.5	1.2	1.2	0.7	0.0	1.6	2.9	0.1	0.5	0.4	0.2	0.0	1.1	1.3	0.1	0.8	0.4	2.4	1.1	0.7	1.0	0.2	0.8	0.1	0.9	0.7	0.7	0.5	0.8	0.2	0.9	0.1	0.4	0.8	1.3	0.8	0.8	1.2	1.5	0.5	0.5	1.0	1.1	2.6	0.6	0.5	0.5	0.3	0.4	0.4	0.5	0.6	0.2	0.7	0.4	0.4	1.4	1.6	0.6	0.5	0.3	0.2	3.3	6.1	20.0	11.7	19.8	6.7	1.0	3.7	1.7	1.0
ID4	bHLHb27	ENSG00000172201	"Inhibitor of DNA binding 4, HLH protein"	P47928	6	19837386-19840684	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"thyroid gland: 154.6"	"Cell line enhanced"	"Detected in some"		"AF22: 16.9;AN3-CA: 22.2;EFO-21: 50.7;HEK 293: 28.4;SCLC-21H: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060800			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA060800: AB_2684368"	"unprognostic (3.25e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.80e-1)"	"unprognostic (6.34e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.65e-2)"	"prognostic favourable (2.49e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.57e-3)"	33.1	2.1	29.3	5.3	29.6	1.1	16.9	13.2	31.1	21.1	5.1	29.0	7.2	4.9	22.9	7.0	12.1	34.1	6.8	25.2	32.3	20.6	11.7	2.4	14.6	3.5	14.5	19.0	22.9	11.8	2.0	13.1	13.2	24.9	18.7	4.6	5.7	16.0	26.6	1.8	31.3	4.0	14.2	12.5	11.4	11.9	10.8	20.0	0.0	154.6	4.4	3.5	10.5	11.5	1.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.3	16.9	22.2	0.5	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.0	0.0	50.7	5.7	8.6	0.0	0.0	0.2	0.0	28.4	0.0	0.0	0.2	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.4	0.0	0.0	0.0	0.0	3.0	6.0	45.8	0.6	0.0	0.7	2.9	1.4	0.0	0.0	0.1	2.6	0.0	0.7	0.0	0.0	0.5	0.7	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	29.3	29.6	13.2	19.2	32.3	20.6	14.5	19.0	24.9	20.0
KCNQ5	Kv7.5	ENSG00000185760	"Potassium voltage-gated channel subfamily Q member 5"	Q9NR82	6	72621792-73198851	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 6.6;brain: 23.0;skeletal muscle: 26.1;thyroid gland: 6.9"	"Cell line enhanced"	"Detected in many"		"BJ: 20.1;HL-60: 17.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA016655	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA016655: AB_1855557"	"unprognostic (4.91e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.09e-2)"	"unprognostic (8.55e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.39e-3)"	0.7	2.8	4.2	3.0	14.9	6.6	1.1	0.6	19.6	0.6	0.9	0.0	0.0	0.8	0.7	0.6	1.7	1.0	0.9	0.6	6.9	2.7	0.6	0.8	0.8	3.4	3.0	7.5	0.7	0.6	0.6	0.5	1.0	23.0	2.4	0.9	2.2	2.1	1.9	26.1	0.6	0.9	1.7	0.9	2.0	0.8	2.0	0.7	1.6	6.9	0.4	3.1	1.2	0.7	2.7	0.5	1.2	0.0	2.2	1.7	0.2	2.5	0.6	0.0	0.1	0.0	0.9	0.0	20.1	3.0	3.0	2.6	0.0	0.0	12.0	0.0	6.8	0.4	0.1	1.2	3.6	0.1	4.2	13.1	0.0	0.0	0.5	17.6	0.0	0.2	0.5	8.6	9.0	0.0	0.7	8.3	5.9	0.1	0.0	7.5	0.7	4.2	0.0	0.6	8.2	1.1	0.0	3.4	1.6	0.0	0.0	8.2	2.5	1.3	0.0	12.5	5.5	0.0	13.3	8.7	0.2	5.5	0.1	8.5	0.7	1.2	0.0	0.0	0.2	0.0	1.1	2.7	0.5	1.5	0.5	1.4	1.7	1.2	0.0	2.2	0.0	0.0	0.0	0.2	4.2	14.9	0.6	19.6	6.9	2.7	3.0	7.5	23.0	0.7
MLNR	GPR38	ENSG00000102539	"Motilin receptor"	O43193	13	49220338-49222377	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"bone marrow: 3.9;stomach 1: 2.8;thyroid gland: 5.6"	"Cell line enhanced"	"Detected in some"		"A549: 1.5;NTERA-2: 3.0;THP-1: 9.0"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 2.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"														"unprognostic (9.75e-2)"	"unprognostic (2.13e-2)"		"unprognostic (2.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.03e-2)"		"unprognostic (7.80e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.61e-4)"	"unprognostic (3.53e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.38e-1)"		0.1	0.1	0.2	0.0	0.2	3.9	0.0	0.0	0.1	0.3	0.2			0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.5	0.1	0.0	0.0	0.0		0.1	0.1	0.0	0.4	0.0		0.1	0.0		0.0	0.3	0.0	0.0	0.4	0.0	0.1	0.1	2.8	0.4			5.6		0.0	0.0	0.1	0.0	0.0	0.7	0.6	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.4	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.8	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0										
MT1G	"MT1, MT1K"	ENSG00000125144	"Metallothionein 1G"	P13640	16	56666731-56668065	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"intestine: 101.1;kidney: 210.7;liver: 396.4;pancreas: 217.1;thyroid gland: 278.4"	"Cell line enriched"	"Detected in some"	4	"U-937: 152.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																"Intracellular and membrane"						"unprognostic (1.62e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.21e-1)"	"prognostic unfavourable (1.67e-7)"	"unprognostic (1.42e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.26e-2)"	10.1	1.0	11.7	10.4	50.7	0.7	2.8	1.1	27.4	1.0	78.1	3.1	1.9	49.6	1.5	15.9	21.7	4.6	23.2	0.9	25.1	7.6	210.7	396.4	2.4	7.0	23.6	11.3	0.6	217.1	0.4	1.0	0.6	46.9	21.6	48.9	22.4	2.4	1.0	0.6	2.9	101.1	7.9	7.7	0.5	47.4	0.6	3.6	0.0	278.4	1.9	1.8	2.4	1.2	0.1	1.1	0.7	1.1	0.3	2.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.2	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.6	0.0	0.4	0.6	0.1	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.1	0.1	0.0	0.5	34.8	0.0	0.0	0.0	0.1	9.9	5.8	0.0	3.1	0.4	0.0	0.1	0.1	0.0	15.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.3	152.3	0.0	0.7	1.1	0.3	1.5	1.1	1.4	0.1	1.7	2.6	1.1	0.0	1.6	2.9	0.1	0.3	0.5	0.3	2.8	1.5	11.7	50.7	1.1	27.4	25.1	7.6	23.6	11.3	46.9	3.6
OR2W3	"OR2W3P, OR2W8P, OST718"	ENSG00000238243	"Olfactory receptor family 2 subfamily W member 3"	Q7Z3T1	1	247895587-247896531	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"bone marrow: 13.8;thyroid gland: 8.2"	"Cell line enhanced"	"Detected in some"		"HEL: 12.8;PC-3: 12.9;U-2 OS: 8.4;U-937: 6.0;WM-115: 9.2"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.5"					"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in many"											HPA045594	Uncertain									"HPA045594: AB_10960280"	"unprognostic (9.44e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.57e-5)"	"unprognostic (1.98e-1)"	"unprognostic (5.11e-2)"		"unprognostic (2.79e-6)"	"unprognostic (2.71e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.71e-3)"	"unprognostic (9.05e-3)"	"unprognostic (9.34e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.48e-1)"	0.2	0.7	0.6	0.3	1.6	13.8	0.2	0.0	2.2	0.4	0.7			0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.4	1.7	0.0	0.1	0.5	0.0	1.1		0.0	0.2	0.0	0.3	1.6		0.5	0.6		0.0	0.0	0.0	0.3	0.2	0.4	0.4	0.8	0.1	1.1			8.2		0.0	0.3	0.2	0.6	1.4	1.0	0.6	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	3.8	0.0	0.0	0.0	0.3	12.8	0.0	0.0	0.0	1.6	0.4	0.4	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.1	0.5	12.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	8.4	0.0	0.0	1.4	0.0	0.0	0.0	6.0	9.2	0.0	0.2	1.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	0.6	0.2	0.0	0.8	0.0	0.5	0.0	0.0	1.5										
SLC5A8	AIT	ENSG00000256870	"Solute carrier family 5 member 8"	Q8N695	12	101155493-101210407	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix, uterine: 14.3;kidney: 13.8;thyroid gland: 21.2"	"Cell line enriched"	"Detected in single"	10	"SK-BR-3: 8.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"prognostic favourable (9.04e-6)"	"unprognostic (1.84e-1)"		"unprognostic (1.17e-2)"		"unprognostic (1.27e-3)"		"unprognostic (1.24e-1)"			"unprognostic (5.20e-1)"	"unprognostic (1.16e-2)"	"prognostic favourable (1.97e-4)"	"unprognostic (6.16e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.87e-2)"		0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	14.3	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	13.8	0.0	1.9	0.0	0.0	0.3	1.0	0.0	0.0	0.1	0.0	0.6	0.9	0.0	1.4	3.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	21.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.6	0.0
TFCP2L1	"CRTR1, LBP-9"	ENSG00000115112	"Transcription factor CP2 like 1"	Q9NZI6	2	121216587-121285207	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 52.2;salivary gland: 93.5;thyroid gland: 37.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.1;HEL: 9.2;hTCEpi: 10.6;RPTEC TERT1: 26.2;RT4: 18.9;SCLC-21H: 8.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"pons and medulla: 7.0"	"Cell type enriched"	"Detected in single"	7	"gdTCR: 2.9"	"Lineage enriched"	"Detected in single"	7	"T-cells: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA029708	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA029708: AB_10602479"	"unprognostic (8.85e-3)"	"unprognostic (4.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.76e-2)"	"prognostic favourable (7.72e-6)"	"unprognostic (1.05e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.01e-1)"	1.0	0.2	0.6	4.0	1.1	0.0	12.9	0.6	0.9	8.7	8.5	1.2	6.3	0.2	0.8	8.2	6.0	1.5	8.7	0.1	0.6	0.1	52.2	0.1	12.3	1.5	0.4	0.0	0.6	2.8	0.4	1.5	4.7	7.0	6.1	10.5	0.8	93.5	2.9	2.4	13.1	1.3	0.4	0.4	0.9	6.2	0.8	0.3	0.4	37.3	7.2	6.3	1.4	4.1	0.0	0.1	0.1	0.1	0.4	2.9	0.0	0.0	1.0	0.0	0.1	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.4	0.0	0.2	2.7	2.6	0.0	0.0	1.9	9.2	0.0	0.0	0.0	0.0	0.3	0.0	10.6	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	1.2	26.2	18.9	8.1	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.1	2.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	1.1	0.6	0.9	0.6	0.1	0.4	0.0	7.0	0.3
TRHR		ENSG00000174417	"Thyrotropin releasing hormone receptor"	P34981	8	109086621-109119584	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 1.0;pituitary gland: 3.3;thyroid gland: 1.6"	"Cell line enhanced"	"Detected in some"		"PC-3: 1.6;SH-SY5Y: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA055162	Approved									"HPA055162: AB_2732592"										"unprognostic (1.92e-2)"				"unprognostic (8.58e-2)"		"unprognostic (1.17e-1)"		0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	1.0	0.0	0.2			0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	3.3	0.0		0.0	0.3		0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0			1.6		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.2	0.3	0.5	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CALCA	CALC1	ENSG00000110680	"Calcitonin related polypeptide alpha"	"P01258, P06881"	11	14966668-14972354	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"parathyroid gland: 122.2;thyroid gland: 55.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.8;hTERT-HME1: 1.7;Karpas-707: 1.8;SCLC-21H: 3.4"	"Cancer enriched"	"Detected in many"	7	"lung cancer: 64.7"	"Region enriched"	"Detected in single"	48	"pons and medulla: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"pons and medulla: 60.6"					HPA059886		Supported			"Secreted to blood"					"HPA059886: "			"unprognostic (1.97e-1)"	"prognostic unfavourable (4.49e-5)"	"unprognostic (5.99e-2)"		"unprognostic (2.42e-1)"	"unprognostic (1.17e-1)"		"unprognostic (6.45e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.02e-2)"	0.2	0.0	0.1	0.3	0.4	0.0	0.8	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	6.2	16.8	0.6	0.0	0.1	0.0	0.0	0.1	122.2	0.2	0.0	19.8	1.2	0.0	0.3	0.4	0.0	0.3	0.0	0.0	0.3	1.5	4.6	0.0	0.0	0.0	0.6	55.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.4	0.1	0.2	0.0	0.2	0.1	0.0	19.8	0.0
IGFBPL1	bA113O24.1	ENSG00000137142	"Insulin like growth factor binding protein like 1"	Q8WX77	9	38408994-38424447	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 11.0;pituitary gland: 7.4;thyroid gland: 27.2"	"Group enriched"	"Detected in some"	6	"AF22: 68.0;NTERA-2: 18.7;RH-30: 19.5;SCLC-21H: 70.0;SH-SY5Y: 67.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basal ganglia: 12.5;olfactory region: 16.2"	"Low region specificity"	"Detected in many"			HPA051354	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted to blood"			"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA051354: "	"unprognostic (5.63e-2)"	"unprognostic (3.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-2)"	"unprognostic (6.67e-2)"	1.6	2.6	3.8	1.1	11.0	0.3	0.4	4.7	4.7	0.7	1.0	1.0	0.0	1.9	2.1	0.5	0.7	1.0	1.9	3.7	3.3	2.3	0.7	0.6	1.2	0.4	1.4	1.5	0.5	1.6	0.4	7.4	1.1	1.8	1.6	0.7	0.2	0.5	2.9	0.3	0.3	1.2	2.1	0.6	0.4	2.5	3.3	1.5	2.6	27.2	0.0	0.4	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	68.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	8.1	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	18.7	0.1	0.0	19.5	0.1	0.0	0.0	70.0	67.9	1.1	0.0	0.0	0.3	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	11.0	4.7	4.7	3.3	2.3	1.4	1.5	1.8	1.5
KNSTRN	"C15orf23, FLJ14502, kinastrin, SKAP, TRAF4AF1"	ENSG00000128944	"Kinetochore localized astrin/SPAG5 binding protein"	Q9Y448	15	40382721-40394246	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 26.2;lymphoid tissue: 18.4;testis: 40.1;thyroid gland: 59.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA042027	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"				"Mitotic spindle, Centriolar satellite"	"Mitotic spindle, Centriolar satellite"	"HPA042027: AB_10797378"	"unprognostic (2.35e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.23e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.47e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (3.43e-5)"	"unprognostic (6.31e-2)"	"prognostic unfavourable (7.88e-9)"	"unprognostic (1.70e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.52e-2)"	5.5	4.4	6.7	5.5	6.3	7.3	9.0	8.1	7.0	3.3	4.5	4.0	8.0	5.3	3.9	7.8	6.2	3.4	2.5	4.1	6.0	5.3	4.2	7.0	4.1	8.0	4.6	7.1	3.4	3.5	6.0	4.2	7.4	6.8	4.4	6.3	2.5	6.4	5.0	7.5	4.2	4.1	5.9	4.3	4.8	6.2	40.1	4.5	18.4	59.8	6.0	9.1	3.8	3.7	5.9	11.0	10.0	26.2	5.5	5.5	4.0	31.1	14.7	29.3	19.2	6.5	10.1	15.3	21.7	16.9	44.8	39.6	31.4	13.8	12.1	11.1	14.5	36.1	31.2	20.1	40.6	21.4	15.2	35.8	33.0	19.8	6.1	19.2	18.7	5.2	11.6	22.6	22.6	25.1	25.8	21.0	37.6	15.8	16.6	15.5	18.4	22.3	17.1	22.1	14.0	15.6	13.0	28.6	19.9	18.1	19.9	4.8	20.9	13.8	12.8	21.6	22.2	22.0	29.9	18.0	29.1	21.7	13.4	25.7	17.6	4.8	10.3	10.0	4.8	14.5	4.4	5.9	3.6	4.4	11.0	5.4	3.5	3.6	5.9	5.5	26.2	7.5	5.5	4.0	6.7	6.3	8.1	7.0	6.0	5.3	4.6	7.1	6.8	4.5
LGI3		ENSG00000168481	"Leucine rich repeat LGI family member 3"	Q8N145	8	22146825-22157084	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 52.2;lung: 17.7;skin 1: 16.3;thyroid gland: 14.9"	"Cell line enhanced"	"Detected in some"		"A549: 3.2;SCLC-21H: 4.5;SK-MEL-30: 4.5;U-2 OS: 2.5;WM-115: 2.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 14.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024826			Approved	Cytosol	"Secreted in brain"			Cytosol	Cytosol	"HPA024826: "	"unprognostic (4.41e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.45e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.59e-5)"	"unprognostic (1.36e-2)"	"unprognostic (9.41e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.14e-2)"	1.2	4.8	13.1	1.1	26.4	1.1	1.2	7.7	52.2	2.6	1.2	35.5	0.0	1.4	1.5	1.3	6.1	2.0	1.1	1.5	20.7	15.7	1.1	1.0	17.7	1.0	24.2	10.4	1.1	1.5	0.9	0.7	1.0	24.9	2.3	1.1	4.6	1.2	4.2	1.0	16.3	1.4	1.7	29.8	1.1	1.3	1.4	14.8	0.0	14.9	0.0	1.3	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.2	0.0	1.0	0.8	0.3	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.3	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	4.5	0.6	0.0	0.0	4.5	0.5	0.0	0.0	0.0	2.5	0.4	0.0	0.0	0.0	0.0	1.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	26.4	7.7	32.1	20.7	15.7	24.2	10.4	24.9	14.8
MGAT4C	HGNT-IV-H	ENSG00000182050	"MGAT4 family member C"	Q9UBM8	12	85955666-86838904	"Enzymes, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"brain: 12.8;epididymis: 10.9;pituitary gland: 25.9;testis: 7.8;thyroid gland: 18.0"	"Group enriched"	"Detected in some"	13	"NTERA-2: 10.9;SCLC-21H: 4.8"	"Cancer enriched"	"Detected in single"	19	"thyroid cancer: 2.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA016418	Approved									"HPA016418: AB_2732416"	"unprognostic (5.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.32e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.64e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.88e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.32e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.85e-10)"	"unprognostic (3.15e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.74e-3)"	1.0	3.0	5.5	1.0	12.3	1.1	0.9	4.9	12.8	1.3	1.2	2.5	0.4	0.9	1.0	10.9	1.1	1.1	1.2	3.6	9.4	3.9	1.0	0.9	1.0	0.9	3.0	9.3	0.9	0.9	0.9	25.9	0.8	10.6	1.1	1.2	0.0	0.9	2.4	0.8	1.0	1.0	1.0	4.3	0.9	1.0	7.8	5.1	0.0	18.0	0.0	0.8	0.9	0.6	0.5	0.3	0.8	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.1	0.1	0.2	0.0	0.2	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.0	10.9	0.1	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.1	0.8	0.2	0.1	0.3	0.2	0.0	5.5	12.3	4.9	12.8	9.4	3.9	3.0	9.3	10.6	5.1
PDE8B		ENSG00000113231	"Phosphodiesterase 8B"	O95263	5	77210449-77429807	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"thyroid gland: 67.7"	"Group enriched"	"Detected in some"	4	"BJ hTERT+: 12.1;HeLa: 27.8;SK-BR-3: 7.4"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 35.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA036911, HPA036912"	Supported		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA036911: AB_2675378, HPA036912: AB_10670377"	"unprognostic (1.30e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.35e-2)"	"unprognostic (7.61e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.19e-2)"	6.8	2.5	9.9	0.7	14.2	0.4	3.8	1.1	16.3	6.3	1.2	2.3	0.3	1.2	11.3	3.2	1.1	10.1	2.1	7.9	8.2	9.2	3.1	1.2	2.2	0.7	5.4	8.3	1.9	4.2	0.3	3.8	13.1	8.6	10.5	0.8	2.0	5.3	7.1	0.4	0.7	1.3	10.3	2.3	0.4	1.5	1.5	5.7	0.3	67.7	0.3	0.7	0.8	1.4	0.2	0.8	1.4	2.3	0.4	0.4	0.1	0.3	3.3	1.3	0.3	1.2	0.0	0.5	1.1	12.1	0.2	0.1	1.3	0.2	0.5	0.2	0.1	0.9	0.1	0.0	0.2	0.2	1.0	0.7	27.8	0.3	0.0	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.6	0.7	0.8	0.1	0.8	1.4	0.7	0.0	0.3	3.7	1.0	1.6	7.4	0.8	1.6	1.1	0.6	0.4	0.2	0.2	0.6	0.9	0.5	0.6	1.6	0.7	0.4	0.0	0.3	1.4	0.3	2.2	0.1	0.2	0.2	0.3	0.8	0.2	0.4	0.0	0.3	0.4	2.3	0.5	0.1	0.1	9.9	14.2	1.1	16.3	8.2	9.2	5.4	8.3	8.6	5.7
PKHD1L1		ENSG00000205038	"PKHD1 like 1"	Q86WI1	8	109362477-109530330	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"thyroid gland: 91.7"	"Cell line enhanced"	"Detected in some"		"HHSteC: 4.1;HUVEC TERT2: 2.3;TIME: 4.6;U-266/70: 4.3"	"Group enriched"	"Detected in some"	18	"endometrial cancer: 5.2;ovarian cancer: 1.9;thyroid cancer: 3.8"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.1"	"Group enriched"	"Detected in some"	9	"memory B-cell: 1.8;naive B-cell: 1.5"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA044458	Uncertain					5100000	5100000			"HPA044458: AB_2678949"	"unprognostic (9.07e-3)"	"unprognostic (3.35e-2)"	"unprognostic (1.37e-2)"	"prognostic favourable (7.61e-4)"	"unprognostic (5.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.76e-6)"	"unprognostic (4.56e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.73e-2)"	12.4	1.5	0.1	4.2	0.1	0.4	2.6	0.0	0.2	13.8	5.7	0.1	2.1	1.1	3.5	8.9	2.5	11.5	3.5	5.2	0.1	0.1	0.8	0.8	16.9	22.5	0.4	0.0	3.5	0.7	0.2	0.4	0.2	1.1	1.4	1.6	4.2	1.7	1.5	2.0	0.9	2.0	3.2	0.2	0.3	0.8	1.6	0.0	0.0	91.7	2.9	1.1	2.1	3.2	1.8	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	4.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.0	1.1	0.0
SH2D6	FLJ35993	ENSG00000152292	"SH2 domain containing 6"	Q7Z4S9	2	85418721-85437029	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 4.2;pancreas: 1.7;testis: 6.4;thyroid gland: 2.4"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 6.5;RH-30: 2.4;SCLC-21H: 1.5"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA053873	Uncertain									"HPA053873: AB_2682286"	"unprognostic (4.70e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.67e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.06e-7)"	"unprognostic (2.54e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.65e-3)"	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.3	0.4	0.0	1.9			4.2	0.0	0.2	0.0	0.0	0.2	0.0	0.4	0.2	0.3	0.2	0.0	0.0	0.6		0.0	1.7	0.0	0.1	0.0		0.0	0.4		0.0	0.0	0.0	0.0	2.8	0.0	0.4	0.0	0.8	6.4			2.4		0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.6	0.3	0.0	0.1	0.6	0.1	0.3	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.3	0.0	0.0	0.2	0.1	0.2	0.4	0.0	0.0	0.2	6.5	0.0	0.0	0.0	0.1	0.4	0.1	2.4	0.0	0.7	0.0	1.5	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	1.2	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.3	0.1	0.0	0.5	0.6	0.0	0.0	0.3	0.0										
TIAM2	STEF	ENSG00000146426	"T cell lymphoma invasion and metastasis 2"	Q8IVF5	6	154832697-155257723	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 11.3;brain: 21.1;intestine: 27.4;testis: 15.6;thyroid gland: 7.8"	"Cell line enhanced"	"Detected in many"		"AF22: 34.4;HDLM-2: 14.7;RH-30: 22.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 11.3"	"Group enriched"	"Detected in many"	4	"B-cells: 3.3;granulocytes: 8.3;monocytes: 11.3"	"Group enriched"	"Detected in many"	5	"amygdala: 20.4;basal ganglia: 31.5;cerebral cortex: 23.6;hippocampal formation: 19.4;olfactory region: 70.6"	"Low region specificity"	"Detected in many"			"HPA011134, HPA013903"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoplasm, Nucleoli fibrillar center"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA011134: , HPA013903: AB_1858004"	"unprognostic (9.14e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.05e-1)"	0.6	2.1	5.3	1.7	9.4	0.7	1.5	7.9	21.1	1.5	11.6	0.7	0.1	11.0	1.2	0.8	1.0	1.2	4.0	3.5	4.7	2.0	0.7	0.7	0.9	2.0	1.7	9.5	0.9	1.8	0.2	1.8	0.8	0.6	3.0	1.1	1.3	2.4	3.6	3.0	1.0	27.4	1.4	0.9	1.2	4.0	15.6	1.9	0.0	7.8	0.0	2.5	2.3	1.2	3.3	0.9	8.3	11.3	0.8	1.8	0.4	4.3	0.8	34.4	4.0	1.5	4.2	0.4	1.8	1.1	1.7	2.9	0.5	2.5	1.0	1.8	3.1	0.6	1.2	0.0	1.2	14.7	1.9	0.2	0.6	2.0	0.9	0.3	1.0	2.8	0.1	0.6	0.1	2.4	0.5	0.1	3.8	0.4	0.4	0.9	2.5	0.9	4.4	22.4	0.4	0.1	0.2	0.9	7.9	0.1	0.4	0.2	0.3	0.5	0.8	0.3	8.7	0.3	0.9	0.2	1.7	0.2	0.1	0.5	2.2	0.4	0.2	3.1	0.2	3.2	0.3	3.3	0.5	0.3	0.9	1.0	0.6	0.4	8.3	0.8	11.3	0.3	1.8	0.4	5.3	9.4	7.9	21.1	4.7	2.0	1.7	9.5	0.6	1.9
ZBED2	MGC10796	ENSG00000177494	"Zinc finger BED-type containing 2"	Q9BTP6	3	111592900-111595443	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 21.0;thyroid gland: 74.5"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 19.7;EFO-21: 13.7;HaCaT: 19.0;HBEC3-KT: 42.6;RPTEC TERT1: 28.4"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 64.0"	"Region enriched"	"Detected in single"	6	"basal ganglia: 1.4"	"Cell type enhanced"	"Detected in many"		"naive B-cell: 4.0"	"Group enriched"	"Detected in many"	6	"B-cells: 4.0;T-cells: 2.5"					"Not detected"	"Not detected"			HPA029786			Approved	"Nuclear bodies,Mitochondria,Cytosol"				"Mitochondria, Cytosol"	"Mitochondria, Cytosol"	"HPA029786: AB_10601028"	"unprognostic (7.31e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.66e-1)"		"unprognostic (2.39e-3)"	"unprognostic (3.49e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavourable (8.83e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.47e-6)"	"unprognostic (3.81e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.29e-2)"	0.1	0.0	0.1	0.9	1.4	0.0	0.1	0.1	0.1	3.7	0.1	0.1	0.1	0.0	0.2	0.2	8.1	11.1	0.2	0.1	0.1	0.0	0.3	0.1	5.6	3.4	0.1	0.1	1.2	0.1	0.0	0.4	4.0	0.1	0.1	0.0	0.1	1.7	0.1	0.1	1.3	0.3	0.1	0.1	0.1	0.1	0.2	0.2	21.0	74.5	7.5	7.4	0.2	6.2	4.0	0.0	0.1	0.0	0.5	2.5	0.3	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.1	13.7	0.0	19.0	0.0	42.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.0	3.6	0.6	0.3	0.0	4.0	1.9	2.5	0.1	0.5	0.0	0.0	1.1	0.3	0.1	1.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2
AC012309.1		ENSG00000267360			19	37093019-37210512	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 2.6;thyroid gland: 2.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.3;LHCN-M2: 1.9;MOLT-4: 1.7;SCLC-21H: 2.6"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"T-reg: 1.9"	"Low lineage specificity"	"Detected in single"																						"unprognostic (2.21e-2)"	"unprognostic (1.81e-1)"		"unprognostic (7.33e-2)"	"unprognostic (1.96e-1)"			"unprognostic (2.68e-1)"		"unprognostic (2.08e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.09e-4)"	"unprognostic (5.94e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.36e-1)"	1.1	0.0	0.6	0.0	1.0	0.2	0.2	0.6	2.6	0.9	0.6			0.0	0.5	0.0	0.0	0.4	1.5	1.1	0.6	0.3	0.1	0.0	0.1	1.7	0.7		0.1	0.0	0.0	0.1	0.2		0.1	0.0		0.0	0.0	0.5	1.2	0.1	0.0	0.4	0.4	0.3	1.3			2.7		0.0	0.2	0.3	0.8	0.2	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.9	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0										
AC022414.1		ENSG00000284762	"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B isoform 11 "		5	77086732-77427124	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"thyroid gland: 27.1"	"Cell line enhanced"	"Detected in some"		"A549: 4.1;HeLa: 12.4;SCLC-21H: 4.4;SK-BR-3: 5.2"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA036912	Supported									"HPA036912: AB_10670377"																		2.9	1.1	3.8	0.8	5.3	0.0	1.5	2.1	5.6	2.6	0.2	7.2	0.9	0.1	4.0	3.9	0.2	4.8	1.0	2.9	3.8		2.0	0.4	0.7	0.0	8.9	1.6	1.6	1.7	0.3	2.0	3.2	4.5	3.6	0.4	1.5	0.9	3.2	0.0	0.0	0.0	3.7	4.3	0.0	0.6	0.6	6.6	0.6	27.1	0.0	0.3	0.1	1.2	0.0	0.8	0.0	0.4	0.6	0.6	0.0	0.2	4.1	0.5	1.4	3.1	0.0	0.0	0.0	1.6	0.4	0.6	0.3	0.3	0.0	1.0	0.0	0.0	0.6	0.0	0.2	0.0	0.7	0.2	12.4	0.1	0.2	0.1	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.7	0.0	1.1	0.6	0.1	0.8	0.2	1.0	0.3	0.0	0.3	0.0	4.4	0.8	2.8	5.2	0.8	1.9	0.1	0.0	0.1	0.5	0.0	0.2	0.3	0.5	0.8	0.2	0.1	0.3	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.1	0.4	0.0	0.6	0.1	0.5	0.0	0.0										
ACADL	"ACAD4, LCAD"	ENSG00000115361	"Acyl-CoA dehydrogenase long chain"	P28330	2	210187939-210225491	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 29.5;thyroid gland: 29.7"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.1;HEK 293: 2.4;HeLa: 7.3;RPTEC TERT1: 6.6;RT4: 2.5;U-2 OS: 3.7"	"Group enriched"	"Detected in many"	8	"liver cancer: 2.2;prostate cancer: 6.8;renal cancer: 8.8;thyroid cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011990	Enhanced	Supported								"HPA011990: AB_1844465"	"unprognostic (6.29e-3)"	"unprognostic (7.61e-2)"		"unprognostic (1.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.66e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.99e-1)"	"prognostic favourable (1.58e-11)"	"unprognostic (4.22e-3)"	"unprognostic (1.18e-4)"	"unprognostic (8.81e-3)"	"unprognostic (1.06e-1)"	9.6	1.1	2.0	1.0	1.8	0.0	10.7	1.4	1.8	3.2	0.8	1.5	4.5	0.1	0.7	6.8	1.3	2.3	2.1	2.2	2.4	1.0	17.3	23.0	29.5	0.0	1.6	2.3	12.2	19.3	11.6	5.8	1.2	3.4	14.5	0.2	3.2	9.9	4.8	7.0	2.2	0.3	1.5	3.1	0.0	3.3	4.2	0.9	0.7	29.7	3.7	0.0	0.7	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.3	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.4	0.0	0.0	2.4	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.6	0.0	0.0	0.0	6.6	2.5	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.8	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.8	1.4	1.8	2.4	1.0	1.6	2.3	3.4	0.9
AFAP1L2	"Em:AC005383.4, FLJ14564, KIAA1914, XB130"	ENSG00000169129	"Actin filament associated protein 1 like 2"	Q8N4X5	10	114294824-114404756	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 47.9"	"Cell line enhanced"	"Detected in some"		"A-431: 25.8;CAPAN-2: 27.9;EFO-21: 20.8;HaCaT: 35.5;RPMI-8226: 18.2;RPTEC TERT1: 21.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 39.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 4.0;T-cells: 4.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"cerebellum: 169.5;olfactory region: 48.1"	HPA037843	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA037843: AB_10669990"	"unprognostic (2.31e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.06e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.80e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (3.76e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (1.55e-5)"	"unprognostic (1.11e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.86e-1)"	4.5	1.7	9.0	5.9	6.3	0.3	7.1	24.7	8.8	12.9	7.1	5.3	30.5	2.4	22.3	9.7	5.9	13.8	3.6	2.9	7.8	7.1	9.1	1.2	3.2	2.4	8.0	6.7	9.3	8.2	35.1	1.8	10.6	5.5	7.9	3.2	8.1	4.2	28.4	1.8	5.7	4.0	11.1	5.7	39.9	4.1	1.5	6.5	3.4	47.9	7.5	4.3	3.7	14.0	4.0	0.3	0.4	0.0	0.8	4.0	1.4	25.8	3.8	3.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	27.9	0.0	20.8	0.2	35.5	0.0	9.7	0.0	0.5	0.0	0.0	0.2	0.0	1.1	0.0	1.0	0.0	10.5	2.9	2.6	0.1	0.0	0.0	0.0	1.0	0.6	0.0	0.2	0.2	0.3	0.3	18.2	21.9	0.2	0.1	0.1	0.8	0.6	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	2.6	3.8	2.7	2.8	0.0	4.0	0.9	2.2	0.4	0.8	0.0	0.3	4.0	1.4	9.0	6.3	24.7	8.5	7.8	7.1	8.0	6.7	5.5	6.5
AL035425.2		ENSG00000260548			X	108722070-108732687	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"ovary: 13.0;pituitary gland: 7.4;thyroid gland: 8.9"	"Cell line enhanced"	"Detected in some"		"HEK 293: 18.6;NTERA-2: 2.6;RT4: 4.8;WM-115: 4.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.6	2.9	0.0			0.0	3.9	0.9	0.0	0.5	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.5		13.0	0.9	0.0	7.4	0.0		0.1	0.0		0.0	0.7	0.0	1.1	0.0	1.5	0.1	0.0	0.4	0.0			8.9		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AMELY	AMGL	ENSG00000099721	"Amelogenin, Y-linked"	Q99218	Y	6865918-6874027	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 1.2;prostate: 1.2;thyroid gland: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"																	"unprognostic (1.62e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0			0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0		0.0	0.9	0.0	0.0	0.2		1.2	0.0		0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8			2.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ANKRD20A8P	ANKRD20B	ENSG00000229089	"Ankyrin repeat domain 20 family member A8, pseudogene"	Q5CZ79	2	94811046-94857282	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"testis: 3.2;thyroid gland: 5.0"	"Group enriched"	"Detected in some"	8	"RT4: 2.7;U-2 OS: 9.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA043239, HPA047112, HPA047167, HPA047766, HPA051753"	Uncertain									"HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592"								"unprognostic (3.08e-1)"		"unprognostic (3.86e-1)"		"unprognostic (3.79e-2)"	"unprognostic (1.30e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.38e-2)"		1.1	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.4	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.9	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	3.2			5.0		0.0	0.0		0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0	0.5	0.0	0.3	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ARG2		ENSG00000081181	"Arginase 2"	P78540	14	67619798-67651720	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 53.7;thyroid gland: 75.4"	"Cell line enhanced"	"Detected in many"		"HAP1: 25.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 49.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000663, CAB009435"	Enhanced		Supported	Mitochondria				Mitochondria	Mitochondria	"CAB009435: AB_2059089, HPA000663: AB_1078192"	"unprognostic (8.74e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.43e-3)"	"unprognostic (4.62e-3)"	"unprognostic (5.37e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.39e-2)"	"unprognostic (4.26e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.26e-1)"	1.5	3.9	2.4	1.7	6.4	0.6	2.7	8.3	5.3	9.3	5.4	0.5	2.0	2.1	3.7	2.3	7.3	0.8	4.9	2.1	3.3	5.5	41.4	2.0	1.7	0.6	3.2	1.7	8.8	2.6	32.1	22.5	4.4	4.6	53.7	1.1	3.4	26.6	3.8	17.2	0.8	10.4	2.2	3.9	0.7	1.4	1.9	2.1	0.1	75.4	13.6	2.2	5.3	4.1	2.5	1.7	2.0	1.4	0.3	2.9	3.4	3.5	0.5	6.2	4.0	0.9	0.0	8.4	2.8	7.5	9.1	15.4	15.3	1.8	6.0	0.7	1.8	0.8	25.0	11.3	11.0	0.2	6.2	2.7	1.1	17.5	2.7	0.6	16.4	0.4	14.8	4.4	21.6	15.3	7.9	0.0	0.6	1.7	0.9	0.6	11.8	0.2	0.2	0.8	6.9	7.4	6.0	13.8	5.2	1.7	1.7	2.6	6.4	0.2	3.1	2.7	6.9	0.2	2.0	0.5	0.9	2.0	5.5	3.1	4.6	0.3	1.4	2.0	1.1	0.5	0.5	0.7	0.3	0.9	1.7	2.5	0.6	0.6	1.7	0.3	1.2	0.1	2.9	3.4	2.4	6.4	8.3	5.3	3.3	5.5	3.2	1.7	4.6	2.1
ATOH8	"bHLHa21, FLJ14708, HATH6"	ENSG00000168874	"Atonal bHLH transcription factor 8"	Q96SQ7	2	85751344-85788066	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"thyroid gland: 41.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.2;RH-30: 18.8;RT4: 12.1;TIME: 17.7;U-2197: 12.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 15.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 2.9;MAIT T-cell: 1.7"	"Group enriched"	"Detected in many"	12	"monocytes: 2.9;T-cells: 1.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA028406			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA028406: AB_2672587"	"unprognostic (7.70e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.56e-1)"	"prognostic favourable (8.98e-6)"	"unprognostic (3.32e-2)"	"prognostic favourable (3.80e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.91e-2)"	36.4	2.4	3.7	2.4	4.3	0.8	19.9	2.9	4.9	10.5	4.0	4.3	4.5	2.7	11.5	2.2	5.0	7.6	5.7	12.9	5.0	2.0	3.6	30.8	21.1	4.5	6.3	2.1	9.7	4.3	1.0	2.3	3.2	5.4	9.0	1.3	6.4	3.5	12.1	25.2	8.4	3.2	5.8	4.1	8.1	4.4	2.0	4.6	0.3	41.8	4.2	1.1	10.4	24.5	0.0	0.2	0.0	2.9	0.0	1.7	0.4	0.0	3.6	5.0	11.2	4.9	0.3	0.1	9.4	1.0	2.8	1.2	0.0	0.0	0.0	3.5	6.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	8.4	0.5	3.2	0.0	0.0	3.7	0.0	0.0	0.0	1.9	0.0	0.0	7.7	0.1	0.0	0.0	0.1	0.1	0.0	18.8	0.1	0.0	12.1	8.3	1.8	1.8	0.0	0.6	0.0	0.0	17.7	4.4	0.1	12.3	0.0	0.0	0.0	0.0	1.5	0.0	8.7	0.0	2.9	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	3.7	4.3	2.9	4.9	5.0	2.0	6.3	2.1	5.4	4.6
ATP13A4	"DKFZp761I1011, FLJ37958"	ENSG00000127249	"ATPase 13A4"	Q4VNC1	3	193402077-193593111	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 46.4;parathyroid gland: 52.5;thyroid gland: 51.2"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 9.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 23.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051932			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA051932: "	"unprognostic (4.97e-2)"	"unprognostic (1.50e-3)"	"unprognostic (4.86e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.72e-2)"	"prognostic favourable (3.91e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.29e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.00e-1)"	0.6	0.7	11.2	0.6	11.1	0.6	17.8	2.6	10.1	1.8	2.2	8.4	9.0	0.9	0.6	46.4	11.8	2.7	4.3	0.6	11.1	5.1	0.8	0.7	22.0	0.8	7.5	7.7	0.8	3.9	52.5	3.5	0.6	9.0	0.6	3.2	0.5	4.5	16.7	0.6	11.2	0.6	0.7	6.1	0.7	7.6	0.8	7.5	0.0	51.2	7.8	9.5	0.6	3.7	0.4	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	9.2	0.2	0.1	1.1	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	1.9	0.9	1.4	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	11.2	11.1	2.6	10.1	11.1	5.1	7.5	7.7	9.0	7.5
BMP7	OP-1	ENSG00000101144	"Bone morphogenetic protein 7"	P18075	20	57168748-57266629	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 37.0;thyroid gland: 44.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 41.5;MCF7: 48.0;RPMI-8226: 18.4;SK-BR-3: 31.3;U-698: 56.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"basophil: 2.4"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA057757			Approved	Nucleoplasm,Nucleoli,Vesicles	"Secreted to blood"			Vesicles	Vesicles	"HPA057757: AB_2683518"	"unprognostic (1.67e-1)"	"unprognostic (9.72e-3)"	"unprognostic (9.67e-2)"	"prognostic unfavourable (2.91e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.78e-2)"	"unprognostic (4.63e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.82e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.59e-1)"	1.5	7.2	16.8	2.4	17.5	0.7	2.1	3.8	19.7	9.2	2.3	23.6	6.0	2.7	1.9	17.7	17.2	10.0	1.2	8.5	13.9	9.9	4.5	0.7	1.8	1.6	14.3	11.2	0.8	1.0	0.8	1.9	24.4	12.2	5.0	2.4	37.0	2.6	10.3	1.0	15.5	2.4	1.0	13.8	1.3	4.1	1.4	13.4	1.8	44.3	5.7	4.9	7.8	7.0	0.1	0.1	2.4	0.0	0.0	0.1	0.0	0.0	0.1	5.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	1.6	41.5	10.6	0.0	12.0	1.2	0.0	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	48.0	0.0	0.0	3.0	0.0	0.0	0.0	18.4	0.0	0.0	0.1	4.5	1.3	31.3	0.1	0.2	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	56.7	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	16.8	17.5	3.8	12.5	13.9	9.9	14.3	11.2	12.2	13.4
BMP8B	"BMP8, OP-2"	ENSG00000116985	"Bone morphogenetic protein 8b"	P34820	1	39757182-39788861	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"intestine: 21.9;thyroid gland: 26.8"	"Cell line enhanced"	"Detected in many"		"THP-1: 46.4;U-266/70: 14.0;U-266/84: 20.0;WM-115: 22.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																"Secreted to blood"						"unprognostic (1.53e-3)"	"unprognostic (7.29e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.64e-3)"	"unprognostic (8.79e-2)"	"unprognostic (3.44e-2)"	"unprognostic (7.27e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.41e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.72e-4)"	"unprognostic (1.79e-2)"	"unprognostic (3.15e-1)"	"unprognostic (9.67e-2)"	"unprognostic (8.68e-3)"	"unprognostic (4.82e-1)"	2.8	8.1	5.5	2.4	6.7	1.4	1.6	2.5	4.1	3.8	13.2	6.9	8.2	7.5	2.6	14.2	3.5	2.3	2.1	1.6	5.0	3.3	1.6	1.0	3.1	3.6	6.1	5.5	1.4	9.9	6.6	5.8	2.3	2.8	5.1	4.0	3.6	3.6	4.7	1.2	3.2	21.9	2.1	3.6	2.4	3.0	3.1	6.2	0.4	26.8	3.4	3.1	2.1	3.3	1.7	0.2	0.8	0.7	2.6	1.9	0.3	1.0	1.9	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	2.1	0.0	0.7	0.0	0.2	1.6	0.0	0.0	0.4	2.3	1.9	1.5	0.1	0.4	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	7.4	0.1	1.5	0.0	1.0	0.3	0.7	1.1	6.3	2.4	1.6	1.0	5.3	1.3	1.7	0.1	5.1	1.3	46.4	0.0	0.0	0.1	1.6	0.1	14.0	20.0	0.8	0.0	1.4	22.4	0.8	0.7	0.1	0.5	0.3	0.6	1.7	0.2	1.9	0.1	0.7	0.3	0.4	0.6	2.6	0.3	0.2	0.1	0.3	5.5	6.7	2.5	4.1	5.0	3.3	6.1	5.5	2.8	6.2
C11orf74	"FLJ38678, HEPIS, NWC"	ENSG00000166352	"Chromosome 11 open reading frame 74"	Q86VG3	11	36594493-36659290	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 66.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044880	Uncertain		Approved	Aggresome,Cytosol				"Aggresome, Cytosol"	"Aggresome, Cytosol"	"HPA044880: AB_10796908"	"unprognostic (9.22e-3)"	"unprognostic (6.79e-2)"	"unprognostic (3.23e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.65e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.24e-1)"	10.7	13.1	16.0	4.2	18.8	8.6	11.5	15.5	20.8	10.5	15.4	8.7	8.3	5.5	11.8	18.5	9.5	25.3	10.1	28.1	14.3	15.4	17.1	13.1	8.1	4.1	17.2	16.5	17.8	10.2	12.5	23.1	7.9	19.6	13.3	8.3	9.0	8.6	8.2	26.5	3.8	7.5	13.1	15.5	5.7	9.7	33.1	14.5	3.5	66.1	10.8	4.0	12.5	7.3	0.3	18.6	7.5	12.5	8.5	8.2	5.8	5.3	9.0	20.0	15.5	16.4	28.1	7.9	11.1	12.6	11.5	20.3	0.3	8.5	0.0	8.8	11.3	2.2	13.5	15.2	22.8	0.0	21.8	8.7	5.1	9.9	13.7	12.0	2.1	17.7	11.8	7.6	10.8	18.8	11.7	0.0	12.7	9.0	2.0	9.8	12.7	13.8	8.6	24.3	5.1	16.0	1.8	0.5	23.7	11.4	3.0	18.2	18.2	6.5	12.0	15.8	11.3	20.9	9.4	3.3	6.1	0.0	13.8	14.3	8.1	7.5	12.5	0.7	1.1	9.7	3.7	0.0	3.3	2.8	13.7	0.3	8.2	2.0	0.7	8.5	9.1	18.6	0.4	5.8	16.0	18.8	15.5	20.8	14.3	15.4	17.2	16.5	19.6	14.5
C12orf49	FLJ21415	ENSG00000111412	"Chromosome 12 open reading frame 49"	Q9H741	12	116710185-116738070	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 41.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026905	Uncertain				"Secreted - unknown location"	260000	260000			"HPA026905: AB_10603446"	"unprognostic (2.74e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.66e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.76e-2)"	"prognostic unfavourable (8.44e-4)"	"unprognostic (2.56e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (1.91e-11)"	"unprognostic (3.28e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.73e-1)"	6.2	8.6	10.9	8.6	14.1	6.3	8.6	5.4	16.9	4.7	12.2	10.1	6.1	7.6	5.3	10.4	9.0	4.4	6.8	6.3	8.8	10.0	13.0	9.1	20.4	9.0	10.8	7.2	4.7	7.6	7.3	6.7	5.2	19.6	4.7	9.9	5.9	14.7	5.6	3.6	6.9	8.2	4.8	9.2	7.8	11.9	8.7	7.0	14.0	41.4	5.5	9.7	5.8	4.3	9.4	7.3	6.4	5.4	4.7	8.2	2.6	7.2	9.9	9.2	9.1	10.7	8.6	11.6	5.1	6.9	5.7	5.0	19.4	5.5	18.8	10.1	7.0	9.5	12.7	7.8	6.5	15.0	10.2	5.3	5.2	18.5	7.6	10.2	16.6	10.4	9.9	7.5	8.5	8.6	5.7	4.4	9.1	11.0	9.2	9.5	14.6	11.5	13.9	6.2	8.2	14.6	19.9	8.5	10.6	8.3	8.4	15.2	10.2	10.7	11.2	8.6	11.9	12.1	10.0	9.1	26.9	26.4	14.0	10.7	10.1	4.1	4.3	6.4	8.1	5.4	8.2	9.4	6.4	6.5	3.8	8.2	5.7	7.5	3.0	4.7	3.7	7.3	6.4	2.6	10.9	14.1	5.4	16.9	8.8	10.0	10.8	7.2	19.6	7.0
C16orf89	MGC45438	ENSG00000153446	"Chromosome 16 open reading frame 89"	Q6UX73	16	5044122-5066110	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 35.8;thyroid gland: 79.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.8;Hep G2: 5.8;HHSteC: 3.1;NTERA-2: 3.6;U-2197: 4.9"	"Group enriched"	"Detected in many"	14	"lung cancer: 64.7;thyroid cancer: 145.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013613, HPA016934"	Enhanced				"Secreted to blood"	1200000	1200000			"HPA013613: AB_1845584, HPA016934: AB_2732417"	"unprognostic (1.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.29e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.39e-2)"	"unprognostic (3.25e-2)"	"unprognostic (6.64e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.54e-2)"	"unprognostic (8.48e-3)"	6.0	1.7	7.7	4.4	9.3	0.3	4.7	5.1	8.6	7.3	2.3	5.2	0.3	5.9	1.4	30.3	2.5	4.6	15.3	7.1	6.1	3.0	5.6	0.3	35.8	0.5	6.2	7.4	1.9	8.2	0.3	1.9	0.5	5.3	4.0	1.9	5.0	11.5	0.6	0.2	0.4	2.8	6.2	7.4	0.4	28.0	1.4	2.9	0.0	79.3	2.7	1.4	4.3	1.8	1.1	0.9	3.3	0.5	1.3	0.6	0.2	0.1	0.2	0.0	0.4	4.8	0.1	0.8	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.4	0.6	1.4	5.8	3.1	0.2	0.5	1.4	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.3	1.6	0.7	3.6	0.1	0.5	0.1	0.3	0.0	0.5	0.6	0.4	0.3	0.6	1.1	0.4	0.0	0.2	0.6	0.3	4.9	0.2	0.4	0.2	0.1	0.4	0.2	0.1	3.3	0.5	0.7	0.4	0.4	0.3	0.7	0.4	0.4	0.2	1.1	0.5	0.6	1.9	1.3	0.2	0.9	0.3	0.2	7.7	9.3	5.1	8.6	6.1	3.0	6.2	7.4	5.3	2.9
C1orf232		ENSG00000282872	"Chromosome 1 open reading frame 230"	A0A0U1RR37	1	26164161-26168581	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 1.4;testis: 2.2;thyroid gland: 1.6"	"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 8.7"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebellum: 1.8"																																	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	1.4	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.8	0.0	0.0	0.0		0.0	0.0	2.2			1.6		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CACNA1I	Cav3.3	ENSG00000100346	"Calcium voltage-gated channel subunit alpha1 I"	Q9P0X4	22	39570753-39689737	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 4.6;brain: 8.1;lymphoid tissue: 4.3;thyroid gland: 4.1"	"Group enriched"	"Detected in some"	5	"SK-BR-3: 6.0;T-47d: 3.6"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 2.1"					"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	20	"T-cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (3.97e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.21e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.64e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.14e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.27e-4)"	0.0	4.6	3.4	1.9	5.8	1.3	0.2	8.1	7.5	0.0	0.2			0.2	0.0	0.0	0.1	0.0	0.4	0.0	5.0	3.6	0.0	0.0	0.2	4.3	0.7		0.0	0.0	0.0	0.0	0.0		0.0	0.1		0.0	0.0	0.0	0.1	0.9	0.0	0.4	1.3	0.5	1.1			4.1		1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	6.0	0.0	3.6	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.5	0.0	0.0	1.9	0.7	0.0	0.0	0.0	0.0	0.8	0.1										
CLDN3	"C7orf1, CPE-R2, CPETR2, HRVP1, RVP1"	ENSG00000165215	"Claudin 3"	O15551	7	73768997-73770270	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 100.4;thyroid gland: 91.6"	"Cell line enhanced"	"Detected in some"		"MCF7: 65.0;PC-3: 13.9;RPMI-8226: 11.1;SCLC-21H: 17.2;T-47d: 30.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"cerebellum: 3.1;pons and medulla: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA014361	Enhanced		Supported	"Cell Junctions"		15000	15000	"Cell Junctions"	"Cell Junctions"	"HPA014361: AB_2668982"	"unprognostic (1.84e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.42e-1)"	"prognostic favourable (3.39e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.18e-2)"	"unprognostic (6.72e-2)"	0.3	0.1	0.1	11.5	0.1	0.2	7.1	3.1	0.2	3.8	77.9	1.6	21.8	24.3	2.8	8.8	0.3	9.4	11.3	0.1	0.2	0.4	20.7	16.0	6.0	0.2	0.0	0.0	4.3	38.0	0.2	7.4	3.1	3.0	14.6	8.0	1.9	31.1	32.1	0.1	2.1	100.4	0.5	0.0	0.1	0.7	1.2	0.0	2.2	91.6	0.9	3.6	0.8	0.4	0.2	0.0	0.1	0.0	0.0	0.1	0.5	0.7	1.0	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	1.2	10.3	0.0	2.9	0.0	0.3	0.1	0.0	0.0	0.0	1.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.0	0.1	0.3	0.6	13.9	0.0	0.0	11.1	0.6	0.0	17.2	0.2	0.0	9.9	0.0	30.9	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	3.1	0.2	0.2	0.4	0.0	0.0	3.0	0.0
CLDN4	"CPE-R, CPETR, CPETR1, hCPE-R, WBSCR8"	ENSG00000189143	"Claudin 4"	O14493	7	73799542-73832693	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 141.0"	"Cell line enhanced"	"Detected in some"		"A-431: 43.1;BEWO: 50.7;CAPAN-2: 94.7;MCF7: 48.3;PC-3: 61.7;RT4: 41.7;SK-BR-3: 80.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB002610	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB002610: "	"unprognostic (1.14e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.07e-1)"	"prognostic unfavourable (3.28e-4)"	"unprognostic (2.16e-3)"	"unprognostic (5.11e-1)"	"prognostic favourable (3.46e-10)"	"unprognostic (5.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.38e-2)"	"unprognostic (4.63e-2)"	0.7	0.2	0.4	17.1	0.4	0.0	17.1	0.4	0.5	17.5	53.7	0.7	23.2	25.0	5.1	15.9	62.3	15.4	15.4	0.5	0.4	0.3	30.2	2.0	28.8	0.4	0.4	0.4	5.5	32.4	2.7	3.5	78.1	1.3	31.8	24.7	0.7	52.0	25.7	0.6	35.3	93.3	2.7	0.4	0.4	2.7	2.5	0.4	3.8	141.0	60.9	55.7	38.5	21.0	0.1	0.1	0.2	0.1	0.1	0.6	0.0	43.1	0.5	0.0	0.2	0.0	0.0	50.7	0.4	0.0	0.0	0.0	22.5	94.7	0.0	3.5	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	2.6	15.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	48.3	0.0	0.2	0.0	61.7	0.0	0.8	1.0	11.6	41.7	10.1	0.2	0.0	80.3	0.1	31.4	0.1	0.0	0.1	1.8	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.6	0.2	0.1	0.0	0.1	0.0	0.0	0.4	0.4	0.4	0.5	0.4	0.3	0.4	0.4	1.3	0.4
CLIC2	XAP121	ENSG00000155962	"Chloride intracellular channel 2"	O15247	X	155276211-155334657	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 62.3;vagina: 66.1"	"Group enriched"	"Detected in some"	5	"HDLM-2: 36.5;K-562: 19.7;Karpas-707: 18.2;RPMI-8226: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 9.5;myeloid DC: 24.5;non-classical monocyte: 6.5"	"Group enriched"	"Detected in many"	14	"dendritic cells: 24.5;monocytes: 9.5"					"Low region specificity"	"Detected in all"			"HPA047381, HPA060101"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		290000	290000	"Plasma membrane"	"Plasma membrane"	"HPA047381: AB_2680022, HPA060101: AB_2684204"	"unprognostic (3.27e-2)"	"unprognostic (5.21e-3)"	"unprognostic (9.70e-2)"	"unprognostic (7.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-1)"	"prognostic unfavourable (1.74e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.97e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.54e-1)"	26.5	3.7	3.8	7.5	6.1	3.4	24.1	2.6	4.8	15.5	6.8	0.6	3.3	4.0	11.3	10.5	10.4	6.5	9.8	9.4	3.7	3.4	5.4	6.3	31.0	15.6	7.5	1.4	12.5	2.6	2.0	7.8	4.5	6.8	9.1	6.9	3.0	5.4	3.2	10.3	5.2	7.3	10.2	5.2	32.1	4.7	5.6	4.3	6.9	62.3	8.7	12.4	14.0	66.1	0.0	24.5	0.6	9.5	1.1	0.1	1.0	0.2	0.0	0.4	0.3	0.3	2.0	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	36.5	0.2	5.1	0.1	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.0	19.7	18.2	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	31.1	0.1	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.4	0.0	1.7	0.5	0.7	0.3	1.1	1.6	0.0	0.9	1.1	0.6	0.0	1.8	0.1	0.0	9.5	0.1	0.0	0.0	0.1	24.5	0.0	0.0	0.0	0.6	1.1	6.5	2.5	0.0	1.0	3.8	6.1	2.6	4.8	3.7	3.4	7.5	1.4	6.8	4.3
CMTM4	CKLFSF4	ENSG00000183723	"CKLF like MARVEL transmembrane domain containing 4"	Q8IZR5	16	66614750-66696707	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 39.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014704, HPA023890"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"				"Golgi apparatus, Vesicles, Plasma membrane"	"Golgi apparatus, Vesicles, Plasma membrane"	"HPA014704: AB_1847005, HPA023890: AB_1847007"	"unprognostic (2.65e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.17e-3)"	"unprognostic (3.43e-1)"	"unprognostic (5.13e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.35e-3)"	"unprognostic (6.06e-3)"	"unprognostic (2.07e-2)"	"unprognostic (3.08e-1)"	"prognostic favourable (4.72e-9)"	"unprognostic (1.41e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.00e-1)"	2.7	4.8	18.9	3.3	18.2	2.9	6.6	8.3	22.1	4.8	16.1	13.5	8.7	12.6	3.2	21.8	4.5	11.5	4.8	3.3	20.0	16.2	18.3	2.5	6.5	1.3	17.0	13.0	2.5	15.1	31.7	9.4	4.3	12.5	6.8	13.4	5.2	10.7	6.9	2.7	7.2	15.8	4.2	13.3	1.8	18.5	6.3	10.3	0.0	39.3	0.5	2.1	4.3	2.6	0.2	1.3	0.1	1.2	0.2	0.9	0.2	9.7	8.3	4.9	12.0	1.6	2.5	20.4	4.1	3.6	2.2	3.6	14.7	11.1	0.4	7.1	2.4	12.4	11.9	4.6	3.3	0.8	10.9	0.9	3.0	8.9	3.5	0.8	1.9	4.0	8.3	2.6	5.2	1.2	4.9	2.7	3.2	10.7	0.1	1.9	5.7	5.5	2.1	6.4	3.0	9.6	8.8	11.6	4.5	16.8	9.2	5.8	9.9	2.0	2.5	4.1	4.7	1.1	4.2	0.9	2.0	0.5	5.0	2.0	4.9	0.0	1.2	0.0	0.3	0.3	0.0	0.0	0.1	0.9	1.3	0.2	0.1	0.2	0.1	0.2	0.7	1.3	0.7	0.2	18.9	18.2	8.3	22.1	20.0	16.2	17.0	13.0	12.5	10.3
CNMD	"BRICD3, CHM-I, CHM1, LECT1, MYETS1"	ENSG00000136110	Chondromodulin	O75829	13	52703264-52739812	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.1;salivary gland: 15.1;thyroid gland: 8.0"	"Cell line enriched"	"Detected in single"	137	"NTERA-2: 32.4"	"Group enriched"	"Detected in many"	5	"glioma: 1.5;lung cancer: 6.0;testis cancer: 5.8;thyroid cancer: 4.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010510	Uncertain				"Secreted to extracellular matrix"					"HPA010510: AB_10602021"	"unprognostic (7.52e-3)"		"unprognostic (1.34e-1)"		"unprognostic (7.36e-2)"			"unprognostic (1.45e-2)"		"unprognostic (1.15e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.96e-1)"		0.3	0.3	3.1	0.3	11.1	0.3	0.4	0.9	2.5	0.3	0.5	4.3	0.0	0.3	0.3	0.3	0.6	0.4	0.3	0.4	3.0	2.6	0.3	0.3	3.9	0.3	3.7	0.9	0.4	1.1	0.3	2.5	0.5	3.1	1.6	0.5	6.1	15.1	0.4	0.5	0.5	0.4	0.3	4.4	1.0	0.4	4.2	4.1	0.0	8.0	0.0	0.6	0.3	0.0	0.0	0.6	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	32.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	3.1	11.1	0.9	2.3	3.0	2.6	3.7	0.9	3.1	4.1
COL23A1	DKFZp434K0621	ENSG00000050767	"Collagen type XXIII alpha 1 chain"	Q86Y22	5	178237618-178590555	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 42.3"	"Group enriched"	"Detected in some"	4	"K-562: 7.9;NB-4: 22.5;THP-1: 22.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 41.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 3.1"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 3.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067824	Uncertain									"HPA067824: AB_2685907"	"unprognostic (5.24e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.65e-2)"	"prognostic unfavourable (6.46e-5)"	"unprognostic (3.04e-1)"	"unprognostic (8.67e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.96e-2)"	"unprognostic (5.93e-3)"	"unprognostic (8.20e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.11e-3)"	"unprognostic (2.37e-1)"	0.6	0.5	1.6	1.9	1.3	6.9	1.5	8.8	3.4	2.2	2.2	0.1	7.6	3.1	1.2	3.6	0.7	2.0	0.9	11.4	1.5	1.0	2.2	1.5	1.4	0.6	0.7	2.3	0.2	1.9	3.0	0.8	0.1	2.9	4.1	0.1	3.7	1.7	12.6	1.3	6.3	3.8	1.1	2.6	1.5	2.2	2.3	0.1	0.3	42.3	2.2	1.6	1.0	1.5	0.0	3.1	0.0	0.5	0.5	0.0	0.2	0.0	0.0	3.9	0.2	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	7.9	0.4	0.0	1.0	0.0	22.5	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	3.1	0.0	0.2	1.6	1.3	8.8	3.4	1.5	1.0	0.7	2.3	2.9	0.1
COL8A1	"C3orf7, MGC9568"	ENSG00000144810	"Collagen type VIII alpha 1 chain"	P27658	3	99638475-99799226	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 56.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 36.4;fHDF/TERT166: 149.5;LHCN-M2: 43.9;TIME: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA053107	Enhanced		Supported	Vesicles	"Secreted to extracellular matrix"			Vesicles	Vesicles	"HPA053107: AB_2682046"	"unprognostic (3.13e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.71e-1)"	"prognostic unfavourable (9.39e-8)"	"unprognostic (2.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.32e-3)"	20.5	4.7	1.0	6.1	3.0	0.1	7.5	2.4	0.9	5.8	16.9	1.8	11.8	0.6	5.9	16.8	15.3	6.4	6.8	26.7	1.2	1.4	9.4	1.9	36.5	0.5	1.8	2.1	7.7	0.9	32.3	9.4	5.5	2.9	13.1	4.8	38.7	5.2	8.8	5.0	2.3	2.7	18.8	3.0	0.9	4.2	6.4	0.6	0.0	56.0	6.4	0.8	21.3	12.1	0.4	0.1	0.9	0.2	0.3	0.4	0.1	0.0	0.0	0.4	0.0	22.0	36.4	0.0	8.9	5.8	9.0	18.1	0.0	0.0	0.0	0.8	149.5	0.0	0.0	11.6	23.5	0.0	0.0	0.0	1.2	0.0	4.0	0.0	0.0	20.7	0.4	7.0	11.8	17.5	0.0	0.0	43.9	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.1	4.2	3.3	0.2	4.7	0.0	0.0	0.0	8.3	0.0	32.1	0.9	0.2	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.0	0.4	0.4	0.4	0.7	0.3	0.1	0.1	0.1	0.1	1.0	3.0	2.4	0.9	1.2	1.4	1.8	2.1	2.9	0.6
CPQ	"LDP, PGCP"	ENSG00000104324	"Carboxypeptidase Q"	Q9Y646	8	96645227-97149654	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 94.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 37.7;ASC TERT1: 43.3;Karpas-707: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 62.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023235, HPA024490"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	51000000	51000000	"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"HPA023235: AB_1855257, HPA024490: AB_1855258"	"unprognostic (4.04e-2)"	"unprognostic (5.46e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-3)"	"unprognostic (3.98e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.38e-3)"	"unprognostic (6.16e-3)"	"prognostic favourable (5.40e-5)"	"unprognostic (6.74e-3)"	"unprognostic (8.71e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.75e-1)"	17.4	12.6	12.5	10.1	18.3	9.5	15.4	8.3	11.3	26.3	16.5	19.4	21.1	9.4	24.5	19.5	9.1	16.8	20.0	24.1	14.0	9.2	26.4	22.1	13.9	12.3	27.6	8.8	35.3	18.8	20.7	14.2	12.4	16.6	18.1	10.9	19.8	10.9	18.6	5.0	9.1	14.1	30.8	15.3	12.9	14.5	7.3	24.5	1.3	94.4	8.1	7.2	16.9	19.3	1.8	12.8	62.6	17.5	6.3	7.3	8.4	0.6	1.9	1.6	0.4	37.7	43.3	0.5	11.5	17.5	4.1	8.5	1.3	0.8	1.1	9.4	18.2	0.6	0.7	0.8	3.9	10.4	1.5	9.8	1.8	5.7	8.3	2.3	12.7	22.6	2.1	4.7	1.2	1.8	9.5	31.5	9.2	0.6	0.3	4.8	1.2	1.9	2.2	0.3	0.5	8.5	4.4	1.2	0.8	4.1	0.4	8.9	4.4	9.5	8.2	18.0	2.1	0.8	4.2	3.1	0.7	0.4	11.4	7.8	11.9	5.4	17.5	10.8	7.3	12.0	7.3	1.5	5.5	6.3	12.8	1.8	5.0	6.7	62.6	6.3	11.0	3.7	5.7	8.4	12.5	18.3	8.3	11.3	14.0	9.2	27.6	8.8	16.6	24.5
CRABP1	"CRABP, CRABP-I, CRABPI, RBP5"	ENSG00000166426	"Cellular retinoic acid binding protein 1"	P29762	15	78340324-78348230	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.1;retina: 73.2;thyroid gland: 80.6"	"Group enriched"	"Detected in some"	8	"AF22: 143.3;NTERA-2: 42.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 117.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"myeloid DC: 1.2"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 1.2"	"Group enriched"	"Detected in many"	5	"amygdala: 6.6;basal ganglia: 20.9;hypothalamus: 15.5;olfactory region: 15.7;pons and medulla: 7.8"	"Low region specificity"	"Detected in some"			HPA017203	Enhanced	Supported								"HPA017203: AB_1846512"	"unprognostic (1.23e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (4.72e-4)"	"unprognostic (2.01e-1)"	"unprognostic (4.35e-2)"		"unprognostic (1.05e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.45e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.69e-1)"	0.7	1.3	6.3	1.8	25.6	0.6	24.8	2.8	12.4	1.2	1.9	3.3	0.3	0.9	1.5	1.9	0.7	0.5	1.2	0.7	1.1	21.9	4.2	0.5	0.8	0.6	16.9	4.5	0.7	0.7	0.5	6.3	7.0	40.1	1.0	1.3	73.2	0.6	24.8	0.5	12.3	2.3	1.3	7.3	21.1	1.9	0.6	2.4	0.4	80.6	2.4	1.0	0.7	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.0	0.9	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	7.6	0.0	42.9	0.1	0.0	0.0	0.0	0.0	0.2	12.0	8.1	0.0	0.0	0.0	0.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	25.6	2.8	12.4	1.1	21.9	16.9	4.5	40.1	2.4
CRYGN		ENSG00000127377	"Crystallin gamma N"	Q8WXF5	7	151428835-151440813	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"seminal vesicle: 4.3;thyroid gland: 16.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.6;CAPAN-2: 2.6;MOLT-4: 2.0;SCLC-21H: 3.6"	"Cancer enriched"	"Detected in some"	25	"thyroid cancer: 15.7"					"Group enriched"	"Detected in some"	31	"memory CD4 T-cell: 3.4;naive CD4 T-cell: 3.4;naive CD8 T-cell: 2.2"	"Lineage enriched"	"Detected in single"	35	"T-cells: 3.4"	"Region enriched"	"Detected in single"	4	"basal ganglia: 9.3"	"Not detected"	"Not detected"			HPA050788	Uncertain									"HPA050788: AB_2681239"	"unprognostic (1.69e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.55e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.94e-5)"	"unprognostic (2.49e-3)"	"unprognostic (1.55e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.48e-2)"	"unprognostic (8.93e-10)"	"unprognostic (2.55e-4)"	"unprognostic (2.71e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.36e-1)"	0.3	0.0	0.3	0.0	0.5	0.0	0.2	0.0	0.4	1.1	0.3			0.0	0.9	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0		0.4	0.0	2.6	0.8	0.3		0.3	0.0		0.1	4.3	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0			16.3		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.4	0.0	0.0	0.0	0.6	0.0	0.0	1.6	0.0	0.3	0.0	0.7	1.0	2.6	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	2.0	0.5	1.1	0.6	0.3	0.0	0.0	0.0	0.0	3.6	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	3.4	2.2	0.0	0.0	0.0	0.0	0.0	0.4										
CSGALNACT1	"ChGn, CSGalNAcT-1, FLJ11264"	ENSG00000147408	"Chondroitin sulfate N-acetylgalactosaminyltransferase 1"	Q8TDX6	8	19404161-19758029	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 57.7"	"Cell line enhanced"	"Detected in some"		"A549: 28.6;BJ hTERT+: 16.1;RPTEC TERT1: 20.0;U-2197: 18.3;U-87 MG: 13.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 22.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 20.1;granulocytes: 10.3;T-cells: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA061336			Uncertain	"Actin filaments"	"Intracellular and membrane"			"Actin filaments"	"Actin filaments"	"HPA061336: AB_2684482"	"unprognostic (8.90e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.17e-3)"	"unprognostic (9.78e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.22e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.02e-2)"	13.8	8.7	22.7	6.0	15.4	6.8	7.2	3.8	21.4	13.0	3.8	9.2	4.0	2.8	7.1	5.9	21.2	8.7	10.8	23.8	17.7	8.2	5.3	2.3	7.9	10.5	9.1	18.7	38.6	10.9	4.2	5.9	25.1	7.0	21.7	2.1	2.6	5.8	7.3	3.9	4.2	4.2	17.2	8.6	6.3	5.4	2.7	10.3	4.0	57.7	4.5	6.1	18.9	9.7	20.1	1.7	10.3	1.2	3.2	25.5	4.8	0.7	28.6	0.2	0.0	4.8	1.1	3.7	0.6	16.1	0.1	0.1	1.4	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1	3.5	0.2	0.0	8.2	0.7	2.1	0.0	0.0	0.4	0.7	0.1	0.1	5.4	0.0	0.0	0.0	1.2	1.1	0.1	0.0	0.9	0.1	0.0	0.0	20.0	0.7	0.1	0.1	8.4	3.4	1.1	0.0	0.0	0.3	0.4	0.4	18.3	0.2	0.1	0.0	0.0	13.2	1.6	5.5	0.0	1.2	10.3	2.5	0.0	0.3	20.1	11.5	3.9	1.1	6.2	20.6	5.2	7.1	3.2	0.1	1.7	25.5	4.8	22.7	15.4	3.8	21.4	17.7	8.2	9.1	18.7	7.0	10.3
CTSB		ENSG00000164733	"Cathepsin B"	P07858	8	11842524-11869448	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 297.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 237.0;fHDF/TERT166: 137.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 1446.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 53.1;classical monocyte: 127.4;intermediate monocyte: 97.0;myeloid DC: 68.0;non-classical monocyte: 54.7;plasmacytoid DC: 95.4"	"Group enriched"	"Detected in all"	5	"dendritic cells: 95.4;granulocytes: 53.1;monocytes: 127.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000457, HPA018156, HPA048998"	Enhanced		Supported	Nucleoli,Vesicles	"Secreted to blood"	130000000	130000000	Vesicles	Vesicles	"CAB000457: , HPA018156: AB_1846069, HPA048998: "	"unprognostic (5.74e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.12e-2)"	"prognostic favourable (5.76e-4)"	"prognostic unfavourable (9.02e-4)"	227.9	42.1	19.6	67.2	24.4	14.7	67.6	14.9	31.4	76.7	49.1	30.1	22.7	29.9	53.2	44.8	54.2	52.4	43.6	120.7	18.3	23.7	95.6	167.8	94.3	175.1	29.1	16.5	44.2	31.6	13.8	21.6	68.7	24.8	42.6	27.9	33.8	63.7	33.6	41.3	22.8	51.2	51.1	35.9	116.4	26.7	21.5	20.4	18.1	297.0	25.9	38.4	56.8	62.2	7.9	95.4	53.1	127.4	5.3	17.1	108.5	6.4	29.1	3.7	16.0	65.8	74.1	11.6	121.4	237.0	42.5	50.4	13.9	37.9	0.1	17.6	137.7	35.4	5.1	33.5	26.9	3.1	5.0	9.4	3.4	34.1	67.0	2.1	7.0	81.1	45.7	38.4	34.4	83.1	7.8	21.5	35.3	5.1	0.8	3.4	3.1	9.8	3.3	3.8	16.4	12.9	10.1	1.6	9.5	14.0	7.6	63.3	12.3	6.3	115.1	72.3	24.5	23.1	22.6	21.4	15.5	0.5	82.9	8.1	33.8	53.1	127.4	16.3	5.2	97.0	7.2	7.9	17.1	5.8	68.0	6.1	9.6	4.1	18.5	5.3	54.7	95.4	13.4	108.5	19.6	24.4	14.9	28.0	18.3	23.7	29.1	16.5	24.8	20.4
CXCL11	"b-R1, H174, I-TAC, IP-9, SCYB11, SCYB9B"	ENSG00000169248	"C-X-C motif chemokine ligand 11"	O14625	4	76033682-76041415	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 20.1"	"Group enriched"	"Detected in some"	6	"BJ hTERT+: 5.2;BJ hTERT+ SV40 Large T+: 8.2;BJ hTERT+ SV40 Large T+ RasG12V: 8.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 2.1"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in some"			CAB009921	Uncertain				"Secreted to blood"					"CAB009921: AB_2088137"	"unprognostic (2.00e-1)"	"unprognostic (3.62e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.87e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.73e-1)"	"prognostic favourable (4.31e-7)"	"prognostic unfavourable (8.18e-5)"	"unprognostic (2.90e-1)"	"prognostic unfavourable (3.29e-6)"	"unprognostic (1.53e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.48e-2)"	"unprognostic (5.32e-2)"	3.6	0.3	3.8	10.5	3.1	0.0	3.4	1.3	2.0	3.3	1.4	0.6	0.1	0.6	1.3	2.0	2.3	1.4	2.0	3.3	2.2	2.8	2.5	2.1	13.7	10.0	3.1	1.5	1.3	8.9	0.0	0.7	3.5	2.8	8.5	4.5	0.3	2.9	1.1	6.4	0.6	1.0	1.4	9.8	7.0	5.6	0.6	1.5	4.3	20.1	3.6	1.4	3.2	0.7	0.0	0.9	0.0	2.1	0.0	0.1	0.6	1.3	0.4	0.0	0.0	0.0	0.1	0.0	0.0	5.2	8.2	8.6	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.0	2.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.6	3.8	3.1	1.3	2.0	2.2	2.8	3.1	1.5	2.8	1.5
CXCL9	"CMK, crg-10, Humig, MIG, SCYB9"	ENSG00000138755	"C-X-C motif chemokine ligand 9"	Q07325	4	76001275-76007488	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 70.6;thyroid gland: 28.6"	"Cell line enriched"	"Detected in single"	8	"RPMI-8226: 4.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.2;non-classical monocyte: 2.6"	"Lineage enriched"	"Detected in single"	27	"monocytes: 2.6"	"Region enhanced"	"Detected in single"		"olfactory region: 0.6"	"Low region specificity"	"Detected in many"								"Secreted to blood"						"prognostic favourable (6.36e-4)"	"unprognostic (6.86e-3)"	"unprognostic (1.25e-2)"	"prognostic favourable (2.07e-4)"	"unprognostic (2.97e-1)"	"unprognostic (3.78e-3)"	"unprognostic (8.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.46e-2)"	"prognostic favourable (8.06e-4)"	"unprognostic (2.18e-3)"	"unprognostic (1.88e-1)"	"prognostic unfavourable (5.15e-6)"	"unprognostic (4.76e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.54e-2)"	6.3	0.4	0.5	30.8	0.8	0.0	4.4	0.4	0.4	6.0	2.4	0.4	1.0	0.5	1.1	3.6	2.5	0.5	2.1	5.3	0.5	0.4	9.9	5.9	16.4	70.6	0.3	0.5	4.5	1.0	0.0	1.5	2.1	1.3	5.0	7.3	2.9	4.9	0.6	7.0	2.2	6.6	3.4	2.6	18.6	4.1	1.9	0.4	17.3	28.6	3.5	15.7	4.3	1.6	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	4.8	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.5	0.8	0.4	0.4	0.5	0.4	0.3	0.5	1.3	0.4
DGKI	DGK-IOTA	ENSG00000157680	"Diacylglycerol kinase iota"	O75912	7	137381037-137847092	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.8;thyroid gland: 32.1"	"Cell line enhanced"	"Detected in some"		"BJ: 4.0;hTEC/SVTERT24-B: 4.1;SCLC-21H: 6.7;U-2197: 18.5;U-87 MG: 6.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.76e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.66e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.01e-2)"	"unprognostic (8.74e-2)"	"unprognostic (4.46e-2)"	"unprognostic (5.98e-5)"	"unprognostic (2.85e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.73e-3)"	1.5	1.3	5.0	1.1	19.8	0.7	1.1	11.4	12.7	0.8	0.9	2.6	0.0	0.9	1.4	0.9	0.9	0.9	1.9	5.0	4.6	3.3	1.7	0.7	0.8	0.8	2.8	9.0	0.8	0.7	0.8	6.0	0.8	6.6	1.0	0.9	10.8	1.0	1.1	0.7	0.9	0.9	2.7	2.5	0.8	0.8	1.9	5.8	0.0	32.1	0.0	0.8	1.1	0.3	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.9	0.9	0.0	4.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.2	0.0	4.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	6.7	2.8	0.0	0.0	0.5	0.0	0.0	0.3	1.6	0.6	18.5	0.9	0.1	0.0	0.0	6.9	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	5.0	19.8	11.4	12.7	4.6	3.3	2.8	9.0	6.6	5.8
DIO2	"SelY, TXDI2"	ENSG00000211448	"Iodothyronine deiodinase 2"	Q92813	14	80197527-80387757	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"cervix, uterine: 67.7;thyroid gland: 128.7"	"Cell line enhanced"	"Detected in some"		"BJ: 26.1;fHDF/TERT166: 14.3;HeLa: 29.9;HHSteC: 14.9;SiHa: 54.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 34.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029544, HPA048002"			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA029544: , HPA048002: AB_2680230"	"unprognostic (1.22e-1)"	"unprognostic (1.69e-1)"	"prognostic favourable (1.67e-4)"	"prognostic favourable (4.62e-6)"	"unprognostic (2.76e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.43e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.15e-2)"	1.3	1.8	13.0	0.9	12.3	0.7	6.1	1.0	19.7	67.7	1.2	1.6	1.9	1.2	15.6	1.1	36.1	0.9	2.5	4.7	14.2	2.7	2.4	0.7	1.2	1.0	4.1	7.6	0.7	1.3	0.9	35.9	5.9	13.2	5.0	1.3	13.1	17.7	12.4	3.0	3.3	1.2	2.4	1.2	0.9	2.5	2.5	1.4	0.0	128.7	15.8	12.0	2.6	13.7	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.4	0.0	26.1	5.5	2.3	0.3	0.0	0.1	0.0	0.1	14.3	0.5	0.9	0.0	1.9	0.0	0.0	0.0	29.9	0.0	14.9	0.0	0.0	1.6	0.0	0.5	0.0	0.5	0.0	0.2	0.1	0.6	0.0	0.0	0.5	0.1	0.2	1.2	0.0	0.0	0.2	0.0	0.0	54.7	11.4	0.1	0.0	0.0	0.3	0.1	2.4	5.5	6.6	0.8	0.0	0.0	2.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	13.0	12.3	1.0	19.7	14.2	2.7	4.1	7.6	13.2	1.4
DMRT3	DMRTA3	ENSG00000064218	"Doublesex and mab-3 related transcription factor 3"	Q9NQL9	9	976964-991731	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 34.2;testis: 11.7;thyroid gland: 11.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.1;HEK 293: 4.1;SCLC-21H: 2.4;THP-1: 6.6;U-2 OS: 1.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 4.6"	"Region enriched"	"Detected in some"	7	"hippocampal formation: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 0.7"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	HPA077685	Approved									"HPA077685: AB_2732357"	"unprognostic (2.42e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.28e-1)"		"unprognostic (2.21e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.12e-3)"			"unprognostic (2.91e-2)"	"unprognostic (5.84e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.11e-1)"	4.0	0.0	0.4	0.0	0.2	0.0	6.4	0.0	1.1	0.2	0.0	1.8	0.0	0.0	0.1	1.0	0.6	0.7	0.0	1.4	8.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.2	0.0	34.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	2.5	0.7	0.0	0.2	0.4	0.0	0.0	11.7	0.0	0.2	11.5	0.6	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	3.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	1.1	8.0	0.0	0.0	0.0	0.0	0.0
DPP6	"DPL1, DPPX"	ENSG00000130226	"Dipeptidyl peptidase like 6"	P42658	7	153887097-154894285	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.7;endometrium 1: 24.5;thyroid gland: 24.1"	"Cell line enriched"	"Detected in some"	9	"NTERA-2: 11.0"	"Cancer enriched"	"Detected in some"	11	"glioma: 12.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050509	Enhanced	Supported								"HPA050509: AB_2681150"	"unprognostic (1.29e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.83e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.04e-3)"	"unprognostic (2.94e-3)"	"unprognostic (1.85e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.61e-3)"	"unprognostic (6.11e-2)"	1.6	7.2	15.4	1.4	32.5	1.3	1.5	26.6	45.7	2.3	6.8	8.7	0.0	1.6	24.5	3.1	1.5	4.6	1.3	1.4	26.6	15.2	3.6	1.2	2.2	1.3	14.0	22.7	1.3	4.0	1.2	4.9	1.3	18.8	1.5	2.4	0.4	1.3	8.1	4.6	3.7	2.0	15.8	7.2	4.2	3.5	7.9	10.0	0.0	24.1	0.0	1.2	1.3	0.4	0.6	0.6	1.9	0.9	0.9	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	11.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.9	0.4	0.7	0.4	0.6	0.7	0.6	0.6	0.4	0.4	0.6	0.7	0.7	1.6	0.9	0.9	0.6	0.5	0.3	15.4	32.5	26.6	32.4	26.6	15.2	14.0	22.7	18.8	10.0
DUXB		ENSG00000282757	"Double homeobox B"		16	75693929-75701459	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"bone marrow: 1.3;retina: 1.8;testis: 1.2;thyroid gland: 1.4"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.1;MCF7: 1.8;NTERA-2: 1.0"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0		0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.1	1.2	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
EGR2	KROX20	ENSG00000122877	"Early growth response 2"	P11161	10	62811996-62919900	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 57.1"	"Cell line enriched"	"Detected in some"	6	"U-87 MG: 22.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 5.5;non-classical monocyte: 5.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"amygdala: 2.5;basal ganglia: 3.8;cerebral cortex: 4.9;hippocampal formation: 4.1;olfactory region: 3.0"	"Group enriched"	"Detected in many"	4	"basal ganglia: 3.7;cerebral cortex: 6.6;hippocampal formation: 5.1;midbrain: 3.0;olfactory region: 9.8"	HPA031165			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA031165: AB_2673768"	"prognostic favourable (7.30e-5)"	"unprognostic (1.86e-3)"	"unprognostic (1.45e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.47e-3)"	"unprognostic (6.54e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.11e-3)"	9.4	4.7	1.8	8.3	9.2	2.7	7.8	1.2	9.9	8.5	2.9	18.7	0.5	0.7	5.8	25.5	3.5	6.1	13.1	16.1	3.3	1.6	3.0	5.2	15.7	5.3	6.0	1.2	7.6	2.2	3.9	10.6	4.9	7.5	7.6	1.5	7.8	3.1	1.3	1.2	15.9	3.1	6.7	3.1	3.6	3.0	4.3	0.7	22.7	57.1	5.0	11.5	8.2	2.4	1.2	1.1	1.5	5.5	0.5	0.4	0.6	0.0	0.2	2.4	1.0	1.8	2.4	0.4	0.5	0.2	0.5	0.8	0.0	0.3	0.6	0.0	0.6	0.3	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.6	3.8	0.3	0.6	1.3	0.2	0.1	0.2	0.8	0.1	1.2	0.0	1.7	0.2	1.3	0.1	0.2	0.4	0.0	0.2	0.1	0.3	0.2	0.8	3.9	0.0	0.5	0.1	0.6	0.4	0.2	0.3	1.4	0.6	0.3	22.4	0.4	0.4	0.0	1.1	0.4	0.4	5.5	0.0	1.0	0.0	0.2	1.1	1.2	0.0	0.4	1.5	0.5	5.3	0.0	0.0	0.6	1.8	9.2	1.2	9.9	3.3	1.6	6.0	1.2	7.5	0.7
ERFE	"C1QTNF15, CTRP15, FAM132B, FLJ37034"	ENSG00000178752	Erythroferrone	Q4G0M1	2	238158982-238168900	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 12.4;testis: 13.8;thyroid gland: 25.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 13.9;REH: 13.8;RH-30: 17.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.2"	"Region enhanced"	"Detected in many"		"cerebellum: 9.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"						"unprognostic (1.66e-1)"	"unprognostic (9.14e-2)"	"unprognostic (3.64e-4)"	"prognostic unfavourable (3.75e-4)"	"unprognostic (2.84e-1)"	"unprognostic (9.61e-4)"	"unprognostic (4.68e-3)"	"unprognostic (3.16e-3)"	"unprognostic (9.63e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.31e-4)"	"unprognostic (7.13e-2)"	"prognostic unfavourable (2.46e-4)"	"unprognostic (4.10e-3)"	"unprognostic (4.33e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.33e-2)"	1.6	0.0	2.4	2.5	1.0	3.5	0.1	9.2	2.5	2.1	0.5	0.4	0.1	0.6	0.9	3.0	0.8	0.1	0.3	3.2	1.9	0.1	3.3	0.3	0.5	0.1	0.1	0.7	0.4	0.3	0.2	0.1	3.5	0.5	0.4	0.3	0.4	1.5	1.6	12.4	0.0	1.1	0.5	0.1	0.5	0.7	13.8	0.1	0.4	25.6	4.8	0.4	1.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.9	2.1	0.6	0.9	1.9	0.1	3.3	0.2	1.3	2.0	3.5	5.7	0.1	5.1	0.0	3.9	0.3	0.2	9.1	0.4	3.1	0.0	13.9	0.0	0.2	0.1	1.2	0.0	0.9	7.2	1.0	13.5	9.6	0.1	3.0	0.0	8.9	2.8	0.0	5.7	1.5	0.9	13.8	17.5	0.5	7.1	0.0	0.3	5.3	2.1	0.3	7.8	0.3	10.3	0.8	5.4	5.0	2.1	7.1	0.0	0.0	0.6	9.1	2.9	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.4	1.0	9.2	2.5	1.9	0.1	0.1	0.7	0.5	0.1
ESM1		ENSG00000164283	"Endothelial cell specific molecule 1"	Q9NQ30	5	54977864-55022671	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 31.4;thyroid gland: 14.8"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 54.2;TIME: 101.3"	"Cancer enriched"	"Detected in all"	8	"renal cancer: 65.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"MAIT T-cell: 1.6;memory CD4 T-cell: 2.7;memory CD8 T-cell: 1.7;naive CD8 T-cell: 1.6;NK-cell: 3.7"	"Group enriched"	"Detected in many"	32	"NK-cells: 3.7;T-cells: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	400000	400000				"unprognostic (4.70e-2)"	"prognostic unfavourable (2.11e-7)"	"unprognostic (2.63e-3)"	"unprognostic (2.31e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavourable (4.00e-4)"	"unprognostic (7.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.94e-1)"	1.5	3.5	0.3	0.4	0.6	0.2	0.6	0.2	0.7	1.5	1.1	0.8	4.2	0.3	3.0	1.1	0.3	0.2	0.9	2.4	0.9	3.7	31.4	2.2	12.9	0.9	0.5	0.3	2.3	1.8	1.7	9.0	0.5	1.3	4.8	0.0	1.5	5.6	3.2	0.7	0.3	2.4	0.4	1.1	4.0	0.5	0.6	0.5	0.6	14.8	0.8	0.4	1.4	1.0	0.0	0.0	0.0	0.0	3.7	2.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	1.7	0.7	0.1	0.0	0.0	0.0	1.3	1.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	54.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	101.3	0.8	2.4	7.0	3.7	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.5	0.0	1.6	0.0	2.7	1.7	0.0	0.0	0.0	1.6	0.0	3.7	0.0	0.0	0.0	0.5	0.3	0.6	0.2	0.7	0.9	3.7	0.5	0.3	1.3	0.5
FAM155B	"CXorf63, TED, TMEM28"	ENSG00000130054	"Family with sequence similarity 155 member B"	O75949	X	69505241-69532508	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 25.0;seminal vesicle: 6.7;thyroid gland: 10.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.8;HAP1: 15.2;Hep G2: 5.5;NTERA-2: 21.0;SCLC-21H: 10.0"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036093	Uncertain									"HPA036093: AB_10673613"	"prognostic unfavourable (4.61e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.09e-4)"	"unprognostic (7.07e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (4.94e-3)"	"prognostic unfavourable (1.83e-4)"	"prognostic favourable (6.63e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.21e-2)"	0.0	0.5	1.4	0.0	1.1	0.0	0.1	3.5	1.4	0.1	0.0			0.0	0.2	0.3	0.0	0.7	0.1	25.0	1.1	2.1	0.5	0.0	0.0	0.0	1.3		0.0	1.8	0.9	1.1	0.0		0.9	0.0		1.1	6.7	0.0	0.0	0.0	0.0	0.4	0.6	0.5	0.8			10.4		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.6	0.0	4.2	0.0	0.0	15.2	0.6	0.0	0.0	4.1	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.7	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.1	0.0	10.0	0.7	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FAM167A	C8orf13	ENSG00000154319	"Family with sequence similarity 167 member A"	Q96KS9	8	11421463-11474715	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.0;thyroid gland: 51.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 24.4;RPMI-8226: 25.8;SH-SY5Y: 19.6;U-698: 19.5;U-87 MG: 16.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 16.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023915, HPA030426"	Approved		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA023915: AB_1845768, HPA030426: AB_10601318"	"unprognostic (8.51e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.25e-3)"	"prognostic unfavourable (5.96e-4)"	"unprognostic (3.08e-2)"	"unprognostic (4.62e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.06e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.77e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.21e-2)"	0.8	1.6	13.8	1.8	11.2	1.3	2.0	7.1	20.0	1.1	1.4	12.6	0.0	1.1	0.9	1.3	1.4	2.0	1.8	0.9	13.8	7.6	6.6	0.8	10.5	2.8	8.6	11.8	0.8	2.8	0.8	12.3	2.5	12.2	2.1	1.4	0.5	3.3	5.7	0.8	11.8	1.3	0.8	7.0	1.9	2.7	3.2	7.6	0.8	51.1	0.3	3.5	1.3	1.0	4.0	1.3	0.1	1.8	0.9	0.1	0.1	2.0	1.3	2.7	0.2	0.2	1.1	0.0	7.3	7.0	4.4	1.9	0.0	0.6	24.4	0.4	7.8	0.7	0.0	1.7	5.3	10.5	0.3	0.0	0.0	0.0	9.3	0.0	0.0	1.3	1.1	2.3	14.4	0.0	0.1	0.9	2.6	0.7	0.0	0.0	0.7	0.0	0.1	0.0	25.8	2.2	0.2	11.6	19.6	0.3	2.1	0.9	0.8	0.0	12.4	0.4	0.7	11.3	0.1	7.8	5.6	19.5	16.1	0.0	0.7	0.1	0.2	0.0	0.0	1.8	0.1	4.0	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.9	1.7	1.3	0.0	0.1	13.8	11.2	7.1	12.5	13.8	7.6	8.6	11.8	12.2	7.6
FAM180B	LOC399888	ENSG00000196666	"Family with sequence similarity 180 member B"		11	47586693-47589194	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"adipose tissue: 4.6;breast: 6.9;skin 1: 5.2;thyroid gland: 3.9"	"Cell line enhanced"	"Detected in some"		"HEL: 2.2;NB-4: 2.0;SK-MEL-30: 4.1;U-937: 3.1"	"Cancer enhanced"	"Detected in some"		"melanoma: 1.7"					"Cell type enriched"	"Detected in single"	5	"memory CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.2"					"Not detected"	"Not detected"			HPA029408	Uncertain									"HPA029408: AB_10601319"	"unprognostic (1.28e-2)"	"unprognostic (4.99e-3)"		"unprognostic (7.48e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.03e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	4.6	0.4	0.2	0.0	1.4	0.3	6.9	0.7	1.2	0.5	0.4			0.1	0.1	0.3	0.0	0.7	0.8	0.6	0.2	0.9	0.0	0.0	0.1	0.1	1.4		0.1	0.0	0.0	0.0	0.0		0.0	0.4		0.8	0.0	1.1	5.2	0.0	0.1	1.2	0.0	0.3	0.7			3.9		0.2	0.5	0.1	0.0	0.0	0.0	0.2	0.1	1.2	0.0	0.0	0.0	1.8	0.0	1.2	1.3	0.3	0.2	0.1	0.0	0.0	0.2	0.1	0.5	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.3	2.2	0.4	0.7	0.0	0.4	0.6	0.5	0.2	0.0	0.0	0.0	0.5	0.2	0.2	2.0	0.1	2.0	0.3	0.2	0.6	0.4	0.0	0.0	0.1	0.0	0.3	0.2	0.0	4.1	0.2	0.6	1.1	0.5	0.3	0.2	0.0	0.3	0.2	0.1	0.0	3.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0										
FAM189A2	"C9orf61, X123"	ENSG00000135063	"Family with sequence similarity 189 member A2"	Q15884	9	69324567-69392558	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 40.1;thyroid gland: 38.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.3;NTERA-2: 8.3;RPTEC TERT1: 3.1;RT4: 3.6;SK-MEL-30: 8.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 22.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029411, HPA057207"	Approved									"HPA029411: AB_10602338, HPA057207: AB_2683369"	"unprognostic (2.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"prognostic favourable (1.16e-6)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.71e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.07e-2)"	"prognostic favourable (1.75e-5)"	"unprognostic (3.42e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.14e-1)"	3.2	3.1	9.2	1.5	11.6	0.8	13.2	4.5	12.2	25.6	3.9	11.4	8.3	1.8	5.6	2.5	5.3	6.0	2.9	11.5	10.3	4.1	2.0	0.8	21.4	1.3	7.2	4.9	15.0	5.2	8.5	4.7	2.2	20.0	8.9	1.9	6.7	6.4	5.0	40.1	6.7	2.3	6.0	17.1	1.1	9.0	1.5	9.3	3.7	38.0	6.0	1.6	4.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.1	1.1	0.0	0.0	0.9	2.7	0.1	2.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	8.3	0.0	0.0	0.2	0.0	3.1	3.6	0.0	0.1	0.0	0.0	8.0	0.2	0.0	1.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	11.6	4.5	12.2	10.3	4.1	7.2	4.9	20.0	9.3
FNDC1	"bA243O10.1, dJ322A24.1, FNDC2, KIAA1866"	ENSG00000164694	"Fibronectin type III domain containing 1"	Q4ZHG4	6	159169397-159272109	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 36.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.8;fHDF/TERT166: 7.6;HEK 293: 1.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 32.5"	"Region enriched"	"Detected in single"	6	"hippocampal formation: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA030962, HPA030963"	Approved		Approved	"Nuclear speckles"	"Secreted to extracellular matrix"			"Nuclear speckles"	"Nuclear speckles"	"HPA030962: AB_10696212, HPA030963: AB_2673676"	"unprognostic (4.59e-2)"	"unprognostic (9.17e-3)"	"unprognostic (7.62e-2)"	"prognostic favourable (6.10e-5)"	"unprognostic (4.57e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (1.93e-6)"	"unprognostic (6.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.76e-3)"	5.2	0.6	0.5	7.6	0.7	0.0	2.5	0.3	0.7	9.7	12.9	3.2	0.0	2.1	4.8	2.2	2.2	0.9	13.1	3.5	4.8	0.5	1.0	1.5	1.2	2.1	0.7	0.0	4.8	1.2	0.0	0.4	0.7	0.5	0.7	1.6	1.0	2.5	0.6	6.2	1.2	7.0	10.2	1.5	0.7	0.7	2.1	0.1	1.0	36.6	11.8	3.6	1.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.1	2.8	7.6	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.3	0.0	0.2	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.3	0.7	4.8	0.5	0.7	0.0	0.5	0.1
FRAS1	"FLJ14927, FLJ22031, KIAA1500"	ENSG00000138759	"Fraser extracellular matrix complex subunit 1"	Q86XX4	4	78057570-78544269	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 17.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 23.1;Hep G2: 13.9;RH-30: 13.3;SiHa: 13.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051601	Approved				"Intracellular and membrane"					"HPA051601: AB_2681547"	"unprognostic (1.33e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.37e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.45e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.09e-2)"	"unprognostic (4.02e-2)"	"prognostic favourable (4.69e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.78e-3)"	"unprognostic (6.09e-2)"	2.0	1.2	6.2	5.0	10.1	0.1	1.3	0.9	6.4	3.6	2.7	0.7	0.1	0.6	3.3	3.1	2.0	1.5	4.1	2.6	2.3	2.3	11.6	0.8	5.2	0.3	1.2	1.8	0.9	7.9	0.7	5.5	8.3	3.8	3.2	2.2	1.3	1.8	1.3	3.7	2.1	1.4	2.2	0.9	1.1	1.6	1.4	1.0	2.1	17.9	1.9	0.4	1.3	1.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.9	4.4	1.8	0.0	4.8	2.0	3.1	0.7	2.7	0.4	0.2	3.4	6.4	0.0	5.5	23.1	0.8	2.5	1.4	0.1	0.0	2.5	2.6	5.2	13.9	0.5	0.0	0.0	9.5	1.5	0.0	3.5	0.1	0.0	0.0	2.6	0.1	0.1	0.0	5.6	0.8	0.0	13.3	0.0	5.8	6.4	3.3	6.4	13.9	4.4	0.8	0.0	0.0	0.0	0.0	3.1	1.9	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.2	10.1	0.9	6.4	2.3	2.3	1.2	1.8	3.8	1.0
FREM2	DKFZp686J0811	ENSG00000150893	"FRAS1 related extracellular matrix protein 2"	Q5SZK8	13	38687129-38887131	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 13.9;lung: 11.2;thyroid gland: 12.2"	"Cell line enhanced"	"Detected in some"		"AF22: 15.5;HAP1: 10.4;MCF7: 7.5;RT4: 7.0;SK-BR-3: 6.3;WM-115: 5.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA028831	Uncertain		Approved	Cytosol		170000	170000	Cytosol	Cytosol	"HPA028831: AB_10603668"	"unprognostic (1.71e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.69e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.54e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.54e-1)"	"prognostic favourable (2.23e-7)"	"unprognostic (7.21e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.14e-1)"	0.6	0.4	1.3	0.1	1.7	0.1	0.5	1.5	6.4	0.7	1.3	1.2	1.1	0.4	1.1	0.5	0.2	0.9	1.5	0.2	2.8	0.4	13.9	3.4	11.2	0.1	0.4	0.8	1.8	5.2	0.1	1.1	2.6	0.8	3.5	0.4	2.9	0.4	1.5	6.3	0.6	0.7	0.7	0.4	0.3	2.2	1.8	1.5	0.1	12.2	4.1	0.1	1.5	0.3	0.3	0.3	0.9	0.2	0.2	0.2	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	10.4	0.0	0.0	0.3	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	2.3	0.2	0.0	1.5	0.1	2.4	7.0	0.2	0.1	0.0	6.3	0.3	1.1	0.0	0.0	0.0	0.9	0.0	1.5	0.0	0.0	0.0	0.0	0.0	5.8	0.9	0.2	0.2	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.2	0.7	0.2	0.2	0.3	0.1	0.0	1.3	1.7	1.5	6.4	2.8	0.4	0.4	0.8	0.8	1.5
FRMPD3	"KIAA1817, RP5-1070B1.1"	ENSG00000147234	"FERM and PDZ domain containing 3"	Q5JV73	X	107522450-107605251	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.6;ovary: 10.3;thyroid gland: 6.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 10.6;SCLC-21H: 3.3;U-698: 2.9;WM-115: 3.9"	"Cancer enhanced"	"Detected in some"		"glioma: 2.6"					"Cell type enhanced"	"Detected in some"		"gdTCR: 1.7;naive B-cell: 1.2"	"Group enriched"	"Detected in many"	15	"B-cells: 1.2;T-cells: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003164	Uncertain									"HPA003164: AB_1078260"	"unprognostic (1.27e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.48e-4)"	"unprognostic (1.69e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.43e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.83e-9)"	"unprognostic (4.59e-2)"	"unprognostic (7.88e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.26e-1)"	0.0	0.5	2.5	0.7	1.8	0.1	0.5	8.6	6.7	0.2	0.1			0.0	0.9	0.0	0.1	0.4	0.4	0.0	3.1	5.0	0.0	0.0	0.2	1.3	2.6		10.3	0.1	0.0	0.4	0.0		0.6	0.2		0.4	2.6	0.0	0.0	0.0	1.1	2.2	0.2	0.0	0.5			6.0		0.9	0.1	0.0	1.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	2.1	0.7	0.0	0.0	0.0	0.8	0.0	0.4	0.2	0.0	0.5	10.6	0.0	0.1	0.0	0.5	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.3	3.3	0.2	0.6	0.2	0.0	0.4	0.0	0.0	1.0	1.2	0.1	0.0	0.0	0.0	2.9	0.1	0.0	3.9	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.2	1.0	0.0	1.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0										
FZD1	DKFZp564G072	ENSG00000157240	"Frizzled class receptor 1"	Q9UP38	7	91264364-91271326	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 61.2"	"Cell line enhanced"	"Detected in many"		"AF22: 16.3;HSkMC: 21.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 4.2;non-classical monocyte: 5.4"	"Lineage enriched"	"Detected in many"	4	"monocytes: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013008	Approved		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB013008: "	"unprognostic (1.46e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.29e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.39e-3)"	"prognostic favourable (8.87e-7)"	"unprognostic (1.05e-2)"	"unprognostic (4.16e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.13e-2)"	5.8	4.6	2.6	4.9	3.5	0.9	10.7	8.2	2.8	17.6	8.5	4.1	9.3	4.9	10.1	9.9	7.8	6.1	11.0	12.3	6.1	1.8	15.3	3.9	10.5	1.4	2.0	3.2	15.0	7.9	2.5	4.6	10.0	5.7	12.3	3.7	11.1	9.2	17.5	3.1	10.7	8.3	7.2	4.6	3.4	4.5	4.4	3.5	1.4	61.2	6.5	2.9	10.4	13.9	0.1	1.3	0.2	5.4	0.0	0.0	0.4	0.5	1.6	16.3	1.7	13.3	11.5	3.0	5.9	3.8	2.2	1.5	0.7	2.8	0.0	1.4	3.8	3.0	2.5	1.3	1.4	0.0	3.2	0.1	3.1	0.8	0.9	2.6	0.7	21.8	2.3	5.0	1.6	0.5	0.9	2.3	6.3	3.9	0.4	0.7	4.2	2.7	3.2	10.0	0.2	3.5	7.6	2.2	4.3	4.5	3.7	0.9	1.9	2.4	2.4	9.3	7.0	9.8	2.4	2.2	1.5	0.2	10.0	2.2	10.7	0.0	1.4	0.0	0.0	4.2	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	5.4	0.1	0.0	0.4	2.6	3.5	8.2	2.8	6.1	1.8	2.0	3.2	5.7	3.5
GAL3ST3	GAL3ST2	ENSG00000175229	"Galactose-3-O-sulfotransferase 3"	Q96A11	11	66041952-66049180	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.4;retina: 14.2;thyroid gland: 28.0"	"Group enriched"	"Detected in some"	5	"NTERA-2: 12.3;SH-SY5Y: 10.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 10.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"naive CD8 T-cell: 1.8"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"									"prognostic unfavourable (6.53e-6)"	"unprognostic (1.24e-1)"			"unprognostic (3.30e-1)"		"unprognostic (1.57e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.01e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.29e-1)"	0.8	0.7	6.3	0.7	15.4	0.7	0.7	7.5	14.5	5.4	0.8	2.4	0.3	0.8	8.0	1.0	0.8	2.5	0.8	5.9	6.1	4.3	4.0	0.7	0.7	0.9	2.9	5.0	0.9	1.5	1.9	3.5	0.7	3.7	2.2	0.7	14.2	0.8	5.9	1.3	1.0	0.8	9.7	1.2	0.7	0.7	2.6	2.0	0.0	28.0	0.0	0.8	0.7	0.2	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	12.3	0.0	0.0	0.0	0.3	0.0	0.0	0.6	10.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.3	15.4	7.5	14.5	6.1	4.3	2.9	5.0	3.7	2.0
GFRA2	"GDNFRB, NTNRA, RETL2, TRNR2"	ENSG00000168546	"GDNF family receptor alpha 2"	O00451	8	21690403-21812357	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.2;thyroid gland: 17.4"	"Cell line enhanced"	"Detected in some"		"HEL: 8.8;HMC-1: 20.2;WM-115: 3.7"	"Cancer enriched"	"Detected in some"	5	"thyroid cancer: 6.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 10.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.1;monocytes: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024704, CAB032791"	Uncertain		Uncertain	Vesicles	"Intracellular and membrane"	3300000	3300000	Vesicles	Vesicles	"CAB032791: AB_2110428, HPA024704: AB_1849629"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.48e-4)"	"unprognostic (2.87e-1)"	"unprognostic (6.11e-2)"	"unprognostic (4.40e-3)"	"unprognostic (2.11e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.50e-4)"	"unprognostic (8.45e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.68e-2)"	"unprognostic (9.63e-3)"	4.2	3.4	2.6	3.4	6.7	1.2	1.4	2.1	19.2	4.9	3.6	0.7	2.6	3.4	1.3	4.0	3.0	4.3	1.2	3.2	6.8	8.9	1.1	1.9	2.2	4.3	4.3	7.1	1.0	0.9	0.2	2.0	11.5	3.2	1.3	2.0	3.7	2.0	4.9	0.4	1.2	3.2	3.5	1.9	12.2	2.2	6.7	0.2	1.0	17.4	0.0	1.5	2.4	2.6	0.1	3.1	0.9	10.9	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	2.4	0.9	0.0	10.9	0.0	0.0	0.0	0.0	3.1	0.1	0.2	0.0	0.5	0.0	1.4	0.0	0.0	0.9	2.6	6.7	2.1	19.2	6.8	8.9	4.3	7.1	3.2	0.2
GFRA4		ENSG00000125861	"GDNF family receptor alpha 4"	Q9GZZ7	20	3659292-3663399	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 1.8;thyroid gland: 4.9"	"Cell line enhanced"	"Detected in single"		"MOLT-4: 1.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"															"unprognostic (3.50e-2)"						"unprognostic (2.36e-1)"		0.0	0.0	1.7	0.0	0.6	0.1	0.0	0.0	0.6	0.3	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.2	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9			4.9		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GGT2	GGT	ENSG00000133475	"Gamma-glutamyltransferase 2"	P36268	22	21207973-21227637	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"kidney: 5.6;salivary gland: 5.5;thyroid gland: 8.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.3;HeLa: 4.5;Karpas-707: 2.0;U-2197: 13.6"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045635, HPA047534, HPA065444"	Supported		Approved	Vesicles				Vesicles	Vesicles	"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (4.27e-1)"	"unprognostic (6.91e-2)"		"unprognostic (7.03e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.38e-5)"	"unprognostic (1.05e-3)"		"unprognostic (5.85e-4)"	"unprognostic (7.97e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.46e-3)"	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.1	0.2	0.0			1.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.1	2.2	0.0	0.0		0.0	0.1	0.0	0.2	0.0		0.0	0.0		5.5	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.3	1.0			8.4		0.0	0.0	0.0	0.1	0.2	0.4	0.4	0.4	0.5	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.5	0.5	13.6	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.3	0.1	0.5	0.0	0.2	0.0	0.1	0.0	0.4	0.4	0.0	0.0	0.5	0.3										
GNAS	"GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI"	ENSG00000087460	"GNAS complex locus"	"O95467, P63092, P84996, Q5JWF2"	20	58839718-58911192	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 303.3;thyroid gland: 304.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010337, HPA018122, HPA027478, HPA028386"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.90e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.82e-2)"	"unprognostic (4.53e-3)"	"unprognostic (8.01e-2)"	"unprognostic (4.29e-2)"	"prognostic favourable (8.76e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (3.49e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.36e-1)"	56.2	79.0	84.2	34.4	44.5	42.1	87.4	86.0	107.4	43.2	42.3	25.4	27.0	33.2	37.2	44.7	41.0	43.6	34.4	106.0	71.0	144.0	39.6	35.3	46.6	44.6	75.8	64.7	43.6	118.1	120.9	303.3	49.8	85.6	36.3	31.5	42.7	171.6	31.1	172.9	26.3	34.9	40.5	61.4	36.9	42.4	18.2	27.4	56.0	304.5	80.6	41.0	37.3	44.6	27.3	41.5	29.9	36.2	25.3	24.2	24.6	9.6	32.5	54.8	25.5	93.1	42.6	49.2	55.8	51.0	63.9	45.8	94.7	50.1	31.7	86.9	72.5	41.8	50.2	74.3	43.3	20.9	30.2	35.2	49.4	62.0	43.1	20.4	22.2	50.7	37.8	31.0	41.7	48.3	30.9	43.3	42.0	132.2	104.3	50.1	17.4	34.4	64.2	48.0	55.9	51.2	38.2	68.0	155.7	77.6	77.0	62.2	58.9	56.1	53.1	84.8	76.2	30.5	52.5	75.9	49.0	66.9	37.2	10.0	43.2	29.9	24.8	29.5	20.7	35.7	22.1	26.7	22.0	22.2	37.8	27.3	21.3	24.2	29.1	25.3	36.2	41.5	23.3	24.6	84.2	44.5	86.0	107.4	71.0	144.0	75.8	64.7	85.6	27.4
GOLGA8M		ENSG00000188626	"Golgin A8 family member M"	H3BSY2	15	28701954-28738384	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"thyroid gland: 12.6"	"Group enriched"	"Detected in some"	8	"HEL: 2.7;U-937: 9.6"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (1.40e-1)"	"unprognostic (3.90e-2)"			"unprognostic (2.04e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.16e-3)"	"unprognostic (8.16e-4)"	"unprognostic (4.32e-2)"	"unprognostic (2.66e-4)"	"unprognostic (8.24e-3)"	"unprognostic (4.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.60e-1)"	2.4	0.5	0.0	0.0	0.1	0.7	1.5	0.0	0.0	0.7	0.0			0.0	0.2	0.9	0.0	0.4	0.5	0.3	0.0	0.0	0.6	2.4	0.2	0.1	0.0		3.3	0.2	0.0	1.1	3.1		0.1	0.0		0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	4.3			12.6		0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GOLGA8R		ENSG00000186399	"Golgin A8 family member R"	I6L899	15	30403740-30414162	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 10.3"	"Group enriched"	"Detected in some"	8	"HEL: 21.5;THP-1: 7.4;U-937: 8.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (1.13e-1)"	"unprognostic (8.96e-3)"	"unprognostic (1.27e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.09e-2)"	"unprognostic (9.79e-4)"	"unprognostic (2.29e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.80e-2)"	"unprognostic (9.68e-2)"	2.3	1.2	0.3	1.7	0.7	5.9	1.9	0.3	0.7	2.2	1.5			1.0	2.3	2.9	1.1	2.1	1.6	2.5	0.4	0.4	1.1	1.5	1.3	0.9	0.7		5.0	3.5	2.8	4.3	0.4		1.2	0.5		1.7	0.9	1.4	2.7	1.5	1.4	1.4	1.6	1.6	4.2			10.3		0.6	2.8	2.1	0.0	0.9	0.3	0.3	0.4	0.9	0.0	0.1	0.0	0.1	0.0	0.0	1.5	0.0	0.6	0.3	0.0	0.2	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	21.5	0.0	0.0	0.3	0.0	0.0	0.4	0.4	0.1	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.1	7.4	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	8.6	0.2	0.0	0.3	0.3	0.9	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.9	0.0	0.0										
GPX3		ENSG00000211445	"Glutathione peroxidase 3"	P22352	5	151020438-151028993	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 844.2;thyroid gland: 424.1"	"Cell line enriched"	"Detected in some"	12	"ASC diff: 417.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 856.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 16.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 16.7"	"Region enhanced"	"Detected in many"		"hypothalamus: 279.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 67.2;hypothalamus: 176.5;midbrain: 58.6;pons and medulla: 52.3"	CAB069456	Approved				"Secreted to blood"	10000000000	10000000000			"CAB069456: AB_1616682"	"unprognostic (4.03e-1)"	"unprognostic (7.35e-2)"	"unprognostic (5.05e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.70e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavourable (1.65e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.26e-1)"	177.5	21.9	1.2	6.6	5.5	1.6	310.9	3.1	6.3	26.2	33.9	5.1	6.5	7.5	11.8	16.8	44.4	27.0	17.3	108.1	2.7	5.0	844.2	64.1	88.2	43.8	3.9	1.8	28.8	13.0	5.5	32.3	44.8	17.6	41.3	8.3	160.8	14.8	12.4	56.7	18.7	18.5	48.5	3.5	29.6	19.5	23.6	1.2	0.5	424.1	19.0	9.8	58.8	164.2	0.0	3.5	16.7	3.6	0.0	0.2	1.2	0.1	0.5	0.4	0.1	417.4	0.3	0.4	0.1	0.0	0.4	0.1	8.9	0.2	0.0	11.4	0.2	0.1	2.0	22.5	0.3	0.3	0.1	0.0	0.2	9.7	16.0	0.0	0.2	35.3	2.1	0.0	0.0	0.5	0.0	0.0	0.5	1.5	0.0	0.0	0.7	0.0	0.0	0.2	0.0	3.9	0.2	0.6	0.6	0.0	1.6	0.1	2.2	0.1	0.1	0.1	1.0	0.1	0.0	0.1	0.7	0.1	0.3	0.1	0.0	0.0	3.6	0.1	0.0	1.4	0.2	0.0	0.0	0.0	3.5	0.0	0.0	0.0	16.7	0.0	0.1	0.0	0.0	1.2	1.2	5.5	3.1	3.6	2.7	5.0	3.9	1.8	17.6	1.2
HHEX	"HEX, HOX11L-PEN, PRHX"	ENSG00000152804	"Hematopoietically expressed homeobox"	Q03014	10	92689951-92695646	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 71.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 25.5;HEL: 27.7;HMC-1: 30.7;HUVEC TERT2: 30.3;K-562: 42.1;NB-4: 28.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 56.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	46	"basophil: 7.9;classical monocyte: 14.7;eosinophil: 21.4;intermediate monocyte: 16.4;memory B-cell: 21.4;myeloid DC: 11.3;naive B-cell: 25.0;neutrophil: 11.8;non-classical monocyte: 17.8;plasmacytoid DC: 13.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA051894, HPA055460"	Approved		Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA051894: AB_2681653, HPA055460: AB_2682820"	"prognostic favourable (8.83e-4)"	"prognostic favourable (3.91e-5)"	"unprognostic (2.98e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavourable (6.23e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (3.25e-5)"	"unprognostic (8.82e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.50e-2)"	6.3	8.2	2.8	12.0	3.6	28.1	13.7	0.9	2.2	4.5	3.2	3.0	1.1	2.3	3.6	3.8	2.9	2.7	18.0	7.3	2.8	2.1	2.8	33.1	15.3	29.7	3.6	0.9	1.9	15.6	0.7	1.5	6.4	2.8	4.3	2.4	2.3	1.9	1.6	2.8	2.2	8.4	9.3	2.9	18.3	2.7	1.9	2.8	1.8	71.4	2.0	11.3	6.5	7.1	25.0	13.5	21.4	17.8	0.3	0.3	4.9	3.0	5.8	3.0	0.0	0.2	0.2	0.0	1.6	13.2	2.1	1.9	1.1	0.7	3.0	25.5	0.2	0.6	2.7	0.0	2.6	0.0	3.1	27.7	2.4	18.6	6.2	16.0	30.7	0.0	0.0	1.9	0.0	30.3	42.1	0.0	0.1	0.9	0.1	28.1	0.0	3.4	9.4	0.8	0.0	0.2	1.2	1.4	0.3	1.7	0.0	0.0	0.9	8.5	10.5	0.0	0.1	0.0	0.0	0.7	0.5	5.8	0.0	22.2	14.6	7.9	14.7	21.4	0.3	16.4	0.1	21.4	0.0	0.0	11.3	25.0	0.0	0.0	11.8	0.3	17.8	13.5	0.1	4.9	2.8	3.6	0.9	2.2	2.8	2.1	3.6	0.9	2.8	2.8
HHIPL2	"FLJ13840, KIAA1822L"	ENSG00000143512	"HHIP like 2"	Q6UWX4	1	222522258-222548103	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"prostate: 9.4;testis: 10.4;thyroid gland: 4.6"	"Cell line enhanced"	"Detected in some"		"A549: 3.9;Hep G2: 5.4;RH-30: 20.3;U-87 MG: 10.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059673	Enhanced		Uncertain	Mitochondria,Cytosol	"Secreted in other tissues"			Mitochondria	Mitochondria	"HPA059673: AB_2684100"	"unprognostic (1.35e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.91e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.74e-3)"	"prognostic unfavourable (4.64e-4)"	"unprognostic (8.07e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.14e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.52e-2)"	"unprognostic (4.21e-4)"	"unprognostic (2.30e-3)"	"unprognostic (8.38e-2)"	0.3	0.7	0.0	0.1	0.6	0.1	0.2	0.1	1.4	0.7	0.0	0.6	0.0	0.0	0.1	0.5	0.5	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.9	9.4	0.2	0.3	1.9	3.9	0.0	0.1	0.1	0.0	0.0	0.1	0.1	10.4	0.0	0.0	4.6	0.0	0.3	0.2	0.7	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.0	3.9	0.1	0.1	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.7	5.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.3	0.0	20.3	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.2	0.0	0.1	0.0	10.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.1	1.4	0.0	0.1	0.0	0.0	0.9	0.0
HIRA	"DGCR1, TUP1, TUPLE1"	ENSG00000100084	"Histone cell cycle regulator"	P54198	22	19330698-19447450	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 50.0"	"Cell line enhanced"	"Detected in all"		"K-562: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB039243, CAB039244, HPA050714, HPA052902"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB039243: , CAB039244: , HPA050714: AB_2681219, HPA052902: AB_2681984"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.45e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.50e-1)"	"prognostic favourable (8.11e-4)"	"prognostic favourable (3.97e-4)"	"unprognostic (9.05e-2)"	"prognostic favourable (5.18e-6)"	"unprognostic (4.84e-2)"	"unprognostic (8.57e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.32e-3)"	9.9	9.8	14.8	10.0	13.6	19.9	7.4	16.7	16.3	8.0	11.7	10.9	9.4	12.4	11.9	8.4	9.7	11.5	10.0	9.2	13.4	11.6	12.8	15.0	9.1	11.4	11.3	10.0	10.8	11.3	25.6	11.4	7.6	9.8	7.6	9.4	8.9	8.6	8.7	15.3	10.8	12.1	10.3	8.3	10.2	10.1	10.5	10.6	20.3	50.0	4.6	10.0	8.9	18.2	8.2	2.9	6.1	1.2	3.6	2.4	1.2	8.0	7.0	9.9	10.3	9.7	6.4	7.0	6.7	7.8	11.1	11.1	16.0	4.6	15.5	3.3	8.6	9.4	14.1	8.5	7.2	9.6	16.3	14.3	7.5	14.5	10.6	33.2	10.6	7.7	8.3	8.7	8.5	8.0	73.7	8.3	6.3	9.9	16.3	11.8	9.0	7.1	13.0	14.1	4.6	6.4	8.9	14.6	9.7	7.7	7.7	9.2	4.9	11.6	9.2	7.7	11.4	7.8	7.9	8.9	8.7	16.3	8.9	10.7	6.3	6.1	1.2	5.0	2.3	1.2	2.4	3.7	1.3	2.3	1.5	8.2	0.6	1.7	2.2	3.6	0.6	2.9	0.6	1.2	14.8	13.6	16.7	16.3	13.4	11.6	11.3	10.0	9.8	10.6
HRK	DP5	ENSG00000135116	"Harakiri, BCL2 interacting protein"	O00198	12	116856144-116881441	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 17.3;lymphoid tissue: 12.9;thyroid gland: 8.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.6;SCLC-21H: 6.5;SH-SY5Y: 5.6;SK-MEL-30: 14.9;U-698: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	23	"eosinophil: 2.2;memory B-cell: 6.7;naive B-cell: 5.5"	"Group enriched"	"Detected in many"	45	"B-cells: 6.7;granulocytes: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB025973	Uncertain									"CAB025973: "	"unprognostic (9.38e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.54e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.24e-3)"	"unprognostic (5.21e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.42e-2)"	0.5	1.9	10.1	1.2	3.2	1.7	2.9	0.5	17.3	0.4	0.6	1.3	0.0	0.4	0.5	0.4	0.5	1.4	0.4	0.6	12.1	3.6	0.4	0.3	0.6	1.9	1.8	4.1	0.4	0.6	0.3	5.0	0.4	2.6	0.4	0.7	0.0	1.0	0.3	1.3	0.6	0.5	0.4	1.1	0.8	0.4	1.4	0.6	12.9	8.1	0.0	1.8	0.4	0.2	6.7	0.0	2.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.3	0.0	3.1	1.7	0.0	0.0	0.0	3.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.7	0.1	0.7	0.0	1.0	0.1	0.0	6.5	5.6	0.4	0.0	14.9	0.4	0.1	0.0	0.0	1.3	0.2	0.0	0.7	0.3	25.8	0.0	0.3	0.0	0.1	0.0	2.2	0.0	0.0	0.0	6.7	0.0	0.0	0.0	5.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	10.1	3.2	0.5	8.5	12.1	3.6	1.8	4.1	2.6	0.6
HSP90B1	"GP96, GRP94, TRA1"	ENSG00000166598	"Heat shock protein 90 beta family member 1"	P14625	12	103930107-103953645	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 325.1;thyroid gland: 338.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003901, CAB005224, HPA008424, CAB078151"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"	410000000	410000000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB005224: AB_2119181, CAB078151: , HPA003901: AB_1851181, HPA008424: AB_1851184"	"unprognostic (1.03e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.00e-2)"	"unprognostic (7.22e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (1.03e-10)"	"unprognostic (2.95e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-2)"	49.0	57.1	26.9	50.0	32.0	45.9	60.3	16.5	25.5	45.7	43.4	17.5	108.5	32.1	42.2	127.2	34.3	42.0	32.4	67.0	27.1	32.0	74.0	325.1	46.6	49.2	31.5	26.0	53.9	95.5	47.1	50.0	123.6	29.4	46.9	46.9	15.8	43.8	136.8	25.4	19.2	54.4	45.0	37.8	89.3	37.0	25.7	27.9	44.5	338.5	24.0	36.9	66.1	106.1	25.6	81.0	22.2	23.8	40.2	53.3	33.9	79.2	43.0	86.8	89.1	88.9	84.0	117.8	133.6	101.0	71.2	95.1	76.6	74.3	23.2	106.3	140.2	55.4	85.4	143.5	96.1	54.8	32.6	62.3	48.5	79.0	137.1	62.8	48.9	49.2	64.0	87.6	125.8	136.9	49.8	88.2	94.0	28.5	37.7	70.3	71.3	51.8	34.4	56.0	96.9	95.2	50.0	25.8	61.8	83.4	86.3	84.3	70.2	93.3	78.7	53.9	46.2	43.8	55.7	90.3	84.5	42.9	107.4	46.5	83.4	22.2	21.2	6.9	45.6	23.8	53.3	25.6	26.7	39.3	28.0	15.9	18.0	31.3	4.9	40.2	19.3	81.0	16.4	33.9	26.9	32.0	16.5	25.5	27.1	32.0	31.5	26.0	29.4	27.9
INPP5J	"INPP5, PIB5PA, PIPP"	ENSG00000185133	"Inositol polyphosphate-5-phosphatase J"	Q15735	22	31122731-31134696	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 65.2;thyroid gland: 71.2"	"Cell line enhanced"	"Detected in many"		"HL-60: 12.1;SK-BR-3: 26.2;T-47d: 16.5;U-698: 11.4"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 63.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 2.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034539			Approved	Nucleoli,Cytosol				Cytosol	Cytosol	"HPA034539: "	"unprognostic (1.76e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.21e-3)"	"prognostic favourable (1.47e-5)"	"unprognostic (6.81e-2)"	"unprognostic (1.86e-2)"	"unprognostic (4.29e-4)"	"unprognostic (1.47e-1)"	"prognostic favourable (1.12e-7)"	"unprognostic (2.79e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.39e-2)"	0.8	0.9	4.6	0.8	6.3	0.5	3.7	27.4	13.4	1.5	6.4	0.8	16.7	7.9	1.3	0.8	1.0	1.0	1.0	9.5	7.4	2.0	9.5	0.5	1.5	0.7	2.3	4.6	0.8	5.3	65.2	3.7	0.5	5.5	3.5	2.2	5.6	15.5	19.2	1.6	1.7	21.7	1.2	0.9	0.6	3.8	1.6	1.1	0.0	71.2	0.0	0.7	1.1	0.9	0.3	2.4	0.0	0.4	0.0	0.0	0.2	1.3	1.3	0.8	1.4	0.2	0.1	0.7	0.5	0.5	2.6	2.6	0.7	0.8	0.0	0.6	0.2	1.5	1.6	0.7	1.1	0.0	4.2	0.0	5.5	0.2	0.5	12.1	0.1	0.1	0.8	2.2	0.2	0.1	1.1	1.8	0.0	4.0	0.1	0.0	1.4	0.2	0.0	0.3	2.8	1.1	1.6	6.4	4.8	1.0	26.2	0.3	16.5	1.0	0.0	0.1	4.8	0.5	0.3	0.0	2.0	11.4	0.4	0.0	2.0	0.0	0.4	0.0	0.0	0.3	0.0	0.3	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.2	4.6	6.3	27.4	13.4	7.4	2.0	2.3	4.6	5.5	1.1
IQCA1	"DRC11, FLJ22527, IQCA"	ENSG00000132321	"IQ motif containing with AAA domain 1"	Q86XH1	2	236324147-236507542	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 27.8;thyroid gland: 30.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 4.2;HBEC3-KT: 3.9;HeLa: 4.7;U-2 OS: 16.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 9.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 4.4"	"Group enriched"	"Detected in many"	4	"NK-cells: 1.2;T-cells: 4.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA057320			Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA057320: "	"unprognostic (1.73e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.62e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.23e-5)"	"unprognostic (1.55e-1)"	"unprognostic (7.23e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.62e-1)"	"prognostic favourable (2.54e-4)"	"unprognostic (1.19e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.91e-3)"	"unprognostic (5.30e-2)"	1.8	2.7	13.4	1.4	19.2	0.8	3.5	3.8	11.6	2.2	1.0	6.7	0.4	0.9	3.4	9.1	1.6	17.8	3.5	1.1	12.9	10.0	6.6	0.8	5.1	1.3	8.8	9.3	4.7	2.4	0.9	27.8	1.1	13.0	3.1	1.0	2.7	2.6	2.8	0.8	0.9	1.2	1.5	3.2	5.5	1.1	7.4	8.0	1.4	30.0	0.0	1.6	3.0	1.0	0.7	0.0	0.0	0.0	1.2	4.4	0.1	0.1	0.0	0.3	0.3	0.0	0.0	0.4	0.2	0.0	0.1	0.4	0.1	0.0	0.0	4.2	0.0	0.0	0.0	3.9	0.0	0.0	0.1	0.0	4.7	0.0	0.1	0.0	0.0	0.3	2.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	16.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.2	0.8	0.0	0.7	1.1	4.4	0.0	1.2	0.0	0.0	0.3	0.1	13.4	19.2	3.8	10.0	12.9	10.0	8.8	9.3	13.0	8.0
ISM1	"bA149I18.1, C20orf82"	ENSG00000101230	"Isthmin 1"	B1AKI9	20	13221771-13300651	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 33.8"	"Group enriched"	"Detected in some"	5	"ASC diff: 35.4;Hep G2: 13.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 4.0;naive CD4 T-cell: 3.3"	"Lineage enriched"	"Detected in single"	40	"T-cells: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (7.13e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.43e-3)"	"unprognostic (5.27e-3)"	"unprognostic (1.84e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (9.32e-6)"	"unprognostic (2.58e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.81e-2)"	7.8	2.4	0.8	0.5	1.1	0.0	17.0	0.7	1.5	2.4	2.1	0.8	2.0	0.3	1.8	2.3	4.5	2.3	4.4	2.2	1.0	1.7	2.4	4.5	3.2	1.0	0.7	0.9	1.1	5.7	0.1	1.0	12.7	1.3	1.9	0.2	0.8	8.9	0.7	2.3	9.2	1.1	1.7	0.6	4.8	1.9	1.2	0.8	1.4	33.8	5.5	1.1	3.8	6.1	0.0	0.0	0.0	0.0	0.0	4.0	1.5	0.0	0.3	0.1	0.5	35.4	5.0	0.2	0.3	2.9	0.0	0.0	1.9	0.3	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	2.8	0.0	0.0	13.5	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.0	0.3	0.0	0.2	1.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	1.0	0.1	0.6	0.0	0.0	0.0	2.0	0.1	0.2	0.0	3.3	0.6	0.0	1.5	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.4	0.0	0.0	3.3	0.5	0.0	0.0	0.0	0.0	0.0	1.5	0.8	1.1	0.7	1.5	1.0	1.7	0.7	0.9	1.3	0.8
ITGB3	"CD61, GP3A, GPIIIa"	ENSG00000259207	"Integrin subunit beta 3"	P05106	17	47253846-47311816	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 36.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 45.5;HEL: 40.3;RPTEC TERT1: 26.2;U-87 MG: 20.6;WM-115: 65.7"	"Group enriched"	"Detected in many"	6	"melanoma: 7.5;renal cancer: 3.6;thyroid cancer: 11.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	19	"basophil: 2.8;neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 2.8"									HPA027852	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	710000000	710000000	"Plasma membrane"	"Plasma membrane"	"HPA027852: AB_10601760"	"unprognostic (1.13e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.47e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.04e-3)"	"unprognostic (3.70e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-1)"	"unprognostic (6.35e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-3)"	10.0	0.6	1.0	6.2	2.5	2.7	7.0	0.4	1.6	4.6	13.6	0.9	2.4	2.2	9.7	5.7	6.4	6.4	2.8	8.5	0.7	0.6	16.0	3.7	5.2	1.2	2.3	0.1	4.6	0.6	0.7	1.6	23.5	1.6	6.4	4.8	1.8	2.5	11.5	4.9	2.4	5.0	17.0	1.8	9.5	3.6	2.6	0.6	0.2	36.6	1.9	0.9	11.0	7.8	0.1	0.0	2.8	0.1	0.0	0.0	9.5	0.0	0.4	0.1	0.0	2.3	1.0	0.0	1.2	6.0	2.6	2.4	0.0	0.0	0.1	45.5	0.3	0.0	0.0	0.0	3.4	0.8	0.0	40.3	0.1	0.0	1.9	0.0	0.0	0.9	0.0	15.2	0.3	11.3	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.0	1.0	0.0	26.2	0.0	0.0	0.1	1.5	0.0	8.2	0.0	0.0	12.3	0.5	0.6	0.3	2.8	0.0	0.0	0.2	20.6	0.0	65.7	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	9.5	1.0	2.5	0.4	1.6	0.7	0.6	2.3	0.1	1.6	0.6
KCNAB1	"AKR6A3, hKvb3, hKvBeta3, KCNA1B, Kvb1.3"	ENSG00000169282	"Potassium voltage-gated channel subfamily A member regulatory beta subunit 1"	Q14722	3	156037701-156539138	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 41.1;thyroid gland: 25.7"	"Cell line enhanced"	"Detected in many"		"HEL: 5.8;hTEC/SVTERT24-B: 9.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 300.5"	"Low region specificity"	"Detected in all"			"HPA036110, HPA044550"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"				Vesicles	Vesicles	"HPA036110: , HPA044550: AB_10797032"	"unprognostic (1.52e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.98e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.83e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.87e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.00e-1)"	12.6	5.9	7.5	1.1	41.1	1.4	3.5	10.7	16.4	5.7	2.9	4.6	2.5	1.6	3.4	11.9	2.1	2.7	2.7	4.8	12.3	4.3	1.8	2.3	3.1	0.9	3.7	10.3	2.8	3.7	1.8	1.2	1.3	3.0	21.1	1.8	7.2	3.4	17.9	1.7	1.3	1.9	2.6	2.6	4.3	1.3	2.7	12.3	0.0	25.7	1.0	0.5	2.0	3.0	1.0	4.3	2.4	1.2	0.9	2.7	0.4	0.8	0.8	1.2	0.3	0.1	0.0	2.5	2.2	0.0	0.0	0.2	1.7	0.2	0.6	1.1	0.0	0.5	0.0	0.0	0.0	0.6	1.7	5.8	1.0	2.6	0.0	1.6	0.5	0.0	0.0	9.1	0.0	3.6	0.2	0.5	0.4	0.2	0.5	1.0	1.8	0.4	0.9	1.2	4.6	0.0	0.4	1.3	1.4	0.5	1.1	1.1	1.4	0.9	3.7	1.5	0.9	2.4	1.9	3.2	0.7	0.7	4.5	1.9	1.6	2.4	0.6	0.2	1.5	0.7	2.7	0.9	1.4	1.3	0.9	1.0	1.2	1.3	0.1	0.9	1.2	4.3	1.7	0.4	7.5	41.1	10.7	16.4	12.3	4.3	3.7	10.3	3.0	12.3
KCNC3	"Kv3.3, SCA13"	ENSG00000131398	"Potassium voltage-gated channel subfamily C member 3"	Q14003	19	50311937-50333515	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 32.1;parathyroid gland: 31.1;thyroid gland: 23.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.7;CAPAN-2: 7.6;HDLM-2: 7.9;HMC-1: 20.9;K-562: 7.7;SK-BR-3: 14.2;T-47d: 13.5;U-2 OS: 9.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018041	Approved									"HPA018041: AB_1855579"	"unprognostic (8.05e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.01e-4)"	"unprognostic (4.41e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.94e-3)"	"unprognostic (2.10e-5)"	"prognostic unfavourable (1.23e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.19e-1)"	1.4	2.2	7.2	5.4	9.4	1.4	2.3	32.1	31.2	3.1	1.1	3.4	3.0	1.8	4.5	5.8	1.1	12.8	1.4	1.7	6.9	4.2	10.6	2.5	4.5	4.7	4.0	6.6	0.6	3.7	31.1	9.7	2.4	15.6	2.4	1.4	3.0	2.3	15.1	1.2	2.1	1.8	1.7	3.8	6.5	2.1	2.4	2.9	1.1	23.9	0.0	3.4	1.8	1.0	0.4	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	4.1	0.0	0.0	0.0	0.0	8.7	7.6	0.7	1.0	0.0	1.1	0.2	0.0	0.0	7.9	1.8	0.0	0.0	1.7	0.0	0.0	20.9	0.1	0.0	0.0	0.0	0.1	7.7	0.0	0.0	2.7	0.1	0.0	1.1	3.3	0.0	0.1	0.0	0.5	0.2	0.0	1.4	1.6	14.2	0.0	13.5	2.1	0.1	0.0	9.3	0.0	0.0	0.0	0.1	0.4	0.3	1.7	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	7.2	9.4	32.1	31.2	6.9	4.2	4.0	6.6	15.6	2.9
KCNJ16	"BIR9, Kir5.1"	ENSG00000153822	"Potassium voltage-gated channel subfamily J member 16"	Q9NPI9	17	70053429-70135608	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 96.5;parathyroid gland: 59.4;thyroid gland: 60.4"	"Cell line enriched"	"Detected in some"	23	"RPTEC TERT1: 78.9"	"Group enriched"	"Detected in many"	10	"renal cancer: 37.2;thyroid cancer: 80.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 5.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059563	Approved		Uncertain	Vesicles				Vesicles	Vesicles	"HPA059563: AB_2684065"	"unprognostic (2.81e-3)"	"unprognostic (2.10e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.38e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.34e-1)"	"prognostic favourable (9.61e-7)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"prognostic favourable (6.58e-4)"	"unprognostic (3.88e-1)"	0.4	0.3	4.1	0.3	4.4	0.4	1.5	22.6	6.1	0.3	0.4	1.7	12.6	0.4	0.4	6.4	0.3	2.0	6.5	0.4	6.0	7.2	96.5	0.9	0.5	0.4	8.3	3.4	0.4	15.8	59.4	0.8	0.5	25.5	1.0	0.3	0.0	4.1	14.3	0.4	0.5	1.2	0.2	7.5	1.1	7.4	0.8	5.3	0.0	60.4	0.0	0.2	0.3	0.3	1.1	0.5	5.1	0.2	0.9	1.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	78.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.6	0.9	0.1	1.2	1.0	1.0	0.5	0.1	1.1	0.7	0.6	5.1	0.9	0.1	0.5	1.1	0.3	4.1	4.4	22.6	6.1	6.0	7.2	8.3	3.4	25.5	5.3
KHDRBS2	"MGC26664, SLM-1, SLM1"	ENSG00000112232	"KH RNA binding domain containing, signal transduction associated 2"	Q5VWX1	6	61679960-62286227	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.4;thyroid gland: 16.9"	"Cell line enhanced"	"Detected in some"		"AF22: 12.5;NTERA-2: 3.2;THP-1: 2.6"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"memory B-cell: 6.8;naive B-cell: 10.4;plasmacytoid DC: 2.6"	"Group enriched"	"Detected in many"	13	"B-cells: 10.4;dendritic cells: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA000500, HPA029392"	Supported									"HPA000500: AB_1079184, HPA029392: AB_10600816"	"unprognostic (6.98e-2)"			"unprognostic (1.21e-1)"	"unprognostic (3.06e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.80e-3)"	"unprognostic (4.35e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.25e-4)"	"unprognostic (1.45e-2)"	"unprognostic (2.19e-5)"	"unprognostic (5.52e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.15e-1)"	1.1	3.0	6.4	4.7	18.4	1.6	0.8	0.9	16.9	0.9	1.6	1.2	0.0	1.0	3.2	0.8	0.9	0.9	1.0	0.9	6.7	8.1	1.9	0.8	9.7	2.4	4.0	14.6	1.2	0.8	0.7	7.3	2.4	3.9	1.0	1.4	1.3	1.2	1.3	1.2	0.7	2.2	1.3	2.2	3.8	1.0	1.0	1.6	0.0	16.9	0.0	2.9	0.9	0.5	10.4	2.6	0.0	0.5	0.1	0.0	0.3	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.2	0.0	6.8	0.0	0.0	0.1	10.4	0.0	0.0	0.0	0.1	0.3	2.6	0.0	0.3	6.4	18.4	0.9	16.9	6.7	8.1	4.0	14.6	3.9	1.6
KLRG2	"CLEC15B, FLJ44186"	ENSG00000188883	"Killer cell lectin like receptor G2"	A4D1S0	7	139452690-139483712	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 9.7;thyroid gland: 22.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.0;HAP1: 11.5;NTERA-2: 6.1;SCLC-21H: 5.5;SK-BR-3: 23.5"	"Cancer enriched"	"Detected in many"	11	"testis cancer: 42.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA018199	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA018199: AB_2133260"	"unprognostic (2.50e-2)"	"unprognostic (3.05e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.38e-8)"	"unprognostic (2.41e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.13e-2)"	"prognostic favourable (8.61e-4)"	"unprognostic (2.14e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.34e-2)"	0.2	0.1	0.0	0.0	0.3	0.0	2.4	0.0	0.8	1.0	0.0	0.2	0.0	0.0	0.2	0.7	7.3	0.2	0.0	0.0	0.0	0.0	4.5	0.0	6.2	0.0	0.1	0.0	0.0	0.2	6.5	0.9	0.7	0.3	0.2	0.1	0.3	9.7	0.3	0.1	4.7	0.0	1.5	1.4	0.0	0.2	2.3	0.0	0.9	22.1	2.6	2.3	0.8	2.4	0.4	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	3.2	0.0	1.6	11.5	0.0	0.0	0.0	2.8	0.0	0.4	0.0	0.1	0.0	0.2	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.8	0.0	6.1	0.1	0.0	0.0	0.0	0.4	0.1	5.5	0.3	1.7	23.5	0.0	5.2	1.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.1	0.0	0.3	0.0
KRT7	"CK7, K2C7, K7, SCL"	ENSG00000135480	"Keratin 7"	P08729	12	52232520-52252186	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 156.6;salivary gland: 142.6;thyroid gland: 199.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 117.7;HBEC3-KT: 262.1;RT4: 312.5;SiHa: 246.4;SK-BR-3: 143.9"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 560.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"intermediate monocyte: 3.8"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000028, HPA007272, HPA007315"	Enhanced		Supported	"Intermediate filaments"		350000000	350000000	"Intermediate filaments"	"Intermediate filaments"	"CAB000028: AB_2134589, HPA007272: AB_1079181, HPA007315: "	"unprognostic (2.71e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavourable (1.99e-4)"	"unprognostic (2.22e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.44e-3)"	"unprognostic (2.74e-1)"	"prognostic unfavourable (9.42e-5)"	"prognostic unfavourable (7.78e-5)"	"unprognostic (4.54e-2)"	"prognostic favourable (2.77e-9)"	"unprognostic (2.82e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.98e-3)"	3.5	0.2	0.2	0.6	0.2	0.0	43.1	0.2	0.2	7.8	0.5	0.1	18.0	0.0	1.7	9.6	14.4	11.7	27.1	1.2	0.2	0.2	35.0	4.3	63.2	0.0	0.2	0.2	3.3	15.1	1.7	2.1	156.6	0.6	23.1	0.0	0.1	142.6	67.3	0.4	10.7	0.3	4.3	0.3	0.2	2.3	4.3	0.0	0.4	199.7	6.1	16.3	58.2	22.3	0.0	0.8	0.0	3.8	0.0	0.0	0.2	0.1	99.7	0.0	0.0	0.1	0.0	117.7	21.4	0.0	11.2	1.0	0.3	71.2	0.0	0.0	7.3	78.5	0.0	262.1	0.5	0.1	0.0	0.0	53.5	0.3	2.5	0.0	0.0	0.0	16.3	0.0	105.7	11.3	0.0	0.0	0.0	0.5	0.0	0.1	0.3	0.1	0.0	0.2	1.5	64.7	312.5	0.1	0.1	246.4	143.9	0.0	5.5	0.0	85.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.6	0.0
LIPG	EDL	ENSG00000101670	"Lipase G, endothelial type"	Q9Y5X9	18	49560699-49599182	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 37.0;placenta: 44.7;thyroid gland: 84.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 30.7;HaCaT: 47.1;RPTEC TERT1: 31.3;TIME: 61.1"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 20.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 3.7;basal ganglia: 2.1;cerebral cortex: 2.9;hippocampal formation: 1.8;olfactory region: 1.9"	"Low region specificity"	"Detected in all"			HPA016966	Uncertain				"Secreted to blood"	170000	170000			"HPA016966: AB_1852893"	"unprognostic (2.20e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.25e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.44e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.98e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.35e-1)"	1.5	0.4	0.8	4.7	0.7	0.1	0.8	2.0	0.7	0.4	5.6	3.9	15.0	1.9	0.4	3.1	1.0	0.5	4.3	1.2	1.1	0.9	5.2	37.0	4.4	0.7	1.1	0.1	0.5	1.0	0.0	0.6	44.7	1.4	1.0	2.2	8.3	0.6	24.6	2.6	1.1	7.6	2.2	1.4	0.4	1.4	5.8	0.4	0.3	84.3	2.1	0.5	2.0	0.6	1.2	0.6	2.1	0.6	1.7	0.8	0.1	0.5	0.0	13.5	30.7	0.1	0.0	0.2	0.1	1.4	0.0	0.0	13.3	4.8	0.0	7.5	0.0	47.1	2.0	9.6	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.2	1.4	10.8	4.8	9.4	7.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.7	31.3	3.6	0.2	0.0	0.2	0.3	0.0	0.0	0.0	61.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.4	0.7	0.4	0.4	0.8	0.5	0.5	0.2	1.2	0.8	0.7	2.1	1.7	0.4	0.6	0.4	0.1	0.8	0.7	2.0	0.5	1.1	0.9	1.1	0.1	1.4	0.4
LRP1B	"LRP-DIT, LRPDIT"	ENSG00000168702	"LDL receptor related protein 1B"	Q9NZR2	2	140231423-142131701	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.7;thyroid gland: 14.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.2;HEK 293: 4.4;HeLa: 2.3;HSkMC: 2.1;U-138 MG: 4.9;U-87 MG: 2.5"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"myeloid DC: 1.4;plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.4"	"Low region specificity"	"Detected in all"							"HPA069094, HPA074788"	Approved		Approved	Vesicles		63000	63000	Vesicles	Vesicles	"HPA069094: AB_2686082, HPA074788: AB_2797273"	"unprognostic (5.31e-4)"	"unprognostic (3.68e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.36e-4)"	"unprognostic (5.19e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.75e-1)"	"unprognostic (7.02e-3)"	"unprognostic (1.64e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.94e-3)"	"unprognostic (4.85e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.36e-1)"	4.8	4.5	17.6	1.3	14.1	1.2	2.6	23.2	25.7	1.4	1.3	6.5	0.0	1.2	1.3	6.8	1.3	1.9	1.4	1.6	18.3	9.3	2.2	1.6	1.4	1.2	10.8	16.7	3.0	1.2	1.1	12.7	1.2	12.8	3.5	1.3	0.1	2.5	3.8	10.5	1.7	1.3	1.3	8.2	1.2	1.5	1.9	10.6	0.0	14.9	0.0	1.3	1.2	1.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	4.2	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.9	0.2	0.2	0.6	4.4	0.0	2.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.2	0.0	0.0	0.0	0.0	0.0	4.9	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	17.6	14.1	23.2	21.3	18.3	9.3	10.8	16.7	12.8	10.6
LRP8	"APOER2, HSZ75190, LRP-8, MCI1"	ENSG00000157193	"LDL receptor related protein 8"	Q14114	1	53242364-53328070	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 22.5;thyroid gland: 48.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.2;T-cells: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073031	Enhanced				"Secreted in other tissues"	240000	240000			"HPA073031: AB_2732217"	"unprognostic (3.83e-2)"	"unprognostic (6.06e-2)"	"unprognostic (6.36e-2)"	"prognostic unfavourable (3.46e-6)"	"unprognostic (3.46e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.03e-3)"	"prognostic unfavourable (7.02e-4)"	"unprognostic (6.65e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.11e-2)"	"unprognostic (8.88e-16)"	"unprognostic (7.73e-3)"	"unprognostic (5.47e-2)"	"unprognostic (6.98e-2)"	"unprognostic (3.00e-2)"	2.6	1.9	7.0	5.5	7.1	5.8	1.9	13.0	15.1	1.8	1.8	2.7	0.3	1.4	2.0	2.8	6.1	3.6	2.3	1.9	7.6	8.0	1.4	0.8	3.2	5.6	5.8	7.9	1.3	0.9	0.8	4.2	5.0	6.6	1.5	2.4	11.9	1.4	1.6	0.8	1.5	1.5	2.9	3.8	2.3	1.3	22.5	3.4	1.7	48.7	2.4	4.9	1.7	2.0	0.3	3.2	0.0	0.4	0.0	1.6	0.2	10.0	21.6	8.4	12.2	5.9	5.7	10.9	12.5	10.4	18.9	13.3	5.9	12.1	16.6	14.6	8.4	17.3	6.7	14.4	9.0	12.1	6.5	9.3	24.6	10.3	6.0	16.8	16.7	1.6	1.6	20.7	11.3	14.8	3.6	7.3	2.8	12.6	10.3	7.8	15.7	15.8	18.3	12.5	14.3	7.4	8.6	19.3	7.3	5.9	33.8	8.0	4.0	11.4	11.9	5.0	8.0	10.8	24.9	11.6	18.0	6.8	24.7	23.3	28.4	0.0	0.4	0.0	1.0	0.0	1.6	0.3	0.6	0.4	0.5	0.2	0.2	0.2	0.0	0.0	0.0	3.2	1.4	0.2	7.0	7.1	13.0	12.7	7.6	8.0	5.8	7.9	6.6	3.4
MBIP		ENSG00000151332	"MAP3K12 binding inhibitory protein 1"	Q9NS73	14	36298558-36320676	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 61.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003388	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol				Cytosol	Cytosol	"HPA003388: AB_1079322"	"unprognostic (8.79e-2)"	"unprognostic (9.92e-2)"	"unprognostic (5.07e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.85e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.71e-1)"	"prognostic favourable (1.52e-4)"	"unprognostic (5.24e-2)"	"prognostic favourable (1.14e-4)"	"unprognostic (4.65e-1)"	"unprognostic (9.27e-2)"	"prognostic favourable (1.25e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.09e-1)"	10.4	11.7	11.4	5.7	17.0	15.4	12.9	16.4	14.9	15.4	12.2	11.5	3.6	8.6	14.0	11.3	14.0	9.1	8.6	7.2	10.7	13.0	19.5	15.0	46.2	8.1	9.9	8.9	20.0	9.0	10.4	25.1	9.8	13.3	13.8	11.7	10.1	7.7	8.9	6.0	14.3	13.2	11.0	13.6	9.8	19.0	8.8	11.8	14.4	61.2	4.0	7.9	12.4	9.3	12.0	10.4	5.1	9.3	8.3	17.9	9.6	16.5	8.7	18.5	18.6	18.6	18.0	14.0	14.2	17.7	18.8	19.8	17.7	16.6	15.7	21.7	18.2	12.6	19.4	13.1	23.2	22.6	14.6	9.2	8.6	30.0	20.3	18.7	10.2	18.4	20.2	12.2	15.9	11.7	15.6	19.6	13.8	15.9	17.9	15.2	15.6	25.8	8.6	16.2	10.9	21.2	12.8	27.7	11.0	11.6	11.3	18.7	18.4	12.2	9.1	21.0	13.7	15.3	14.6	16.3	18.7	24.5	8.0	9.6	14.5	1.4	9.3	2.0	11.2	6.8	14.1	12.0	13.7	13.8	9.2	8.7	17.9	14.5	5.1	8.3	5.3	10.4	16.1	9.6	11.4	17.0	16.4	14.9	10.7	13.0	9.9	8.9	13.3	11.8
MEI4		ENSG00000269964	"Meiotic double-stranded break formation protein 4"	A8MW99	6	77690658-77926974	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"kidney: 8.5;pancreas: 4.1;testis: 4.7;thyroid gland: 4.6"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.7;TIME: 3.0;U-266/70: 1.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (3.47e-1)"				"unprognostic (9.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.62e-2)"	"unprognostic (9.70e-4)"	"unprognostic (3.16e-1)"	"unprognostic (2.86e-4)"	"unprognostic (3.35e-2)"	"unprognostic (4.17e-2)"	"unprognostic (4.85e-2)"	0.0	1.3	0.4	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0			0.0	0.0	0.8	0.0	0.0	0.3	1.0	0.2	0.9	8.5	1.7	0.0	0.0	0.8		0.0	4.1	0.0	2.6	0.0		0.0	0.0		0.1	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.2	4.7			4.6		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.5	0.9	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0										
METTL7A	DKFZP586A0522	ENSG00000185432	"Methyltransferase like 7A"	Q9H8H3	12	50923472-50932517	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 126.5;thyroid gland: 120.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 75.5;Karpas-707: 75.4;RPMI-8226: 41.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 29.7;classical monocyte: 12.7;eosinophil: 25.8;intermediate monocyte: 14.2;memory B-cell: 13.6;myeloid DC: 11.5;naive B-cell: 14.7;non-classical monocyte: 20.2;plasmacytoid DC: 10.1"	"Low lineage specificity"	"Detected in all"											HPA017434			Supported	"Lipid droplets"		140000	140000	"Lipid droplets"	"Lipid droplets"	"HPA017434: "	"unprognostic (2.31e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.85e-3)"	"unprognostic (9.43e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.68e-3)"	"unprognostic (5.48e-2)"	"unprognostic (9.94e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.49e-2)"	"prognostic favourable (0.00e+0)"	"unprognostic (8.64e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.22e-2)"	38.3	35.2	25.3	10.3	32.1	4.4	44.8	22.7	21.5	21.4	36.6	17.8	15.6	18.3	16.1	13.0	19.9	29.1	25.2	12.8	27.1	12.6	43.0	126.5	26.4	24.5	29.3	22.2	29.0	35.6	11.9	10.5	7.9	26.5	13.6	20.0	13.0	19.0	14.2	16.1	10.9	22.3	19.4	32.2	16.0	28.1	17.3	25.9	3.6	120.3	9.4	16.0	29.1	15.8	14.7	11.5	29.7	20.2	3.8	3.7	5.4	0.2	0.0	1.8	10.9	75.5	21.7	23.8	0.2	1.8	0.1	0.3	0.9	1.0	12.8	0.9	0.8	1.5	1.1	1.2	0.0	1.3	2.8	3.1	2.3	7.3	16.4	0.7	6.6	22.6	0.1	0.1	0.0	5.0	1.8	75.4	0.7	0.0	0.6	3.3	8.9	0.0	0.7	0.1	41.6	3.5	13.5	4.2	6.9	0.2	7.4	0.2	21.6	0.7	2.9	0.1	0.2	0.9	0.0	3.8	0.6	5.7	1.4	1.5	0.0	29.7	12.7	25.8	1.0	14.2	0.6	13.6	0.4	0.8	11.5	14.7	0.1	0.7	0.8	3.8	20.2	10.1	3.7	5.4	25.3	32.1	22.7	20.0	27.1	12.6	29.3	22.2	26.5	25.9
MPPED2	"239FB, C11orf8, D11S302E, dJ1024C24.1, dJ873F21.1, FAM1B, Hs.46638"	ENSG00000066382	"Metallophosphoesterase domain containing 2"	Q15777	11	30384493-30586872	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix, uterine: 31.0;thyroid gland: 30.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 19.4;HAP1: 11.5;RT4: 8.1;SH-SY5Y: 6.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062575			Approved	Nucleoli,Vesicles,Mitochondria				Nucleoli	Nucleoli	"HPA062575: AB_2684797"	"unprognostic (9.60e-3)"	"unprognostic (6.12e-3)"	"unprognostic (3.70e-3)"	"unprognostic (4.56e-2)"	"unprognostic (5.46e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.98e-4)"	"unprognostic (6.82e-2)"	"unprognostic (2.47e-7)"	"unprognostic (3.64e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.57e-2)"	2.9	7.0	6.3	1.7	19.3	1.1	5.5	4.6	8.9	31.0	4.2	1.8	4.4	1.5	8.3	7.9	1.6	11.1	1.9	4.6	8.5	9.7	12.2	1.2	1.1	0.9	7.0	6.7	1.2	2.5	5.0	10.7	2.5	11.2	15.6	1.4	7.1	12.1	10.1	5.7	1.0	1.4	5.1	4.6	3.1	1.9	3.8	3.4	9.1	30.0	1.2	1.0	4.7	4.9	1.3	0.7	0.3	0.2	2.0	4.8	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	11.5	0.0	0.0	0.0	2.1	0.0	0.2	0.2	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	3.2	0.0	0.0	3.1	0.2	0.0	8.1	0.1	6.1	0.0	0.0	3.1	1.8	0.0	0.1	0.0	1.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.1	0.3	0.2	0.0	0.9	0.0	4.8	0.0	0.0	0.6	0.4	1.3	1.3	0.2	0.2	2.0	0.0	0.7	0.1	0.2	6.3	19.3	4.6	8.8	8.5	9.7	7.0	6.7	11.2	3.4
MROH2A	HEATR7B1	ENSG00000185038	"Maestro heat like repeat family member 2A"	A6NES4	2	233775679-233833423	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 1.8;testis: 5.0;thyroid gland: 5.1"	"Cell line enriched"	"Detected in some"	7	"RT4: 11.4"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052107	Uncertain		Uncertain	Cytosol				Cytosol	Cytosol	"HPA052107: AB_2681729"	"unprognostic (7.00e-2)"	"unprognostic (3.37e-3)"	"unprognostic (4.77e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.05e-2)"	"unprognostic (4.06e-9)"	"unprognostic (5.65e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.41e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	5.0			5.1		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MT1F	MT1	ENSG00000198417	"Metallothionein 1F"	P04733	16	56657694-56660698	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 84.1;liver: 98.0;thyroid gland: 152.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 18.0;NB-4: 29.2;NTERA-2: 18.7;RPTEC TERT1: 80.9;THP-1: 17.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 14.7;classical monocyte: 10.2;gdTCR: 14.0;MAIT T-cell: 12.7;memory B-cell: 7.4;memory CD4 T-cell: 15.3;memory CD8 T-cell: 23.9;naive CD4 T-cell: 15.2;naive CD8 T-cell: 25.4;T-reg: 23.9"	"Low lineage specificity"	"Detected in all"																						"unprognostic (4.15e-2)"	"unprognostic (3.60e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.88e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavourable (2.02e-7)"	"unprognostic (2.78e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.85e-1)"	6.4	12.1	14.8	5.8	22.9	2.4	3.1	5.9	18.6	2.2	24.6	9.7	4.9	15.9	2.3	13.5	2.2	3.7	10.6	1.9	16.0	13.7	84.1	98.0	2.5	6.5	27.5	15.7	1.3	55.7	1.4	4.5	1.5	37.0	11.6	17.6	8.3	3.9	4.3	1.1	2.0	37.9	3.3	23.8	3.9	15.1	1.6	9.2	0.0	152.5	0.0	2.8	3.3	1.1	7.4	2.5	14.7	10.2	2.3	25.4	14.4	1.2	0.8	0.0	0.0	0.0	0.0	1.6	0.9	1.8	0.6	1.0	0.3	4.8	0.0	3.2	0.1	4.5	5.7	0.9	0.7	18.0	0.8	1.3	0.2	0.5	0.4	0.0	14.9	0.1	0.2	0.6	0.2	0.0	0.0	0.0	0.0	2.4	0.0	29.2	18.7	1.8	0.0	0.0	0.7	80.9	0.8	9.4	1.1	1.1	0.3	0.5	0.6	17.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	13.6	15.7	0.1	14.7	10.2	2.8	14.0	0.9	12.7	7.4	15.3	23.9	2.5	3.0	15.2	25.4	1.5	2.3	0.4	0.8	23.9	14.4	14.8	22.9	5.9	18.6	16.0	13.7	27.5	15.7	37.0	9.2
MT1H	MT1	ENSG00000205358	"Metallothionein 1H"	P80294	16	56669814-56671129	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 53.9;kidney: 88.1;liver: 134.0;pancreas: 50.2;thyroid gland: 60.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;EFO-21: 8.3;NB-4: 2.9;SCLC-21H: 2.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 173.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.6"	"Low lineage specificity"	"Detected in single"																						"unprognostic (1.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.51e-1)"	"unprognostic (8.65e-2)"	"prognostic unfavourable (2.37e-7)"	"unprognostic (8.48e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (5.44e-5)"	"unprognostic (5.77e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.34e-1)"	0.6	0.0	1.4	1.1	20.1	0.0	0.2	0.2	4.7	0.3	21.7	0.6	0.2	9.4	0.8	3.1	4.1	0.2	2.8	0.2	7.4	0.9	88.1	134.0	0.3	1.3	4.4	1.6	0.3	50.2	0.0	0.2	0.3	8.3	2.3	11.0	1.6	0.5	0.2	0.3	0.7	53.9	1.4	1.9	0.2	6.7	0.4	1.5	0.2	60.3	0.9	0.4	1.0	0.2	0.2	0.1	0.0	1.6	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.3	2.9	0.4	0.0	0.3	0.0	1.6	0.6	0.0	2.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.5	1.4	20.1	0.2	4.7	7.4	0.9	4.4	1.6	8.3	1.5
MUC15		ENSG00000169550	"Mucin 15, cell surface associated"	Q8N387	11	26559033-26572233	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 265.1;placenta: 56.8;thyroid gland: 77.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.9;K-562: 9.8;SK-BR-3: 16.7;U-266/70: 6.6;U-266/84: 17.6"	"Cancer enriched"	"Detected in many"	11	"thyroid cancer: 56.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebellum: 1.3;thalamus: 1.5"	"Low region specificity"	"Detected in all"			"HPA026110, HPA073304"	Enhanced				"Intracellular and membrane"					"HPA026110: AB_1854200, HPA073304: "	"unprognostic (1.49e-1)"	"unprognostic (2.08e-3)"		"unprognostic (7.71e-5)"		"unprognostic (5.09e-3)"	"unprognostic (2.77e-2)"	"unprognostic (3.04e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.96e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.70e-2)"	"unprognostic (4.54e-3)"	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	3.9	0.0	0.0	9.3	0.0	0.1	265.1	11.0	1.0	0.1	0.1	0.0	0.0	5.2	0.1	4.8	0.1	0.0	0.0	0.1	1.8	0.0	2.1	56.8	0.0	0.8	0.0	0.0	14.4	1.0	0.0	12.0	0.0	0.0	0.0	0.0	0.2	4.1	0.0	1.1	77.8	8.1	1.7	3.0	6.5	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	9.8	0.1	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	0.6	0.0	16.7	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	6.6	17.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MUM1L1	FLJ33516	ENSG00000157502	"MUM1 like 1"	Q5H9M0	X	106168305-106208956	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 79.4;thyroid gland: 26.9"	"Cell line enhanced"	"Detected in some"		"AF22: 5.1;HHSteC: 2.8;HSkMC: 5.2;LHCN-M2: 9.4;NTERA-2: 3.6;T-47d: 3.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000168, HPA020464"	Enhanced									"HPA000168: AB_1079431, HPA020464: AB_1854209"	"unprognostic (2.79e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.83e-2)"	"unprognostic (6.08e-2)"	"unprognostic (5.06e-2)"	"unprognostic (4.12e-6)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-1)"		"unprognostic (3.86e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.43e-3)"	"unprognostic (2.11e-5)"	"unprognostic (1.66e-1)"	"prognostic unfavourable (5.95e-4)"	"unprognostic (2.53e-2)"	1.5	1.8	5.2	0.2	1.3	0.2	0.6	0.1	8.8	7.3	0.2	0.0	2.0	0.2	7.3	4.2	0.3	6.7	0.7	1.9	2.9	2.3	1.0	0.8	0.4	0.2	0.5	4.9	79.4	11.4	0.2	12.8	4.8	4.8	2.3	0.2	0.0	0.2	1.7	4.1	0.2	0.2	1.5	0.3	0.2	0.6	17.0	0.8	0.0	26.9	1.5	0.2	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.1	0.0	0.0	2.8	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.1	3.6	0.0	0.0	1.5	0.0	0.0	0.7	0.0	0.0	0.0	1.2	0.0	3.2	0.0	0.0	0.4	2.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	1.3	0.1	8.8	2.9	2.3	0.5	4.9	4.8	0.8
NAT16	"C7orf52, FLJ39237"	ENSG00000167011	"N-acetyltransferase 16 (putative)"	Q8N8M0	7	101170493-101180276	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.1;pancreas: 6.0;pituitary gland: 5.8;thyroid gland: 4.6"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 4.5;SH-SY5Y: 6.8;SK-MEL-30: 5.0;U-2 OS: 5.9;U-87 MG: 3.4"	"Cancer enhanced"	"Detected in some"		"melanoma: 2.1"	"Group enriched"	"Detected in many"	4	"amygdala: 3.1;basal ganglia: 9.1;cerebral cortex: 2.9;hypothalamus: 4.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA021918	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA021918: AB_1848922"	"unprognostic (4.32e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.69e-3)"	"unprognostic (4.58e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.35e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.62e-2)"	"unprognostic (5.53e-5)"	"unprognostic (7.65e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.02e-5)"	"unprognostic (1.59e-1)"	0.2	0.4	3.1	0.2	9.1	0.7	0.1	0.4	8.2	0.1	0.2	0.0	0.0	0.2	0.0	0.3	0.1	0.2	0.1	0.1	0.9	4.8	0.1	0.5	0.1	0.2	0.7	0.6	0.1	6.0	0.2	5.8	0.1	0.8	0.2	0.3	0.5	0.3	0.1	0.3	0.4	0.2	0.2	0.4	0.3	1.2	0.4	1.2	0.0	4.6	0.0	0.0	0.1	0.0	1.2	0.7	2.2	0.6	1.3	0.8	0.0	0.5	0.0	0.1	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.7	0.2	0.0	0.0	0.1	0.0	0.0	1.3	0.5	0.5	0.1	0.1	0.8	0.6	0.2	0.1	4.5	0.0	0.4	0.1	6.8	0.0	0.3	5.0	0.3	0.0	0.0	0.4	5.9	0.5	0.1	0.1	0.0	0.1	3.4	0.0	1.6	0.4	0.6	0.3	0.3	0.4	0.3	0.2	0.2	0.1	0.2	1.2	0.8	0.4	2.2	1.3	0.3	0.7	0.3	0.0	3.1	9.1	0.4	2.9	0.9	4.8	0.7	0.6	0.8	1.2
NPM2		ENSG00000158806	"Nucleophosmin/nucleoplasmin 2"	Q86SE8	8	22024125-22036897	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.6;parathyroid gland: 40.2;thyroid gland: 23.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 13.1;HEL: 10.6;Hep G2: 23.4;THP-1: 8.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 10.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 4.1;T-cells: 2.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA041070	Enhanced		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA041070: AB_2677285"	"unprognostic (1.40e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.01e-1)"	"prognostic favourable (9.02e-4)"	"unprognostic (2.23e-1)"	"prognostic favourable (3.18e-6)"	"unprognostic (8.05e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.30e-1)"	0.8	15.6	14.4	0.5	11.4	1.3	2.3	20.4	27.6	1.9	1.4	0.8	0.3	2.4	4.9	1.3	1.4	2.8	2.2	1.5	13.0	13.8	2.9	1.3	2.0	1.0	14.9	15.7	0.8	7.4	40.2	7.8	0.9	7.2	4.7	1.4	3.7	3.1	1.8	0.8	2.0	1.4	4.0	3.0	7.5	2.0	3.1	2.4	0.1	23.2	0.0	0.8	1.4	0.8	0.4	0.0	4.1	0.0	0.0	2.2	0.1	2.8	0.4	0.1	0.2	0.7	0.0	1.2	0.3	0.4	1.8	3.7	1.2	2.7	0.0	0.9	0.0	13.1	0.3	0.0	1.1	0.1	0.3	10.6	0.7	23.4	2.4	1.4	1.0	0.4	1.8	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.1	2.8	0.5	0.3	0.2	1.0	0.6	4.4	0.0	2.8	0.2	0.0	0.0	3.5	0.5	8.3	0.0	0.0	0.2	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.9	0.0	2.2	0.0	0.9	2.1	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.0	1.4	0.1	14.4	11.4	20.4	27.6	13.0	13.8	14.9	15.7	7.2	2.4
NPNT	"EGFL6L, POEM"	ENSG00000168743	Nephronectin	Q6UXI9	4	105894775-106004027	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 125.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 14.9;HeLa: 16.8;Hep G2: 13.5;MCF7: 12.0;RPTEC TERT1: 19.6;T-47d: 26.3"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 104.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003711, HPA050203"	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to extracellular matrix"			"Nucleoplasm, Cell Junctions, Cytosol"	"Nucleoplasm, Cell Junctions, Cytosol"	"HPA003711: AB_1854591, HPA050203: AB_2681050"	"unprognostic (1.24e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.85e-3)"	"unprognostic (4.78e-4)"	"unprognostic (1.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"prognostic favourable (8.28e-8)"	"unprognostic (4.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.31e-2)"	5.4	1.6	3.4	2.4	4.4	0.0	8.3	0.7	2.5	13.3	11.0	1.9	4.2	16.4	8.7	11.4	5.7	5.9	19.0	2.5	2.5	2.7	22.7	1.3	34.9	0.9	7.5	2.4	4.1	11.6	0.0	14.6	3.0	2.2	26.3	7.6	16.9	2.8	5.7	2.6	2.1	37.7	4.0	0.9	4.4	4.0	3.0	2.8	3.4	125.3	3.7	2.3	3.7	6.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	14.9	0.1	0.0	0.0	0.0	7.4	9.7	0.1	0.4	0.1	0.9	3.7	0.0	0.0	0.0	3.8	0.3	16.8	13.5	0.0	0.0	0.1	1.6	1.3	0.0	0.0	0.0	0.0	0.2	0.0	12.0	0.2	0.7	0.1	6.0	0.0	0.0	0.1	19.6	0.8	0.8	0.3	0.9	7.2	0.0	26.3	0.6	0.0	0.3	0.2	0.2	0.5	0.1	0.5	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	4.4	0.7	2.5	2.5	2.7	7.5	2.4	2.2	2.8
NTRK2	TRKB	ENSG00000148053	"Neurotrophic receptor tyrosine kinase 2"	Q16620	9	84668551-85027070	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 133.8;thyroid gland: 63.4"	"Cell line enhanced"	"Detected in some"		"AF22: 10.4;HaCaT: 3.7;RPTEC TERT1: 11.6;SH-SY5Y: 13.3"	"Group enriched"	"Detected in many"	5	"glioma: 31.6;head and neck cancer: 8.0;lung cancer: 9.8;thyroid cancer: 26.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007637, CAB010346"	Enhanced		Approved	Cytosol		13000000	13000000	Cytosol	Cytosol	"CAB010346: AB_2155274, HPA007637: AB_1080385"	"unprognostic (2.75e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.39e-3)"	19.8	2.7	66.1	2.0	56.7	1.2	33.2	15.1	133.8	6.4	4.4	27.4	0.0	1.4	3.0	3.3	5.6	3.7	18.7	5.8	61.0	30.7	12.5	2.1	6.3	2.7	32.4	41.4	6.6	18.9	1.6	3.0	2.1	34.1	3.8	3.1	2.0	8.6	11.9	2.0	7.2	1.6	3.0	22.1	6.5	1.4	2.4	34.1	0.0	63.4	2.6	3.4	3.5	3.8	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	1.6	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.6	0.8	0.9	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.1	0.0	0.4	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	66.1	56.7	15.1	45.6	61.0	30.7	32.4	41.4	34.1	34.1
OCLN	PPP1R115	ENSG00000197822	Occludin	Q16625	5	69492292-69558104	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 58.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 20.9;CAPAN-2: 27.8;HaCaT: 22.4;MCF7: 22.1;RPTEC TERT1: 17.3;RT4: 18.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005933, CAB013075, CAB068212, CAB068213, CAB068214"	Enhanced		Supported	"Plasma membrane,Cell Junctions"	"Intracellular and membrane"			"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"CAB013075: AB_2533101, CAB068212: AB_2665711, CAB068213: AB_2665712, CAB068214: , HPA005933: AB_1079520"	"unprognostic (2.28e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.25e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.48e-1)"	"prognostic favourable (6.59e-11)"	"unprognostic (2.83e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.35e-1)"	1.2	0.8	3.4	3.8	3.7	0.5	7.6	3.9	2.9	4.3	15.5	3.2	21.9	10.2	1.7	7.4	10.6	7.9	17.1	1.1	4.0	2.9	15.3	31.7	29.2	0.4	4.0	1.7	2.3	33.2	12.0	3.2	9.0	6.7	5.7	10.9	7.7	7.1	25.0	0.5	8.7	24.5	1.2	3.8	2.1	15.1	2.0	1.5	0.4	58.1	9.8	8.6	5.0	6.5	1.2	1.2	1.8	0.3	2.0	0.9	0.1	15.0	6.1	0.1	0.5	0.2	0.3	12.2	0.0	1.5	2.0	3.0	20.9	27.8	0.1	5.3	0.3	22.4	6.2	3.0	5.6	0.1	10.8	1.1	0.2	6.3	0.1	0.5	1.5	0.0	3.1	4.7	0.2	1.2	0.0	0.1	0.0	22.1	0.6	0.4	2.4	2.5	0.0	4.6	0.5	17.3	18.9	2.0	0.9	0.1	16.5	0.2	9.3	1.9	0.2	0.1	6.2	1.2	1.5	0.3	0.1	0.1	0.1	0.1	0.1	0.8	0.3	0.7	0.8	0.2	0.2	0.8	0.9	0.3	0.1	1.2	0.7	0.9	1.8	2.0	0.2	1.2	0.4	0.1	3.4	3.7	3.9	2.9	4.0	2.9	4.0	1.7	6.7	1.5
OR10R2	OR10R2Q	ENSG00000198965	"Olfactory receptor family 10 subfamily R member 2"	Q8NGX6	1	158472220-158480936	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"thyroid gland: 1.2"	"Cell line enriched"	"Detected in some"	12	"MOLT-4: 25.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA059775, HPA060399"	Uncertain									"HPA059775: AB_2684124, HPA060399: AB_2684276"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0			0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7			1.2		0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR10S1		ENSG00000196248	"Olfactory receptor family 10 subfamily S member 1"	Q8NGN2	11	123976661-123977781	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"thyroid gland: 1.4"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.3;hTCEpi: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA019038	Uncertain									"HPA019038: AB_1854785"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.9	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			1.4		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR11L1		ENSG00000197591	"Olfactory receptor family 11 subfamily L member 1"	Q8NGX0	1	247840928-247841896	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"thyroid gland: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																															0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8			2.4		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4										
OR2A1		ENSG00000221970	"Olfactory receptor family 2 subfamily A member 1"	Q8NGT9	7	144312464-144322668	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"thyroid gland: 5.2"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 2.4;WM-115: 1.9"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	4	"basophil: 1.1;T-reg: 1.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.1;T-cells: 1.0"									HPA058272	Uncertain									"HPA058272: AB_2683662"	"unprognostic (3.98e-1)"							"unprognostic (6.53e-2)"					"unprognostic (1.13e-2)"		"unprognostic (9.14e-2)"	"unprognostic (2.22e-1)"		1.1	1.1	0.0	0.8	0.0	1.8	1.4	0.0	0.3	1.0	0.6			0.4	0.8	0.7	0.2	0.8	1.0	0.8	0.0	0.0	0.8	0.5	1.4	0.8	0.0		2.4	0.4	0.0	0.5	0.2		0.7	0.0		0.5	0.3	0.5	1.0	1.0	0.5	0.0	1.4	0.4	0.2			5.2		0.4	0.7	1.0	0.2	0.0	1.1	0.1	0.0	1.0	0.1	0.3	0.0	0.0	0.2	0.1	0.2	0.9	0.1	0.1	0.2	0.0	0.1	0.1	0.5	0.2	0.2	0.3	0.1	0.0	0.4	0.3	0.0	0.4	0.3	0.0	0.3	0.2	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.7	0.1	0.3	0.6	0.7	0.2	0.0	0.2	0.5	0.3	0.0	0.1	0.5	0.2	2.4	0.1	0.2	0.0	0.1	0.3	0.1	0.9	0.3	0.1	0.3	0.0	0.1	1.9	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1										
OR2A42		ENSG00000212807	"Olfactory receptor family 2 subfamily A member 42"	Q8NGT9	7	144228244-144239605	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"thyroid gland: 3.8"	"Cell line enhanced"	"Detected in some"		"THP-1: 1.1;WM-115: 3.8"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA058272	Uncertain									"HPA058272: AB_2683662"													"unprognostic (1.41e-1)"			"unprognostic (3.14e-1)"		0.6	0.8	0.1	0.0	0.1	1.7	0.9	0.0	0.0	0.7	0.2			0.1	0.4	0.5	0.2	0.3	0.5	0.5	0.0	0.0	0.7	0.2	0.7	1.2	0.1		1.2	0.3	0.0	0.4	0.0		0.4	0.2		0.7	0.1	0.3	1.9	0.9	0.0	0.0	1.4	0.3	0.2			3.8		0.0	1.0	0.4	1.4	0.5	1.5	0.5	1.0	1.0	0.0	0.9	0.2	0.0	0.2	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.0	0.5	0.3	0.0	0.0	0.0	0.8	0.2	0.6	0.0	0.2	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.1	1.1	0.8	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	3.8	1.1	0.5	0.4	0.4	0.3	0.3	0.6	0.4	0.3	0.2	1.4	0.5	0.4	1.5	1.0	0.3	0.5	1.0	0.0										
OR2AJ1	"OR2AJ1P, OR2AJ1Q"	ENSG00000177275	"Olfactory receptor family 2 subfamily AJ member 1"	Q8NGZ0	1	247924889-247935339	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 1.5;thyroid gland: 1.1"	"Cell line enhanced"	"Detected in single"		"HEL: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.3	0.0	0.3	0.6	0.0	0.0	0.6	0.2	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.2		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.1			1.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR2T33		ENSG00000177212	"Olfactory receptor family 2 subfamily T member 33"	Q8NG76	1	248269917-248277976	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 2.2;thyroid gland: 2.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.1;PC-3: 1.8;U-2197: 1.8"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"																															"unprognostic (5.79e-2)"						"unprognostic (2.22e-1)"		0.1	0.2	0.4	0.2	1.0	2.2	0.1	0.0	0.8	0.5	0.1			0.5	0.0	0.5	0.1	0.2	0.3	0.0	0.2	1.1	0.1	0.2	0.0	0.2	0.8		0.5	0.0	0.0	0.1	0.1		0.5	0.0		1.5	0.0	0.7	0.3	0.6	0.0	0.1	0.3	0.7	1.7			2.4		0.1	0.6	0.0	0.6	0.9	1.3	0.3	0.4	0.7	0.0	0.6	0.0	0.3	0.4	0.2	0.0	0.3	0.5	0.0	0.0	0.0	0.2	0.4	2.1	0.5	0.0	0.6	0.0	0.0	0.0	0.6	0.1	1.7	0.7	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.6	0.5	0.7	0.4	1.8	0.3	0.5	0.0	0.0	0.3	0.0	0.2	0.3	0.2	0.3	0.1	0.4	0.6	0.7	0.9	1.8	0.1	0.8	0.3	0.8	0.2	1.2	0.5	1.3	0.2	0.3	0.5	0.3	0.3	0.6	0.4	0.4	0.2	0.6	0.7	0.7	0.7	0.4	0.3	0.9	0.2	0.0										
OR2T8	OR2T8P	ENSG00000177462	"Olfactory receptor family 2 subfamily T member 8"	A6NH00	1	247920252-247921956	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"bone marrow: 2.4;thyroid gland: 3.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.3;HEL: 3.0;PC-3: 2.1;U-2 OS: 1.3;U-937: 2.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (7.26e-2)"									"unprognostic (4.16e-1)"		"unprognostic (2.88e-1)"			"unprognostic (1.06e-1)"	"unprognostic (2.83e-2)"		0.1	0.0	0.3	0.1	1.1	2.4	0.2	0.0	0.7	0.2	0.1			0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.1	1.3	0.0	0.0	0.1	0.0	0.6		0.0	0.0	0.0	0.0	0.3		0.5	0.4		0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	1.4			3.8		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.4	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.0	2.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0										
PBX4		ENSG00000105717	"PBX homeobox 4"	Q9BYU1	19	19561707-19618916	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"testis: 16.9;thyroid gland: 14.4"	"Cell line enhanced"	"Detected in some"		"A-431: 4.0;PC-3: 4.2;RT4: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"gdTCR: 2.8;MAIT T-cell: 3.3;memory CD4 T-cell: 2.0;memory CD8 T-cell: 2.9;naive CD4 T-cell: 1.8;naive CD8 T-cell: 1.7;T-reg: 5.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA049859, HPA056469"	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA049859: AB_2680918, HPA056469: AB_2797256"	"unprognostic (5.36e-3)"	"prognostic favourable (8.69e-6)"	"unprognostic (9.39e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.07e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.86e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.44e-6)"	"unprognostic (2.20e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.89e-2)"	"prognostic favourable (5.94e-7)"	1.0	0.5	2.2	4.5	3.4	1.7	1.0	1.2	1.9	0.9	1.6	0.0	4.6	1.1	0.6	1.3	0.8	1.0	7.1	0.6	2.3	2.5	1.0	0.5	1.8	3.6	0.8	1.2	1.2	0.5	0.7	1.7	1.2	1.5	1.1	1.1	0.7	1.4	2.7	0.5	2.0	1.7	0.5	0.7	1.8	1.7	16.9	0.6	6.1	14.4	0.5	9.6	1.4	0.8	0.3	0.0	0.0	0.1	0.0	5.4	0.8	4.0	0.2	1.8	0.0	0.0	0.0	2.1	0.0	1.6	1.7	1.7	0.0	1.4	0.4	0.9	1.0	1.6	2.7	0.0	0.7	0.3	0.8	0.0	0.9	0.1	0.3	0.0	1.3	0.5	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.8	1.4	0.1	0.3	4.2	0.8	0.0	0.0	1.1	5.2	1.2	2.3	1.5	0.2	0.8	0.8	0.0	0.0	0.0	1.0	2.1	0.8	0.0	1.7	0.3	0.1	0.2	0.0	0.0	0.0	0.0	2.8	0.0	3.3	0.3	2.0	2.9	0.0	0.0	1.8	1.7	0.0	0.0	0.1	0.0	5.4	0.8	2.2	3.4	1.2	1.9	2.3	2.5	0.8	1.2	1.5	0.6
PCSK2	"NEC2, PC2, SPC2"	ENSG00000125851	"Proprotein convertase subtilisin/kexin type 2"	P16519	20	17226107-17484578	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 35.0;thyroid gland: 79.5"	"Group enriched"	"Detected in some"	5	"AF22: 35.8;SCLC-21H: 9.4"	"Group enriched"	"Detected in many"	6	"pancreatic cancer: 14.6;thyroid cancer: 65.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"basophil: 2.2"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049627	Approved		Approved	Vesicles	"Secreted in other tissues"			Vesicles	Vesicles	"HPA049627: AB_2680835"	"unprognostic (2.03e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.84e-2)"		"unprognostic (3.07e-3)"	"unprognostic (4.31e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.26e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.14e-1)"	1.6	35.0	16.3	1.7	20.5	1.3	1.3	7.7	27.8	2.9	4.2	1.6	0.0	6.2	0.9	1.2	2.1	2.0	1.4	3.1	18.0	11.1	1.1	1.0	2.2	0.8	4.1	16.2	11.6	23.7	0.9	1.7	1.5	9.0	1.3	2.8	16.6	2.7	2.3	1.0	16.6	3.3	1.3	5.4	0.9	11.9	4.7	3.8	0.0	79.5	0.0	0.9	1.9	1.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	20.5	7.7	27.8	18.0	11.1	4.1	16.2	9.0	3.8
PDE11A		ENSG00000284741	"Phosphodiesterase 11A"		2	177628069-178108339	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"breast: 1.2;parathyroid gland: 1.5;testis: 3.6;thyroid gland: 1.6"	"Cell line enhanced"	"Detected in single"		"fHDF/TERT166: 2.9"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA034560	Uncertain									"HPA034560: AB_10602140"																		0.0	0.0		0.0		0.0	1.2		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	1.5		0.0		0.9	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	3.6			1.6		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.8	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PLEKHH1	KIAA1200	ENSG00000054690	"Pleckstrin homology, MyTH4 and FERM domain containing H1"	Q9ULM0	14	67533301-67589612	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 61.0;thyroid gland: 30.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 9.9;BEWO: 9.6;RT4: 9.7;SK-MEL-30: 12.0;T-47d: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047707, HPA051964"	Uncertain		Approved	Centrosome				Centrosome	Centrosome	"HPA047707: AB_2680126, HPA051964: AB_2681675"	"unprognostic (2.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (3.94e-2)"	"prognostic favourable (8.03e-5)"	"unprognostic (4.74e-1)"	"unprognostic (9.15e-3)"	"unprognostic (8.43e-5)"	"unprognostic (1.54e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.85e-1)"	"prognostic favourable (4.03e-7)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	"prognostic favourable (2.26e-4)"	1.3	4.5	9.7	1.6	33.7	0.5	2.9	8.6	26.8	3.5	6.8	61.0	2.5	11.6	1.9	8.9	1.6	3.8	2.5	1.1	16.2	8.7	2.7	0.8	1.2	0.6	35.8	16.6	0.6	7.7	10.3	3.3	2.0	26.9	10.7	7.0	5.1	20.3	2.9	1.1	4.1	9.0	1.3	38.1	1.3	6.6	2.3	34.4	0.0	30.2	0.0	0.7	2.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	1.2	2.0	9.9	0.2	0.0	9.6	0.0	0.0	0.1	0.1	3.1	1.5	0.0	1.6	0.0	2.2	3.5	0.8	0.1	0.3	3.4	0.0	1.6	1.9	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	3.7	0.0	0.0	7.1	0.0	0.2	3.0	0.6	0.1	0.3	1.4	1.1	9.7	2.7	2.5	0.8	1.8	12.0	9.5	2.0	0.0	0.8	3.6	0.9	0.6	0.0	0.0	0.0	0.5	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	33.7	8.6	18.1	16.2	8.7	35.8	16.6	26.9	34.4
PPP1R14C	"CPI17-like, KEPI, NY-BR-81"	ENSG00000198729	"Protein phosphatase 1 regulatory inhibitor subunit 14C"	Q8TAE6	6	150143076-150250357	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 50.0;skeletal muscle: 32.0;skin 1: 37.1;thyroid gland: 32.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 15.4;HBEC3-KT: 32.6;hTCEpi: 39.9;hTERT-HME1: 16.0;SK-BR-3: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"														"unprognostic (1.81e-3)"	"unprognostic (7.65e-2)"	"unprognostic (4.25e-3)"	"unprognostic (6.92e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.63e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.49e-3)"	"unprognostic (6.77e-2)"	0.3	0.4	4.2	1.9	7.7	0.3	3.7	1.3	12.8	4.5	6.8	0.8	0.0	5.7	1.0	0.7	8.0	9.0	0.3	50.0	4.7	3.7	5.3	0.3	6.7	0.4	2.7	7.6	0.2	0.5	4.7	0.8	13.9	7.7	0.9	5.0	0.1	1.5	0.3	32.0	37.1	1.2	0.7	1.3	0.3	0.7	3.5	1.0	0.0	32.4	8.8	3.2	0.4	8.3	0.0	0.0	0.0	0.2	0.0	1.2	0.1	10.2	0.0	4.5	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.5	1.4	0.2	3.1	2.0	15.4	2.3	32.6	0.0	0.0	13.8	0.1	0.0	0.0	0.0	0.0	0.4	0.0	39.9	0.0	16.0	0.0	8.6	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	13.7	0.5	2.4	0.0	0.2	14.5	0.8	0.0	0.7	0.0	0.0	7.9	12.5	3.5	0.0	0.0	0.0	5.5	6.0	0.7	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.9	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	4.2	7.7	1.3	12.8	4.7	3.7	2.7	7.6	7.7	1.0
PRR15L	"ATAD4, MGC11242"	ENSG00000167183	"Proline rich 15 like"	Q9BU68	17	47951967-47957878	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 113.1;pancreas: 75.4;thyroid gland: 61.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 13.4;MCF7: 12.4;SCLC-21H: 7.8;SK-BR-3: 23.5;T-47d: 15.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 2.2"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 19.0"	HPA022918	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA022918: AB_2060743"	"unprognostic (9.91e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.32e-2)"	"prognostic favourable (6.29e-13)"	"prognostic favourable (1.69e-5)"	"unprognostic (1.36e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.34e-2)"	0.9	0.2	0.2	13.5	0.2	0.0	10.0	0.2	0.3	3.2	88.7	0.6	22.9	44.9	0.6	8.3	4.9	6.6	21.2	0.3	0.4	0.2	37.3	1.6	20.3	0.2	0.2	0.2	1.9	75.4	0.0	8.5	0.2	2.2	8.1	32.0	0.4	38.7	26.7	0.2	3.7	113.1	0.5	0.2	0.2	27.2	1.3	0.2	0.3	61.0	2.5	5.8	2.1	2.4	1.3	0.5	0.0	0.2	1.2	2.2	0.0	2.4	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.5	3.8	0.1	0.2	0.0	13.4	0.0	0.0	0.0	0.2	0.4	0.1	0.0	1.6	0.0	0.2	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.2	0.2	0.0	0.5	0.2	0.0	0.9	0.7	1.6	7.8	0.3	0.0	23.5	0.0	15.8	0.0	0.0	0.2	0.0	0.5	0.1	0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.2	0.0	0.4	0.2	2.2	0.1	0.0	0.5	0.5	1.3	0.8	0.6	0.0	1.2	0.2	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.4	0.2	0.2	0.2	2.2	0.2
PRTG	"FLJ25756, IGDCC5"	ENSG00000166450	Protogenin	Q2VWP7	15	55611546-55743090	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 16.5;thyroid gland: 23.9"	"Cell line enriched"	"Detected in many"	6	"AF22: 57.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	18	"non-classical monocyte: 1.7"	"Lineage enriched"	"Detected in single"	18	"monocytes: 1.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA032138			Approved	"Vesicles,Plasma membrane,Cytosol"				Cytosol	Cytosol	"HPA032138: AB_10669675"	"unprognostic (2.80e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.32e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.42e-6)"	"unprognostic (8.81e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.70e-1)"	1.3	2.2	1.5	1.1	1.8	0.6	2.4	1.2	2.2	4.7	1.4	3.6	1.1	0.7	11.0	4.6	0.7	2.4	1.0	1.3	1.6	1.6	2.6	0.6	5.0	0.6	3.0	2.0	4.5	0.6	6.4	2.7	6.5	4.3	1.4	0.9	16.5	0.9	1.4	3.9	0.6	0.9	2.9	3.5	0.5	1.5	6.5	2.3	0.0	23.9	0.8	0.9	1.2	1.6	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.5	1.2	57.4	1.2	0.0	0.0	5.8	0.4	1.7	1.4	2.1	9.6	0.3	0.0	2.4	0.0	0.0	0.2	0.1	2.0	0.0	3.0	0.4	0.4	3.6	0.4	0.4	0.0	0.2	0.0	0.6	1.0	1.0	1.0	0.0	0.8	0.8	0.0	0.0	2.3	1.4	0.0	9.1	0.0	1.1	0.1	0.7	3.3	0.5	0.7	3.1	0.2	0.1	0.1	0.8	0.6	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.5	1.8	1.2	2.2	1.6	1.6	3.0	2.0	4.3	2.3
RAP1GAP	"KIAA0474, RAP1GA1, RAP1GAP1, RAP1GAPII"	ENSG00000076864	"RAP1 GTPase activating protein"	P47736	1	21596215-21669363	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 89.3;thyroid gland: 72.5"	"Cell line enhanced"	"Detected in many"		"A549: 24.0;Hep G2: 11.2;K-562: 14.8;SCLC-21H: 27.8;SK-BR-3: 14.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 286.1"	"HPA001922, CAB003851"	Enhanced	Supported	Approved	Cytosol				Cytosol	Cytosol	"CAB003851: AB_562338, HPA001922: AB_1079743"	"unprognostic (1.17e-2)"	"unprognostic (4.33e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (5.85e-4)"	"unprognostic (8.33e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.35e-2)"	"prognostic favourable (1.12e-6)"	"unprognostic (1.11e-1)"	"unprognostic (9.85e-3)"	"unprognostic (4.86e-3)"	"unprognostic (3.64e-2)"	0.9	38.2	30.2	1.9	89.3	1.1	3.1	27.1	40.1	4.7	10.5	5.7	0.0	6.9	1.7	1.8	2.9	3.0	13.4	2.7	17.8	12.9	33.2	10.3	7.8	1.2	8.6	20.6	1.6	49.3	7.1	8.2	5.8	14.6	7.4	9.4	2.4	43.9	1.2	0.7	2.1	11.6	1.1	3.2	0.9	28.4	2.1	14.2	0.0	72.5	0.9	1.6	2.5	0.5	0.0	0.0	1.1	0.0	0.0	0.0	0.3	3.1	24.0	0.2	1.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.2	3.3	0.0	2.4	0.1	4.1	2.3	0.1	0.0	0.5	1.2	1.1	2.3	11.2	0.4	0.0	3.5	0.1	1.6	0.0	0.0	0.0	14.8	0.6	0.0	7.9	3.8	0.3	1.5	3.7	2.2	0.6	0.5	5.5	1.7	27.8	5.0	4.0	14.5	4.6	1.4	2.7	0.0	0.0	1.7	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	30.2	89.3	27.1	30.4	17.8	12.9	8.6	20.6	14.6	14.2
RGL3	FLJ32585	ENSG00000205517	"Ral guanine nucleotide dissociation stimulator like 3"	Q3MIN7	19	11384341-11419342	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 65.1;thyroid gland: 38.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 14.5;CACO-2: 8.2;RT4: 17.0;SK-BR-3: 7.6;T-47d: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.4"	"Region enriched"	"Detected in single"	6	"cerebellum: 10.1"					"HPA042763, HPA043615, HPA064578"	Uncertain		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042763: AB_10968569, HPA043615: AB_10959470, HPA064578: "	"prognostic favourable (7.35e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.19e-3)"	"unprognostic (5.99e-2)"	"prognostic favourable (6.61e-4)"	"unprognostic (4.17e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.12e-3)"	4.3	6.2	5.3	1.2	7.9	0.7	4.3	1.9	6.8	7.6	1.9	3.4	23.3	1.8	4.9	14.5	1.1	5.3	6.5	5.2	8.2	1.3	20.7	6.0	7.5	1.2	6.7	3.0	1.6	12.1	65.1	9.1	5.8	7.9	4.1	1.8	7.3	3.5	23.9	5.0	1.1	1.2	1.4	9.5	5.1	6.8	1.1	7.3	0.0	38.2	0.4	0.9	4.5	4.5	0.3	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.9	0.1	14.5	0.9	1.1	0.5	1.6	8.2	5.9	0.0	5.2	1.0	3.7	0.0	0.0	0.0	0.0	0.0	0.1	3.0	2.5	2.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.6	1.6	5.0	17.0	0.8	4.3	0.2	7.6	2.5	12.5	0.0	0.0	2.6	0.0	2.0	0.6	0.0	0.4	0.7	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	5.3	7.9	1.9	6.8	8.2	1.3	6.7	3.0	7.9	7.3
RGS16	"A28-RGS14, RGS-r"	ENSG00000143333	"Regulator of G protein signaling 16"	O15492	1	182598623-182604408	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"thyroid gland: 67.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 31.3;NB-4: 17.2;SCLC-21H: 32.7;U-266/70: 37.0;U-698: 46.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.5"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"thalamus: 87.4"	"Group enriched"	"Detected in many"	6	"midbrain: 92.1;pons and medulla: 72.2;thalamus: 126.3"	"HPA053250, HPA055824"	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA053250: AB_2682090, HPA055824: AB_2682934"	"unprognostic (4.03e-2)"	"unprognostic (6.08e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.04e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (1.93e-2)"	"unprognostic (3.65e-2)"	"unprognostic (9.07e-3)"	"unprognostic (5.39e-2)"	17.8	7.5	4.5	18.6	9.8	3.0	5.2	3.3	9.9	2.4	6.4	20.7	7.2	2.3	2.6	3.7	4.5	8.0	10.8	3.6	7.4	12.3	6.7	6.8	13.3	10.8	12.0	1.3	2.9	4.3	6.0	28.1	7.9	16.5	3.7	4.1	9.1	3.3	40.8	5.2	3.0	3.5	8.0	25.0	6.1	5.1	1.2	10.7	0.3	67.5	16.2	4.9	6.1	4.2	5.8	11.5	2.2	0.9	3.4	5.4	1.4	0.2	0.0	1.9	0.0	0.3	0.0	14.5	0.0	0.5	0.0	0.0	0.0	0.1	31.3	0.1	0.0	0.1	3.5	0.3	0.0	3.5	2.5	3.3	0.3	0.0	0.5	5.2	2.8	0.7	5.3	0.0	0.2	0.0	0.1	5.5	0.0	3.5	0.1	17.2	10.1	1.0	0.0	10.4	7.4	0.0	1.5	32.7	3.4	0.0	2.7	0.0	1.0	4.1	0.0	0.1	0.7	0.9	1.6	37.0	1.6	46.2	0.1	3.3	1.7	2.2	0.4	0.7	0.4	0.5	0.8	5.8	5.4	0.6	0.6	2.3	2.5	0.8	1.4	3.4	0.9	11.5	3.2	1.4	4.5	9.8	3.3	9.9	7.4	12.3	12.0	1.3	16.5	10.7
RGS8	"MGC119067, MGC119068, MGC119069"	ENSG00000135824	"Regulator of G protein signaling 8"	P57771	1	182641816-182684576	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 29.8;thyroid gland: 15.0"	"Cell line enhanced"	"Detected in some"		"AF22: 6.5;Daudi: 2.3;SCLC-21H: 18.1;U-698: 3.7"	"Group enriched"	"Detected in some"	13	"glioma: 0.6;testis cancer: 0.8;thyroid cancer: 0.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"cerebellum: 477.3"	"Low region specificity"	"Detected in all"			HPA076764	Enhanced									"HPA076764: AB_2732321"	"unprognostic (6.75e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.29e-5)"	"unprognostic (2.60e-1)"	"unprognostic (2.37e-1)"		"unprognostic (9.29e-3)"		"unprognostic (1.16e-1)"	"unprognostic (3.78e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.23e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.02e-1)"	0.3	2.6	2.0	0.4	23.3	0.3	0.3	3.7	7.5	0.3	0.3	2.7	0.0	0.5	0.3	0.4	0.5	0.3	0.5	0.3	1.4	3.3	0.4	0.4	0.4	0.6	3.9	2.0	1.2	0.3	0.3	0.5	0.3	29.8	0.3	0.4	1.3	0.6	0.3	0.3	0.3	0.3	0.6	2.6	0.3	0.4	5.7	7.1	0.0	15.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	3.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	23.3	3.7	3.5	1.4	3.3	3.9	2.0	29.8	7.1
RNF128	"FLJ23516, GRAIL"	ENSG00000133135	"Ring finger protein 128, E3 ubiquitin protein ligase"	Q8TEB7	X	106693794-106796993	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 54.6;liver: 48.4;thyroid gland: 38.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 17.9;CAPAN-2: 14.8;Hep G2: 12.6;RPTEC TERT1: 13.0;RT4: 37.2;WM-115: 22.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019675	Uncertain									"HPA019675: AB_2670225"	"unprognostic (1.78e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.92e-4)"	"unprognostic (2.14e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavourable (1.07e-7)"	"unprognostic (1.11e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.30e-2)"	"unprognostic (5.30e-3)"	1.4	20.6	2.4	2.2	7.2	0.0	3.0	0.7	4.2	0.5	24.4	0.9	0.4	24.2	0.2	2.2	4.0	0.3	27.2	0.6	2.8	5.1	24.4	48.4	6.7	0.0	2.4	2.1	0.7	14.5	0.0	11.0	10.5	4.0	3.4	7.8	0.0	25.4	0.8	3.0	3.6	54.6	0.9	1.1	0.2	17.9	0.3	1.0	1.1	38.4	2.3	2.7	10.2	3.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	4.5	0.0	0.0	0.0	1.5	0.8	17.9	0.0	0.1	0.0	0.0	7.8	14.8	0.0	0.0	0.2	5.6	0.0	0.0	0.0	0.0	8.7	0.0	0.1	12.6	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	13.0	37.2	0.0	0.0	0.0	0.9	0.9	0.9	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	6.5	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	7.2	0.7	4.2	2.8	5.1	2.4	2.1	4.0	1.0
S100A5	S100D	ENSG00000196420	"S100 calcium binding protein A5"	P33763	1	153537147-153541765	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 7.6;thyroid gland: 9.1"	"Cell line enhanced"	"Detected in many"		"PC-3: 8.3;RPTEC TERT1: 10.1;RT4: 16.7;SCLC-21H: 15.0;SK-BR-3: 7.7"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 3.7;thyroid cancer: 11.7;urothelial cancer: 2.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	85	"olfactory region: 1210.8"	"Region enriched"	"Detected in single"	29	"olfactory region: 16.8"	HPA064184			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA064184: AB_2685206"	"unprognostic (6.09e-2)"	"unprognostic (2.92e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.63e-5)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"		"unprognostic (1.52e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.39e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.70e-2)"	"unprognostic (4.68e-3)"	0.5	0.1	0.8	2.4	0.2	0.9	0.4	0.2	0.9	0.6	0.3	0.2	0.2	2.3	1.0	0.2	1.3	0.7	1.6	0.2	0.4	0.1	2.3	0.2	3.0	4.6	0.2	0.2	0.2	0.2	0.0	0.4	1.1	0.2	1.5	0.0	0.2	3.8	0.2	0.2	6.0	0.5	0.2	0.2	1.1	1.9	0.2	0.2	1.6	9.1	0.2	2.6	1.8	0.6	0.9	4.6	2.3	1.2	0.0	7.6	1.2	1.8	4.8	0.0	0.0	0.5	0.4	0.3	0.8	1.1	0.6	1.2	0.5	3.5	0.0	3.2	1.7	1.5	0.1	0.8	0.8	0.4	0.0	2.2	1.8	0.2	0.4	0.0	3.0	0.0	0.9	2.3	0.7	0.5	0.6	0.2	2.5	0.2	0.4	1.1	0.1	8.3	0.0	1.5	0.9	10.1	16.7	15.0	0.0	0.2	7.7	0.7	0.0	0.4	0.4	0.1	1.1	2.2	1.4	0.0	0.7	0.0	0.5	0.6	0.3	0.0	1.2	2.3	2.0	0.2	7.6	0.9	4.2	2.2	2.8	0.5	2.4	1.1	1.9	0.0	0.6	4.6	6.1	1.2	0.8	0.2	0.2	0.9	0.4	0.1	0.2	0.2	0.2	0.2
SALL4	"dJ1112F19.1, ZNF797"	ENSG00000101115	"Spalt like transcription factor 4"	Q9UJQ4	20	51782331-51802520	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 8.8;testis: 11.7;thyroid gland: 8.6"	"Cell line enhanced"	"Detected in some"		"AF22: 13.6;AN3-CA: 9.5;BEWO: 18.2;NTERA-2: 32.7;SiHa: 8.3"	"Cancer enriched"	"Detected in many"	11	"testis cancer: 22.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"NK-cell: 6.3"	"Lineage enriched"	"Detected in single"	9	"NK-cells: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015291, HPA015791"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA015291: AB_1856548, HPA015791: AB_1856547"	"unprognostic (1.30e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.55e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.23e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.42e-8)"	"unprognostic (5.90e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.00e-5)"	"unprognostic (7.41e-2)"	0.3	0.4	0.3	0.3	0.9	1.2	0.3	0.8	0.9	0.4	0.7	0.3	2.2	0.1	0.3	0.8	0.3	0.2	0.3	0.3	0.3	0.1	0.5	1.9	0.3	0.3	0.3	0.3	0.3	4.6	8.8	0.6	0.3	0.9	3.1	0.2	4.5	2.2	0.4	0.3	0.3	0.7	0.3	0.3	0.8	0.3	11.7	0.3	0.3	8.6	0.3	0.3	0.9	0.3	0.1	0.1	0.6	0.1	6.3	0.2	0.0	0.0	0.9	13.6	9.5	0.0	0.1	18.2	0.0	0.1	0.0	0.1	4.7	0.1	0.0	0.1	0.1	2.3	0.1	0.0	0.2	0.2	0.0	0.0	3.2	0.2	0.1	0.0	1.0	0.4	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	32.7	0.2	1.2	0.0	0.0	0.0	0.3	3.1	1.7	8.3	0.0	0.8	0.0	0.5	0.0	0.5	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.6	6.3	0.1	0.1	0.0	0.0	0.3	0.9	0.8	0.9	0.3	0.1	0.3	0.3	0.9	0.3
SCUBE3	"CEGF3, FLJ34743"	ENSG00000146197	"Signal peptide, CUB domain and EGF like domain containing 3"	Q8IX30	6	35214419-35253079	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 38.0"	"Cell line enhanced"	"Detected in some"		"AF22: 10.4;ASC diff: 31.7;ASC TERT1: 42.6;HSkMC: 19.8;hTEC/SVTERT24-B: 12.1;U-138 MG: 11.8;WM-115: 10.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 9.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040606	Uncertain		Approved	"Plasma membrane"	"Secreted to blood"	110000	110000	"Plasma membrane"	"Plasma membrane"	"HPA040606: AB_10795383"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.83e-8)"	"unprognostic (1.54e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (1.38e-4)"	"unprognostic (3.06e-3)"	1.6	2.6	0.5	1.1	0.4	0.2	0.3	0.3	0.7	1.6	3.3	0.0	2.8	0.2	1.3	7.0	1.5	0.7	0.7	6.4	0.3	0.5	2.3	0.2	1.3	0.2	0.4	0.6	0.9	0.2	0.3	1.6	0.9	0.6	7.0	1.1	6.8	1.1	5.3	0.8	0.7	0.8	13.8	0.6	0.3	1.2	1.7	0.0	0.0	38.0	0.3	0.3	11.4	2.5	1.1	1.6	2.5	0.7	1.1	1.1	0.1	0.0	0.0	10.4	0.1	31.7	42.6	0.1	2.6	1.3	0.0	0.0	0.2	0.0	0.0	0.3	6.1	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	19.8	0.0	12.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.2	0.7	0.2	0.0	0.6	11.8	0.5	0.0	0.1	0.0	0.0	0.0	1.8	0.0	10.0	1.4	0.7	1.3	1.1	0.5	0.3	0.8	0.7	0.3	0.1	1.1	0.8	0.8	2.5	1.1	0.5	1.6	0.8	0.1	0.5	0.4	0.3	0.7	0.3	0.5	0.4	0.6	0.6	0.0
SCX	"bHLHa41, bHLHa48, SCXA, SCXB"	ENSG00000260428	"Scleraxis bHLH transcription factor"	Q7RTU7	8	144266560-144268481	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 18.8;thyroid gland: 33.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 7.9;HaCaT: 8.5"	"Group enriched"	"Detected in all"	6	"endometrial cancer: 12.8;ovarian cancer: 34.4;thyroid cancer: 37.7"					"Cell type enriched"	"Detected in single"	6	"memory B-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"B-cells: 2.4"	"Region enhanced"	"Detected in some"		"cerebellum: 12.0"	"Region enriched"	"Detected in single"	4	"cerebellum: 4.7"	HPA043183	Uncertain									"HPA043183: AB_2678357"	"unprognostic (5.32e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.37e-3)"	"unprognostic (1.87e-3)"	"prognostic unfavourable (2.86e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.89e-3)"	0.5	1.1	0.4	1.3	0.0	0.8	0.0	3.0	0.9	4.8	2.8	0.0	0.0	1.4	2.2	4.5	1.7	0.2	3.7	5.5	0.0		0.4	0.1	0.4	0.7	0.0	0.0	0.9	2.8	2.7	2.3	0.3	10.3	1.8	0.3	4.2	3.3	0.5	18.8	1.6	1.8	0.9	0.0	1.3	2.3	4.7	0.0	7.6	33.2	4.5	0.5	1.7	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.7	0.2	0.9	0.0	0.1	7.9	0.2	0.1	0.2	0.1	0.3	2.4	2.2	2.4	0.4	8.5	0.0	0.0	0.0	1.1	1.5	0.5	2.8	0.3	0.3	0.1	3.6	0.1	0.9	0.0	0.4	0.0	0.4	1.0	0.2	5.0	0.8	1.7	1.9	3.7	2.7	0.4	1.4	0.2	3.4	0.3	1.5	0.9	3.1	3.4	4.0	1.6	0.5	0.7	5.9	2.7	0.4	2.6	0.8	0.5	1.5	2.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SDC2	"CD362, fibroglycan, HSPG, HSPG1, SYND2"	ENSG00000169439	"Syndecan 2"	P34741	8	96493351-96611780	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 115.1;thyroid gland: 111.2"	"Cell line enhanced"	"Detected in many"		"AF22: 101.9;EFO-21: 47.8;fHDF/TERT166: 44.1;RPTEC TERT1: 53.2;U-138 MG: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 13.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025123, HPA044416"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB025123: , HPA044416: AB_2678934"	"unprognostic (1.25e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.52e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.23e-1)"	43.2	9.9	13.9	9.1	16.9	2.5	17.0	12.7	8.4	43.4	18.7	7.3	21.2	5.8	21.9	15.3	13.3	21.0	15.0	19.1	12.0	12.6	23.9	115.1	14.4	4.4	9.7	9.3	45.9	16.8	1.6	24.0	31.3	10.7	25.9	10.7	51.4	6.3	28.1	9.4	6.5	9.6	34.3	9.5	7.5	11.9	8.7	9.3	0.5	111.2	13.8	3.5	35.9	26.3	0.0	1.3	13.9	1.9	0.0	0.2	0.5	0.0	0.0	101.9	0.0	36.8	34.4	0.1	14.7	17.5	8.6	9.5	3.0	0.0	0.0	47.8	44.1	0.0	17.6	0.2	7.4	0.0	6.9	0.0	9.8	37.4	1.1	0.2	0.4	13.3	0.4	19.4	0.5	0.3	9.6	0.0	3.5	0.8	0.0	2.5	10.8	0.1	0.1	16.0	0.3	53.2	8.7	3.0	7.9	0.0	0.0	0.7	4.3	11.4	8.0	49.4	15.1	0.2	8.2	0.9	0.0	0.1	15.7	0.0	15.4	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	13.9	0.0	0.1	0.0	0.0	0.5	13.9	16.9	12.7	8.4	12.0	12.6	9.7	9.3	10.7	9.3
SEC14L3	TAP2	ENSG00000100012	"SEC14 like lipid binding 3"	Q9UDX4	22	30447959-30472049	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 6.8;liver: 6.0;thyroid gland: 3.5"	"Cell line enhanced"	"Detected in some"		"WM-115: 3.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059450	Uncertain									"HPA059450: AB_2684024"		"unprognostic (2.42e-1)"		"unprognostic (2.56e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.00e-4)"	"unprognostic (3.62e-3)"		"unprognostic (6.68e-2)"	"unprognostic (3.19e-1)"		"unprognostic (2.41e-10)"	"unprognostic (1.27e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.10e-1)"		0.0	0.1	0.0	0.0	0.3	6.8	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	6.0	2.4	0.0	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.4			3.5		0.0	0.0	0.0	0.5	0.3	1.3	0.1	0.1	0.3	0.0	0.2	0.2	0.1	1.0	0.6	0.0	0.9	0.3	0.0	0.1	0.2	0.0	0.8	0.2	0.3	0.0	0.6	0.3	0.0	0.2	0.3	1.5	0.1	0.6	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.6	1.2	0.4	0.6	0.1	0.3	0.3	0.2	0.3	0.3	0.4	0.4	0.3	0.6	1.0	0.1	0.3	0.0	0.3	0.7	0.0	0.9	0.4	0.7	0.1	0.2	0.2	0.3	0.0	0.9	3.1	1.3	0.1	0.1	0.2	0.0	0.1	0.2	0.3	0.1	0.0	0.5	0.1	0.1	0.7	0.1	0.1	0.3	0.2	0.0										
SEMA3D	"coll-2, Sema-Z2"	ENSG00000153993	"Semaphorin 3D"	O95025	7	84995553-85186855	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 33.8;thyroid gland: 33.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 16.8;HaCaT: 17.1;TIME: 26.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"amygdala: 17.1"	"Cell type enriched"	"Detected in single"	5	"naive B-cell: 2.0"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037522	Uncertain		Approved	"Golgi apparatus,Plasma membrane"	"Secreted in other tissues"	77000	77000	"Golgi apparatus"	"Golgi apparatus"	"HPA037522: AB_10672494"	"unprognostic (7.05e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.58e-3)"	"unprognostic (4.02e-3)"	"unprognostic (9.94e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-3)"	"unprognostic (5.25e-3)"	4.1	2.2	17.1	1.9	2.3	0.1	4.3	0.8	2.8	4.6	2.9	1.8	2.5	1.4	1.9	7.4	1.3	3.9	1.4	2.0	3.6	2.7	3.0	1.0	3.6	6.1	2.4	3.1	4.1	0.8	0.4	1.5	0.6	5.4	6.2	2.6	2.6	5.6	2.9	0.7	2.1	2.7	3.2	4.8	33.8	2.4	4.3	2.5	0.0	33.0	0.6	1.1	4.7	3.9	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.3	4.5	4.9	5.4	2.6	0.0	0.0	0.0	1.4	16.8	17.1	1.9	0.0	3.6	0.0	3.5	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	4.4	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	4.5	1.2	5.4	3.9	1.7	0.0	0.1	0.6	0.0	0.0	0.2	0.2	0.0	26.2	0.0	1.7	0.2	0.0	3.3	1.9	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	17.1	2.3	0.8	2.2	3.6	2.7	2.4	3.1	5.4	2.5
SH3D21	"C1orf113, FLJ22938"	ENSG00000214193	"SH3 domain containing 21"	A4FU49	1	36306387-36324886	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 26.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 16.1;SK-BR-3: 12.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.0;NK-cell: 2.7"	"Low lineage specificity"	"Detected in many"											"HPA042212, HPA042456, HPA066168"	Approved		Supported	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"HPA042212: AB_10961180, HPA042456: AB_10959746, HPA066168: AB_2685627"	"prognostic favourable (2.60e-4)"	"unprognostic (8.35e-3)"	"unprognostic (3.86e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.07e-3)"	"unprognostic (7.32e-3)"	"unprognostic (2.04e-4)"	"unprognostic (7.47e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.38e-3)"	"prognostic unfavourable (1.76e-6)"	"unprognostic (8.88e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.59e-2)"	1.6	1.1	11.6	3.4	9.5	1.9	10.1	12.2	11.3	4.4	5.3	1.1	1.4	16.6	2.8	2.7	7.1	1.9	3.0	2.2	5.2	2.2	8.6	1.4	4.5	2.8	1.9	7.0	4.0	1.0	1.3	2.2	19.4	7.4	7.0	6.0	12.4	12.7	2.6	1.0	16.2	24.3	2.0	2.4	1.6	2.3	6.6	1.9	0.0	26.2	4.1	4.5	3.7	6.7	0.1	0.3	2.0	0.5	2.7	0.6	0.0	9.9	0.3	1.9	2.2	0.6	1.2	10.8	4.8	1.0	3.6	1.6	5.6	4.0	1.8	5.3	2.0	16.1	1.7	3.6	3.0	0.5	0.7	1.6	3.4	4.4	1.6	0.9	2.4	0.6	3.0	2.4	1.8	1.3	0.2	3.1	1.7	5.9	1.6	0.9	1.2	1.9	2.4	0.1	1.2	4.1	1.2	4.0	2.0	1.1	12.1	3.8	0.4	0.4	2.8	1.5	0.8	4.8	0.5	3.5	1.1	2.1	4.1	0.9	0.3	0.0	0.5	0.0	0.4	0.0	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.0	2.0	2.7	0.0	0.0	0.0	0.0	11.6	9.5	12.2	11.3	5.2	2.2	1.9	7.0	7.4	1.9
SHISA2	"bA398O19.2, C13orf13, hShisa, PRO28631, TMEM46, WGAR9166"	ENSG00000180730	"Shisa family member 2"	Q6UWI4	13	26044597-26051031	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 12.9;skeletal muscle: 10.2;thyroid gland: 20.8"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 13.8;NTERA-2: 10.0;RH-30: 32.0;U-2197: 20.0"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA049752, HPA050172"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"				Nucleoplasm	Nucleoplasm	"HPA049752: , HPA050172: AB_2681041"	"unprognostic (2.08e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.41e-1)"	"unprognostic (9.71e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.20e-1)"	"prognostic favourable (3.30e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.17e-2)"	"prognostic favourable (2.43e-4)"	"unprognostic (5.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.51e-2)"	0.3	0.0	0.7	0.0	2.0	0.0	12.9	0.0	0.5	1.5	0.0			0.4	0.0	7.9	0.0	0.0	0.3	0.0	2.0	0.6	3.0	0.0	3.7	0.1	1.1		0.0	0.0	0.0	1.7	0.0		0.4	0.0		1.9	0.0	10.2	1.0	0.3	0.0	3.5	0.0	1.6	0.9			20.8		0.3	0.0	0.0	0.8	0.6	2.2	1.1	1.0	5.6	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.6	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.2	2.6	1.0	0.0	0.0	1.2	0.7	0.0	0.0	13.8	0.7	1.4	0.3	10.0	5.0	0.0	32.0	0.2	1.2	4.5	0.3	0.0	0.2	0.0	3.5	0.4	0.1	1.1	0.0	0.5	20.0	4.3	0.0	0.0	0.0	0.0	0.0	2.7	2.2	0.4	1.7	0.6	0.7	1.0	0.6	1.7	0.7	0.3	0.8	3.9	5.6	1.6	1.0	1.1	0.6	0.7	0.4										
SKIDA1	"C10orf140, FLJ45187"	ENSG00000180592	"SKI/DACH domain containing 1"		10	21513478-21526368	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"thyroid gland: 9.6"	"Cell line enhanced"	"Detected in some"		"AF22: 22.6;AN3-CA: 5.8;BEWO: 10.5;SH-SY5Y: 5.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039208, HPA040439"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				Cytosol	Cytosol	"HPA039208: AB_10795034, HPA040439: AB_10796122"	"unprognostic (5.36e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.32e-3)"	"unprognostic (6.45e-4)"	"unprognostic (9.97e-2)"	"unprognostic (3.23e-3)"	"unprognostic (3.61e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.23e-1)"	"unprognostic (9.35e-3)"	"unprognostic (5.93e-2)"	"unprognostic (3.38e-6)"	"unprognostic (8.13e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.20e-2)"	"unprognostic (8.52e-3)"	0.9	1.9	1.9	0.4	3.3	1.7	2.2	3.1	5.9	1.3	1.7	0.0	0.0	0.3	1.0	1.0	0.9	1.7	0.6	5.5	2.5	1.8	4.1	4.3	1.0	0.3	1.4	3.4	4.2	1.5	7.3	1.8	2.5	3.0	1.1	0.6	4.1	2.6	2.0	0.5	2.9	0.5	1.0	1.2	0.4	0.6	4.6	0.3	0.9	9.6	0.7	0.3	1.1	1.1	0.6	0.5	1.5	0.6	0.5	0.3	0.1	0.4	0.9	22.6	5.8	0.5	0.2	10.5	0.4	0.3	0.0	0.0	2.1	0.1	0.2	0.9	0.3	1.4	2.0	0.4	0.0	0.0	2.5	0.1	1.0	0.2	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.9	0.7	0.1	1.3	0.0	0.3	0.7	0.0	0.4	0.5	2.5	5.2	0.8	3.9	0.1	0.4	4.5	0.3	0.2	0.7	0.2	0.5	0.1	0.0	0.2	1.4	0.0	0.2	1.5	0.3	0.5	0.2	0.3	0.3	0.3	0.2	0.2	0.3	0.6	0.3	0.3	1.3	0.5	0.6	0.5	0.2	0.1	1.9	3.3	3.1	5.9	2.5	1.8	1.4	3.4	3.0	0.3
SLC12A8	CCC9	ENSG00000221955	"Solute carrier family 12 member 8"	A0AV02	3	125082636-125212864	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.4;thyroid gland: 20.5"	"Cell line enhanced"	"Detected in many"		"CACO-2: 10.9;HHSteC: 18.4;U-2197: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA031123	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA031123: AB_2301872"	"unprognostic (4.74e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.35e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.13e-2)"	"prognostic unfavourable (5.56e-4)"	"unprognostic (7.18e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.78e-2)"	1.1	1.1	11.1	0.7	19.4	0.0	2.0	0.8	7.0	1.2	3.0	1.7	0.4	4.9	0.4	2.9	3.5	1.7	8.1	0.5	3.8	1.2	2.1	5.7	1.9	0.4	1.0	3.6	0.5	9.0	8.2	1.9	2.2	8.6	2.5	4.1	6.2	10.0	0.4	1.8	1.0	3.4	0.4	1.3	0.4	3.8	4.6	2.0	0.4	20.5	0.4	0.7	1.9	1.7	0.2	0.2	1.8	0.5	0.0	0.2	0.0	8.3	0.0	1.4	0.0	1.8	2.5	4.1	0.4	1.0	0.5	0.9	10.9	4.0	0.0	1.0	3.7	5.1	0.0	0.0	0.2	0.0	0.0	0.0	3.7	0.0	18.4	0.0	0.6	4.7	5.0	1.4	0.6	0.0	0.0	0.3	0.7	2.2	0.0	0.0	5.7	0.4	0.0	0.1	0.0	4.2	0.6	2.4	0.0	4.9	5.1	0.1	9.2	0.2	0.1	0.1	0.7	35.7	0.0	0.1	1.0	2.8	1.7	0.0	0.7	1.8	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	19.4	0.8	7.0	3.8	1.2	1.0	3.6	8.6	2.0
SLC25A29	"C14orf69, FLJ38975"	ENSG00000197119	"Solute carrier family 25 member 29"	Q8N8R3	14	100291111-100306547	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 83.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030781	Uncertain									"HPA030781: AB_10603029"	"unprognostic (8.64e-3)"	"unprognostic (1.20e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.39e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.00e-1)"	"prognostic favourable (2.90e-4)"	"unprognostic (1.32e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"	"prognostic favourable (5.26e-4)"	6.3	11.1	9.0	4.3	15.2	8.3	10.5	7.0	14.0	13.5	4.4	29.7	9.5	5.9	9.8	32.0	6.8	22.7	8.7	7.8	10.3	9.7	19.5	6.3	10.5	5.2	29.7	10.3	10.9	5.9	5.7	13.1	4.9	25.4	12.9	4.3	22.1	20.9	9.8	6.2	14.1	5.2	6.3	30.9	6.5	8.3	9.6	23.1	2.4	83.5	3.9	5.4	5.1	5.1	1.2	2.8	4.9	2.8	0.3	2.4	0.7	4.5	10.1	13.5	17.7	3.1	1.2	8.1	3.6	4.1	7.7	4.6	2.3	2.9	0.0	9.3	1.2	5.1	5.8	1.9	2.6	1.7	2.7	4.6	13.9	4.3	7.6	2.7	6.0	3.5	5.9	3.5	3.3	10.6	1.4	0.5	2.2	14.9	16.3	14.7	6.8	10.8	20.8	5.6	0.3	25.6	3.3	19.7	24.5	8.5	6.1	6.6	14.8	4.5	10.9	2.7	5.4	3.9	5.6	1.4	0.5	0.6	3.1	6.6	3.3	3.6	2.8	4.9	2.3	0.4	0.0	0.4	1.1	2.4	2.8	1.2	0.3	1.6	3.2	0.3	0.1	1.3	1.6	0.7	9.0	15.2	7.0	14.0	10.3	9.7	29.7	10.3	25.4	23.1
SLC39A10	"DKFZp564L2123, FLJ90515, KIAA1265"	ENSG00000196950	"Solute carrier family 39 member 10"	Q9ULF5	2	195575977-195737702	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 41.0;thyroid gland: 39.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036512, HPA036513, HPA066087"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		49000	49000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA036512: AB_2675165, HPA036513: AB_10670801, HPA066087: "	"unprognostic (1.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.33e-3)"	"prognostic favourable (1.46e-5)"	"unprognostic (7.40e-2)"	"prognostic unfavourable (4.39e-5)"	"unprognostic (2.10e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavourable (3.23e-4)"	"unprognostic (8.46e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.47e-2)"	"unprognostic (6.89e-2)"	6.6	10.9	16.0	6.0	24.8	3.7	6.2	10.8	41.0	9.8	3.8	4.2	4.9	3.6	9.4	3.3	3.5	8.5	7.6	4.7	15.0	11.2	7.8	2.1	6.3	6.5	8.5	24.4	7.4	5.7	5.8	5.7	10.7	15.7	16.7	4.0	1.4	4.8	6.5	3.3	5.7	5.7	6.7	10.2	14.4	4.3	7.9	6.2	10.6	39.9	1.7	6.4	6.1	4.9	9.4	18.4	19.3	2.7	11.0	4.6	1.5	3.1	10.5	20.2	5.5	3.9	9.4	10.4	14.6	7.1	7.1	3.5	15.7	11.3	4.3	22.3	8.3	4.5	12.3	13.5	8.9	2.3	9.1	4.9	16.4	12.9	4.4	17.9	2.1	5.5	2.0	7.8	9.0	15.8	14.1	6.1	11.3	3.0	5.1	5.6	23.5	8.3	12.0	7.1	10.8	30.7	5.2	7.8	10.7	14.6	29.9	7.6	4.8	11.1	15.4	12.9	14.9	8.4	7.6	2.1	1.3	2.6	10.4	8.4	13.0	19.3	2.7	1.9	4.5	2.5	3.5	6.8	4.0	3.7	3.3	9.4	3.5	4.6	0.5	11.0	1.8	18.4	3.9	1.5	16.0	24.8	10.8	39.7	15.0	11.2	8.5	24.4	15.7	6.2
SLC43A3	"DKFZp762A227, Eeg1, FOAP-13, PRO1659, SEEEG-1"	ENSG00000134802	"Solute carrier family 43 member 3"	Q8NBI5	11	57406954-57427580	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 149.9;thyroid gland: 69.0"	"Cell line enhanced"	"Detected in many"		"HL-60: 69.9;HMC-1: 61.7;RPMI-8226: 78.8;WM-115: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"olfactory region: 12.7"	"Low region specificity"	"Detected in all"			"HPA030551, HPA077244"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"				Vesicles	Vesicles	"HPA030551: AB_10604094, HPA077244: AB_2732335"	"unprognostic (2.64e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.67e-3)"	"unprognostic (7.41e-3)"	"unprognostic (6.59e-3)"	"unprognostic (5.30e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.26e-1)"	"unprognostic (5.73e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavourable (3.97e-13)"	"unprognostic (8.16e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.00e-1)"	32.3	6.3	2.5	12.4	4.3	18.8	16.8	2.2	3.0	11.9	9.6	3.6	2.4	2.7	10.1	6.5	12.6	8.9	11.4	12.5	3.1	1.5	4.2	149.9	16.5	8.8	4.0	1.8	16.0	7.2	1.2	1.8	5.1	3.4	11.6	4.2	9.4	12.2	3.1	15.4	11.0	6.2	10.3	4.7	11.6	6.9	6.8	2.3	10.4	69.0	11.5	13.8	20.3	15.4	2.7	23.6	6.1	36.8	1.1	7.8	14.0	39.3	0.0	2.3	0.0	7.7	11.3	0.1	3.0	13.1	4.5	7.8	0.0	8.6	22.8	1.4	7.2	22.7	6.6	4.0	9.1	0.1	0.0	35.4	13.5	0.0	15.6	69.9	61.7	33.9	0.1	43.9	0.5	12.6	40.4	22.0	17.5	0.0	14.6	44.9	3.4	0.7	30.4	0.4	78.8	10.8	0.0	5.4	0.0	8.7	0.2	36.7	3.4	10.6	6.7	0.2	11.8	29.9	8.6	0.0	0.1	5.7	27.1	25.4	75.2	3.2	28.8	6.1	5.7	34.5	6.5	2.7	4.0	7.8	23.6	2.0	3.1	3.2	2.5	1.1	36.8	23.6	6.9	14.0	2.5	4.3	2.2	3.0	3.1	1.5	4.0	1.8	3.4	2.3
SLC4A11	"BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1"	ENSG00000088836	"Solute carrier family 4 member 11"	Q8NBS3	20	3227417-3239559	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 34.4;thyroid gland: 42.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 35.2;Hep G2: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 1.4;T-reg: 1.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA018120, HPA058377"	Uncertain		Uncertain	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA018120: AB_1857186, HPA058377: "	"unprognostic (2.33e-1)"	"prognostic favourable (9.03e-4)"	"unprognostic (1.18e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.52e-2)"	"unprognostic (9.66e-3)"	"unprognostic (3.73e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.64e-1)"	"prognostic favourable (6.21e-6)"	"unprognostic (7.37e-2)"	"unprognostic (4.30e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.89e-3)"	0.8	3.1	3.3	0.8	4.9	0.3	2.4	2.1	2.8	8.6	0.2	1.3	0.8	0.1	0.9	2.0	7.5	1.1	2.2	0.5	3.0	0.6	11.4	0.1	1.3	0.9	1.4	1.1	0.6	0.1	0.4	2.4	0.3	1.8	2.2	0.3	1.1	34.4	5.8	3.5	5.3	0.3	0.2	1.4	0.3	1.9	3.2	1.2	0.2	42.7	3.3	5.1	2.6	2.1	0.0	0.7	0.0	1.4	0.0	1.1	0.4	5.3	7.6	0.9	4.0	2.6	0.7	10.9	2.7	1.7	1.4	0.8	0.5	7.0	0.0	3.1	0.9	35.2	4.2	8.3	0.2	0.0	1.7	0.3	3.3	20.6	1.6	1.9	6.9	0.3	3.4	1.7	1.6	3.5	0.7	4.9	1.4	3.4	0.2	0.2	6.1	10.3	1.2	5.2	1.7	8.5	15.0	0.4	2.5	1.4	8.8	0.2	3.4	3.3	5.9	1.0	3.6	0.2	1.3	0.2	0.3	0.0	0.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.7	0.0	0.3	0.0	0.0	0.0	1.4	0.0	1.1	0.4	3.3	4.9	2.1	2.8	3.0	0.6	1.4	1.1	1.8	1.2
SMAD9	"MADH6, MADH9, SMAD8, SMAD8/9"	ENSG00000120693	"SMAD family member 9"	O15198	13	36844831-36920765	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 38.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 8.6;SH-SY5Y: 27.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009119, HPA031162"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"CAB009119: AB_2286517, HPA031162: AB_2673767"	"unprognostic (2.88e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.68e-3)"	"unprognostic (3.50e-3)"	"prognostic favourable (5.99e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.71e-3)"	"unprognostic (4.23e-2)"	"unprognostic (6.62e-2)"	"unprognostic (4.07e-3)"	"unprognostic (3.74e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (4.92e-4)"	"unprognostic (2.47e-2)"	4.4	3.1	7.0	3.2	6.2	0.6	4.1	10.7	11.8	6.3	8.2	14.3	4.1	2.6	10.0	11.3	5.8	5.1	7.4	6.9	15.0	6.2	5.0	1.4	5.3	2.6	10.7	8.9	10.1	1.3	3.0	6.2	6.7	10.2	14.9	6.0	11.9	17.7	12.4	13.8	2.1	4.0	8.4	15.5	1.5	5.9	2.7	11.0	0.0	38.9	1.9	3.4	7.7	12.6	1.7	1.7	1.1	0.8	0.7	1.4	0.2	0.0	0.1	0.5	5.8	1.7	0.8	0.2	6.6	0.7	1.8	1.1	0.0	0.1	0.2	4.2	8.6	0.3	5.8	0.1	2.0	0.2	8.2	0.0	3.0	4.6	1.8	0.5	0.1	3.0	0.5	0.0	0.0	3.5	0.0	0.0	4.2	0.3	0.1	0.5	0.8	0.6	0.1	6.2	0.0	0.0	0.9	5.1	27.6	1.3	0.2	0.3	0.4	0.2	6.3	2.7	2.2	1.5	1.6	0.1	0.0	0.0	1.9	0.2	0.4	1.1	0.4	0.3	1.2	0.8	0.8	1.0	1.2	1.3	0.2	1.7	1.2	1.4	0.9	0.7	0.5	1.7	0.4	0.2	7.0	6.2	10.7	7.8	15.0	6.2	10.7	8.9	10.2	11.0
SMPDL3B	ASML3B	ENSG00000130768	"Sphingomyelin phosphodiesterase acid like 3B"	Q92485	1	27934993-27959157	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.0;pancreas: 48.0;salivary gland: 25.5;thyroid gland: 24.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 22.6;CAPAN-2: 17.4;NTERA-2: 13.5;RPMI-8226: 14.0;SK-BR-3: 22.6;T-47d: 16.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 5.6"	"Group enriched"	"Detected in some"	7	"eosinophil: 6.3;myeloid DC: 2.7;neutrophil: 3.8"	"Group enriched"	"Detected in many"	8	"dendritic cells: 2.7;granulocytes: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030561			Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	330000	330000	"Golgi apparatus, Cytosol"	"Golgi apparatus, Cytosol"	"HPA030561: "	"unprognostic (1.22e-2)"	"unprognostic (4.45e-1)"	"unprognostic (4.58e-3)"	"unprognostic (3.83e-2)"	"unprognostic (3.35e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.09e-3)"	1.3	0.2	1.1	2.7	1.4	0.6	2.7	5.6	1.2	1.3	14.0	0.5	0.5	12.5	1.1	8.6	1.1	3.5	3.6	0.5	0.8	0.5	5.8	0.8	7.3	2.0	0.3	0.9	1.3	48.0	5.0	1.5	1.0	1.0	2.3	12.6	1.3	25.5	0.5	0.3	0.9	25.0	0.8	0.8	1.6	9.1	1.0	0.3	0.7	24.4	1.4	3.5	1.4	0.5	0.5	2.7	6.3	0.3	0.5	0.2	0.2	2.5	1.2	0.0	0.1	0.0	0.0	22.6	0.0	0.5	0.3	1.7	5.7	17.4	0.8	4.1	0.0	2.8	1.8	1.5	0.2	0.0	11.6	3.7	0.2	1.4	0.0	1.2	0.0	0.1	1.4	3.4	0.2	0.4	0.5	0.2	0.0	9.2	0.0	0.3	13.5	2.1	0.2	0.1	14.0	12.2	4.5	11.7	0.2	0.0	22.6	0.6	16.3	0.7	0.0	0.0	3.9	0.0	0.0	0.1	5.9	0.3	0.3	0.0	0.0	0.4	0.3	6.3	0.0	0.3	0.0	0.5	0.1	0.0	2.7	0.5	0.2	0.0	3.8	0.5	0.0	0.1	0.0	0.2	1.1	1.4	5.6	1.2	0.8	0.5	0.3	0.9	1.0	0.3
SNX22	FLJ13952	ENSG00000157734	"Sorting nexin 22"	Q96L94	15	64151715-64157481	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 23.2;thyroid gland: 41.1"	"Cell line enriched"	"Detected in some"	4	"Daudi: 19.5"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 47.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory B-cell: 6.6;naive B-cell: 11.5"	"Lineage enriched"	"Detected in many"	9	"B-cells: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038470	Approved		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA038470: AB_10673174"	"prognostic favourable (2.89e-5)"	"unprognostic (8.93e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.24e-1)"	"unprognostic (5.38e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-4)"	"unprognostic (3.92e-1)"	"unprognostic (2.52e-1)"	"prognostic favourable (2.19e-4)"	"unprognostic (1.74e-2)"	1.1	1.5	11.9	7.6	8.9	10.2	1.2	3.4	16.5	0.7	1.1	23.2	11.8	1.5	1.2	3.5	0.9	0.8	1.3	7.9	13.4	9.0	1.1	1.9	4.7	11.4	13.7	8.1	1.3	1.6	0.4	2.2	1.0	12.3	3.0	0.7	0.0	3.6	8.4	0.7	2.0	2.2	0.9	17.0	6.1	2.1	1.0	6.6	1.6	41.1	0.0	13.3	2.1	0.3	11.5	1.2	0.0	0.2	0.1	0.1	1.6	0.2	0.4	0.9	0.8	0.1	0.0	0.7	0.8	0.0	0.0	0.2	0.4	0.9	19.5	0.5	0.1	0.4	1.7	0.0	0.0	0.1	2.3	0.3	2.2	2.4	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.6	3.3	0.0	1.1	0.2	0.0	1.3	0.3	4.0	0.3	1.2	0.8	0.8	4.5	0.9	0.2	0.7	0.0	1.9	0.0	0.0	1.1	1.4	0.2	0.5	4.2	1.7	4.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	1.2	11.5	0.0	0.0	0.0	0.1	0.2	0.0	0.1	1.6	11.9	8.9	3.4	9.3	13.4	9.0	13.7	8.1	12.3	6.6
SORCS1	sorCS1	ENSG00000108018	"Sortilin related VPS10 domain containing receptor 1"	Q8WY21	10	106573663-107164534	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 18.5"	"Group enriched"	"Detected in some"	12	"RH-30: 33.2;SH-SY5Y: 43.3"	"Cancer enhanced"	"Detected in some"		"melanoma: 3.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	24	"intermediate monocyte: 2.4"	"Lineage enriched"	"Detected in single"	24	"monocytes: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011948	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA011948: AB_1857366"	"unprognostic (5.86e-3)"	"unprognostic (8.45e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.52e-2)"	"unprognostic (5.58e-2)"	"unprognostic (6.82e-3)"	"unprognostic (5.81e-2)"	"unprognostic (6.48e-4)"	"unprognostic (2.51e-2)"	"unprognostic (8.89e-3)"	"unprognostic (2.22e-1)"	"unprognostic (2.69e-4)"	1.4	5.8	6.0	4.5	14.1	0.4	1.8	0.5	13.2	2.2	10.7	1.1	1.9	1.4	2.1	1.2	2.0	3.2	2.8	4.2	2.6	4.7	8.0	0.5	0.5	1.9	2.1	6.6	1.2	3.0	0.6	1.2	0.4	3.3	2.7	3.6	6.5	2.4	4.9	0.8	2.3	4.5	2.7	2.1	1.7	3.4	2.3	2.7	0.2	18.5	1.1	2.7	4.7	3.8	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	33.2	0.0	0.0	0.0	0.0	43.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	14.1	0.5	11.3	2.6	4.7	2.1	6.6	3.3	2.7
SORD		ENSG00000140263	"Sorbitol dehydrogenase"	Q00796	15	45023104-45077185	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 66.3;liver: 98.4;thyroid gland: 116.3"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"prostate cancer: 72.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"eosinophil: 36.4"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 36.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040260, HPA040621"	Enhanced		Approved	Cytosol		430000	430000	Cytosol	Cytosol	"HPA040260: AB_10794872, HPA040621: AB_10795384"	"unprognostic (8.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.90e-2)"	"prognostic favourable (6.14e-5)"	"unprognostic (3.33e-3)"	"unprognostic (1.67e-1)"	"unprognostic (4.95e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.56e-1)"	1.4	10.2	3.0	1.5	3.2	1.0	7.1	3.1	3.8	66.3	5.5	6.2	39.2	2.6	2.6	3.2	6.7	3.5	3.9	3.4	3.0	3.0	20.9	98.4	1.6	2.2	4.2	2.3	1.6	7.3	1.2	1.8	0.5	5.0	48.5	3.8	2.3	7.6	46.7	1.4	8.0	8.7	2.0	5.0	2.4	5.6	2.5	3.9	3.1	116.3	3.8	3.5	4.2	4.4	1.6	2.4	36.4	2.7	0.4	1.0	1.3	15.8	13.9	3.5	11.4	3.1	5.4	3.7	4.4	3.0	10.0	8.5	11.5	8.6	2.0	9.9	5.4	23.8	18.2	16.6	8.0	34.3	11.3	15.9	18.2	25.5	2.3	27.5	26.6	6.9	12.6	5.7	9.2	9.3	17.7	5.6	9.4	6.3	16.6	14.9	13.6	14.8	0.0	23.0	7.7	7.3	15.4	25.0	13.1	8.9	14.1	6.7	20.3	11.3	8.3	8.0	7.0	17.8	10.5	1.0	6.9	2.0	12.9	24.4	20.7	5.0	2.7	36.4	0.6	2.5	1.0	1.2	0.6	0.8	2.4	1.6	0.5	0.6	1.4	0.4	2.5	1.3	0.6	1.3	3.0	3.2	3.1	3.8	3.0	3.0	4.2	2.3	5.0	3.9
SSC4D	"S4D-SRCRB, SRCRB-S4D, SRCRB4D"	ENSG00000146700	"Scavenger receptor cysteine rich family member with 4 domains"	Q8WTU2	7	76389334-76409695	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"salivary gland: 9.3;seminal vesicle: 9.5;thyroid gland: 8.6"	"Group enriched"	"Detected in some"	13	"EFO-21: 6.0;Hep G2: 8.1;U-2 OS: 23.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.6"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA062611	Uncertain				"Secreted - unknown location"					"HPA062611: AB_2684807"	"unprognostic (3.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavourable (2.83e-6)"	"prognostic unfavourable (7.08e-4)"	"unprognostic (3.52e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.49e-3)"	"unprognostic (3.18e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavourable (4.71e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.73e-2)"	1.1	0.5	0.1	0.1	0.1	0.0	0.4	0.0	0.2	1.0	0.2	0.3	3.0	0.2	0.3	0.8	0.0	0.4	0.1	0.0	0.2	0.2	7.7	0.7	0.2	0.1	0.2	0.8	2.3	4.4	7.8	7.2	0.7	0.4	0.1	0.0	0.8	9.3	9.5	0.4	0.0	0.0	0.2	0.7	0.3	0.1	0.3	0.0	0.0	8.6	0.0	0.2	0.0	0.0	0.3	0.1	0.0	1.6	0.0	0.2	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.2	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.4	0.0	0.0	0.8	0.2	0.0	0.7	0.1	0.0	0.0	0.1	0.9	0.4	0.0	0.0	0.1	0.0	0.0	0.0	23.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.6	0.1	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.2	0.2	0.8	0.4	0.0
SSX5		ENSG00000165583	"SSX family member 5"	O60225	X	48186220-48196763	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"testis: 4.3;thyroid gland: 2.9"	"Cell line enriched"	"Detected in some"	4	"BEWO: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045683	Uncertain		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA045683: AB_2679418"									"unprognostic (1.20e-1)"						"unprognostic (2.96e-1)"	"unprognostic (1.23e-1)"		0.4	0.0	0.1	0.1	0.4	1.0	0.1	0.1	0.1	0.1	1.2	0.1	0.1	0.0	0.5	0.2	0.1	0.8	0.1	0.8	0.1	0.1	0.1	0.1	0.2	0.3	0.1	0.1	0.3	0.1	1.6	0.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.6	0.2	0.1	0.1	0.8	0.0	4.3	0.1	0.1	2.9	0.1	0.1	0.1	0.1	0.5	0.2	0.9	0.2	0.6	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.6	1.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.2	0.4	0.3	0.4	0.1	0.5	0.1	0.4	0.9	0.6	0.0	0.2	0.2	0.0	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
ST6GAL2	"KIAA1877, SIAT2, St6gal2, St6GalII"	ENSG00000144057	"ST6 beta-galactoside alpha-2,6-sialyltransferase 2"	Q96JF0	2	106801600-106887108	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.7;thyroid gland: 34.0"	"Cell line enhanced"	"Detected in some"		"A549: 5.7;NTERA-2: 4.9;PC-3: 6.5;RPMI-8226: 10.2;SCLC-21H: 6.8;U-138 MG: 8.3;U-266/70: 10.9"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 16.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014459	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA014459: AB_1857528"	"unprognostic (2.08e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.29e-4)"	"unprognostic (4.56e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.01e-4)"	"unprognostic (4.70e-4)"	"unprognostic (4.06e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.07e-2)"	1.2	0.7	14.1	0.7	5.6	1.5	1.3	2.3	16.7	2.1	1.5	4.1	1.7	0.7	3.7	1.9	2.7	1.2	12.7	1.9	5.4	4.0	1.1	3.4	1.2	0.9	3.8	7.1	0.9	0.5	0.5	0.3	2.3	4.2	1.6	3.3	0.0	1.6	1.6	0.7	1.3	0.7	2.8	1.9	0.6	0.9	7.9	1.5	0.0	34.0	1.6	0.8	1.5	1.4	0.7	0.6	1.8	0.5	1.0	0.7	0.5	0.0	5.7	3.2	0.1	0.0	0.0	0.1	0.3	0.0	1.3	0.4	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	4.9	6.5	0.0	0.0	10.2	0.2	0.0	6.8	4.4	0.0	0.1	0.0	0.0	0.1	0.0	8.3	0.1	0.2	0.0	10.9	0.2	0.1	0.0	0.0	0.0	1.4	0.5	0.4	0.6	0.3	0.5	0.4	0.4	0.5	0.2	0.7	0.5	0.7	1.8	1.0	0.3	0.6	0.5	0.5	14.1	5.6	2.3	14.8	5.4	4.0	3.8	7.1	4.2	1.5
TBL1Y	TBL1	ENSG00000092377	"Transducin beta like 1 Y-linked"	Q9BQ87	Y	6910686-7091683	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 15.1;thyroid gland: 10.8"	"Cell line enriched"	"Detected in some"	6	"U-698: 14.1"	"Cancer enriched"	"Detected in single"	6	"prostate cancer: 1.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	14	"MAIT T-cell: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"									HPA060073	Uncertain									"HPA060073: AB_2684196"						"unprognostic (2.81e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.06e-1)"			"unprognostic (7.76e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.47e-1)"		"unprognostic (3.24e-2)"	1.0	0.0	0.1	0.2	0.5	0.1	1.0	0.1	0.4	0.0	0.4	0.5	0.0	0.2	0.1	1.5	1.3	0.1	3.8	0.1	0.1	0.2	1.4	3.3	3.0	0.8	0.1	0.0	0.1	15.1	0.0	0.1	0.3	0.7	7.2	0.4	1.6	5.8	0.7	1.3	0.6	0.3	0.1	0.0	0.1	0.7	3.5	0.0	0.1	10.8	2.9	1.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	2.2	0.0	2.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.4	0.1	0.2	0.1	0.0	0.7	0.0
TCERG1L	FLJ38950	ENSG00000176769	"Transcription elongation regulator 1 like"	Q5VWI1	10	131092391-131311721	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.7;thyroid gland: 24.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 9.5;NTERA-2: 1.4;RPMI-8226: 2.3;SCLC-21H: 1.2;U-2 OS: 2.4"	"Cancer enriched"	"Detected in some"	14	"thyroid cancer: 20.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (6.61e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.69e-2)"		"unprognostic (1.62e-1)"	"unprognostic (4.96e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.08e-5)"	"unprognostic (1.28e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.03e-1)"	0.4	1.9	2.7	0.4	4.1	0.4	0.6	3.0	9.7	0.5	0.4	0.0	0.0	0.4	0.6	1.1	0.6	0.4	0.4	0.4	3.8	3.5	0.4	0.4	0.5	0.4	0.9	3.9	5.5	0.8	0.4	4.8	0.4	1.5	1.4	0.4	3.8	0.3	1.3	0.3	1.2	0.4	0.4	2.2	0.6	0.5	1.8	0.0	0.6	24.1	0.0	0.6	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	2.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.7	4.1	3.0	9.7	3.8	3.5	0.9	3.9	1.5	0.0
TFF3	"HITF, ITF"	ENSG00000160180	"Trefoil factor 3"		21	42311667-42315651	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"gallbladder: 230.9;thyroid gland: 258.3"	"Cell line enhanced"	"Detected in some"		"MCF7: 32.1;SCLC-21H: 9.8;T-47d: 15.0;TIME: 41.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	30	"eosinophil: 9.5"	"Lineage enriched"	"Detected in single"	63	"granulocytes: 9.5"	"Region enriched"	"Detected in single"	20	"cerebellum: 1.7"	"Region enriched"	"Detected in single"	8	"olfactory region: 1.0"	"CAB020681, HPA035464"	Enhanced		Approved	Nucleoplasm,Nucleoli	"Secreted to blood"			Nucleoplasm	Nucleoplasm	"CAB020681: , HPA035464: AB_2674636"	"unprognostic (2.84e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.07e-1)"	"prognostic favourable (5.60e-6)"	"unprognostic (1.28e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.71e-1)"	"unprognostic (6.90e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.86e-2)"	2.2	1.2	0.2	16.8	0.2	0.0	4.3	0.2	0.2	45.1	66.3	0.2	0.5	40.8	2.8	1.2	5.1	8.0	230.9	0.7	0.2	0.3	1.0	0.6	12.6	0.6	0.4	0.2	2.0	4.8	0.0	0.5	0.5	0.2	3.6	63.3	0.3	54.8	0.7	0.6	1.6	70.6	1.5	0.5	5.0	1.1	0.4	0.2	0.3	258.3	14.4	72.6	1.1	1.6	0.0	0.0	9.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	32.1	0.0	0.5	0.1	4.8	0.0	3.6	0.4	0.0	0.0	9.8	0.1	0.0	1.0	0.0	15.0	0.0	41.7	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.3	0.4	0.2	0.2	0.2
TMEM171	PRP2	ENSG00000157111	"Transmembrane protein 171"	Q8WVE6	5	73120292-73131817	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 18.2;intestine: 20.1;kidney: 25.4;stomach 1: 16.7;thyroid gland: 25.9"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 20.5;RPTEC TERT1: 15.6;WM-115: 57.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"MAIT T-cell: 18.2;memory CD8 T-cell: 6.3"	"Lineage enriched"	"Detected in single"	86	"T-cells: 18.2"	"Region enriched"	"Detected in single"	5	"hippocampal formation: 0.9"	"Region enhanced"	"Detected in single"		"pons and medulla: 3.6"	HPA042308	Approved									"HPA042308: AB_10796901"	"unprognostic (7.34e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.81e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.22e-1)"	"prognostic favourable (3.93e-10)"	"unprognostic (6.13e-3)"	"unprognostic (2.43e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.57e-1)"	0.2	0.2	0.8	5.6	2.1	0.0	0.7	0.7	3.3	0.4	20.1	3.2	2.2	16.2	0.2	1.4	3.9	0.2	1.5	0.2	1.2	0.7	25.4	3.9	0.4	0.1	0.9	1.6	0.2	0.6	0.0	0.3	0.1	1.1	0.5	18.9	0.6	1.4	2.8	0.6	0.7	18.8	0.6	1.4	14.6	16.7	0.6	0.6	0.0	25.9	3.2	6.3	0.4	0.3	0.0	0.0	0.2	0.0	0.0	18.2	0.5	7.3	0.3	0.0	0.0	2.4	3.2	0.0	2.3	10.9	4.4	7.5	0.2	3.5	0.0	5.0	2.9	5.5	0.1	0.3	3.5	0.0	1.1	0.0	0.0	0.0	0.8	0.0	0.3	0.7	0.2	6.0	0.5	2.7	0.0	0.1	20.5	0.7	0.0	0.0	0.6	0.4	0.0	0.0	3.7	15.6	0.1	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.0	0.0	0.3	6.5	0.1	0.0	0.0	0.0	6.0	0.0	57.2	0.0	0.0	0.0	1.3	0.0	18.2	0.0	0.7	6.3	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.5	0.8	2.1	0.7	3.3	1.2	0.7	0.9	1.6	1.1	0.6
TMEM30B	CDC50B	ENSG00000182107	"Transmembrane protein 30B"	Q3MIR4	14	61277370-61281840	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 50.3"	"Cell line enhanced"	"Detected in some"		"A-431: 24.5;CAPAN-2: 20.1;HaCaT: 11.7;HBEC3-KT: 14.2;hTCEpi: 10.8;MCF7: 15.8;RT4: 34.4;T-47d: 11.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.8"	"Lineage enriched"	"Detected in single"	4	"T-cells: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA043162	Uncertain									"HPA043162: AB_10796688"	"unprognostic (4.06e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.43e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.26e-1)"	"prognostic favourable (5.89e-5)"	"unprognostic (2.21e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.85e-1)"	3.7	1.2	0.8	1.6	1.3	0.0	4.7	0.7	1.0	5.4	11.5	0.5	18.0	14.1	3.9	14.6	8.1	4.8	10.6	1.5	0.8	0.8	6.7	5.5	6.4	0.4	0.8	0.7	4.8	23.3	20.3	27.3	11.6	3.4	9.1	8.4	1.0	18.9	14.4	1.6	3.9	19.5	2.0	1.7	0.9	13.3	6.3	0.2	2.3	50.3	6.2	4.7	9.6	5.7	0.0	0.0	0.0	0.0	0.7	2.8	0.5	24.5	0.0	0.0	0.0	2.8	0.6	0.0	0.0	0.0	0.0	0.0	4.2	20.1	0.0	0.0	0.0	11.7	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.8	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.2	0.5	0.0	0.5	0.0	0.0	34.4	4.1	0.0	0.3	9.5	0.0	11.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.6	0.0	1.2	0.6	0.0	0.0	2.8	1.8	0.0	0.7	0.0	0.0	0.0	0.5	0.8	1.3	0.7	1.0	0.8	0.8	0.8	0.7	3.4	0.2
TNFRSF11B	"OCIF, OPG, TR1"	ENSG00000164761	"TNF receptor superfamily member 11b"	O00300	8	118923557-118952200	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 18.6;thyroid gland: 52.8"	"Group enriched"	"Detected in some"	4	"BJ: 49.7;BJ hTERT+: 184.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	66	"plasmacytoid DC: 6.5"	"Lineage enriched"	"Detected in single"	66	"dendritic cells: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB034939	Approved				"Secreted in other tissues"					"CAB034939: "	"unprognostic (1.39e-2)"	"prognostic unfavourable (6.22e-4)"	"unprognostic (5.27e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.21e-3)"	"unprognostic (5.50e-2)"	"unprognostic (9.94e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.43e-1)"	"prognostic favourable (6.79e-4)"	"unprognostic (1.32e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.61e-3)"	"prognostic unfavourable (3.88e-4)"	3.0	3.0	2.2	2.8	2.8	0.2	4.4	2.9	5.2	1.2	1.5	0.7	0.5	0.9	5.5	4.1	1.0	1.7	3.2	7.3	2.8	1.4	18.6	7.6	8.1	5.3	1.7	0.8	0.5	2.8	0.3	1.9	4.0	12.0	1.1	2.0	1.8	1.4	0.8	0.6	0.7	1.4	1.5	7.9	1.5	0.8	0.3	2.7	0.9	52.8	0.8	1.7	1.7	1.1	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.6	0.5	0.0	49.7	184.9	2.4	0.6	0.5	0.1	0.0	13.4	27.5	0.5	0.0	0.0	1.2	0.0	0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	6.9	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	1.5	0.8	0.9	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	2.2	2.8	2.9	5.2	2.8	1.4	1.7	0.8	12.0	2.7
TPMT		ENSG00000137364	"Thiopurine S-methyltransferase"	P51580	6	18128311-18155074	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 48.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019851	Enhanced									"HPA019851: AB_1858213"	"unprognostic (6.24e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.46e-3)"	"prognostic unfavourable (8.45e-5)"	"unprognostic (4.98e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.16e-2)"	"unprognostic (4.36e-3)"	"unprognostic (9.62e-2)"	"prognostic favourable (1.41e-4)"	"unprognostic (4.49e-2)"	"unprognostic (3.40e-2)"	"prognostic favourable (1.10e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.39e-3)"	5.3	13.2	11.5	6.6	10.2	4.9	5.6	13.1	14.3	4.6	18.2	4.1	6.2	18.4	6.5	10.1	8.9	4.1	7.6	6.5	9.0	8.0	40.2	36.2	6.5	6.2	9.3	7.5	3.8	9.4	12.9	11.6	3.3	8.5	6.2	19.4	6.9	12.9	7.2	7.0	5.7	29.4	6.2	7.2	9.4	6.6	4.1	7.5	5.4	48.2	6.3	5.3	6.4	5.6	1.6	16.9	3.7	23.8	5.4	8.3	8.3	11.7	3.6	4.0	9.8	6.6	12.9	9.8	13.7	15.2	11.7	18.3	8.3	2.9	1.5	10.2	18.0	5.9	5.6	9.8	19.6	7.7	8.1	9.7	6.1	12.1	7.2	4.4	8.8	7.4	10.6	13.0	8.3	16.2	19.1	2.8	8.5	5.4	4.5	6.1	6.6	10.3	5.7	9.8	6.6	13.6	12.1	6.5	5.0	8.9	15.9	17.5	11.5	4.5	6.9	26.9	5.2	14.0	19.3	4.1	18.2	3.8	9.6	6.1	26.9	3.4	12.0	3.7	6.5	23.8	8.3	1.5	5.3	6.2	16.9	1.6	4.8	6.5	1.2	5.4	19.6	3.7	8.2	8.3	11.5	10.2	13.1	14.3	9.0	8.0	9.3	7.5	8.5	7.5
TRIB1	"C8FW, GIG2, TRB1"	ENSG00000173334	"Tribbles pseudokinase 1"	Q96RU8	8	125430321-125438405	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 84.2;thyroid gland: 90.7"	"Cell line enhanced"	"Detected in many"		"HEL: 54.0;U-266/70: 33.1;U-266/84: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 10.8;neutrophil: 5.8;non-classical monocyte: 3.7;T-reg: 3.1"	"Group enriched"	"Detected in many"	11	"granulocytes: 10.8;monocytes: 3.7;T-cells: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063982			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA063982: AB_2685165"	"unprognostic (1.90e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.34e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.81e-3)"	"unprognostic (9.36e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.08e-2)"	26.7	6.5	5.9	17.6	6.5	84.2	13.3	4.3	6.1	10.4	12.4	4.4	6.6	4.9	6.2	6.7	10.9	10.9	21.0	11.1	4.3	4.0	16.6	63.5	28.9	14.6	4.2	3.9	6.4	23.6	20.9	7.2	15.5	4.5	12.1	13.3	15.0	14.5	9.1	22.3	10.4	16.9	11.3	3.1	15.9	18.5	5.6	3.1	9.2	90.7	17.6	12.1	12.4	9.0	0.2	0.5	10.8	3.7	0.0	3.1	0.1	4.0	4.6	0.6	1.3	1.3	2.6	7.3	2.6	3.7	1.9	0.6	6.2	5.4	7.4	2.5	1.9	3.1	2.0	2.6	1.7	3.2	9.7	54.0	2.0	12.0	3.4	27.0	4.9	2.5	3.9	8.1	18.4	5.7	4.7	23.5	0.2	4.3	2.5	4.2	4.5	9.0	5.1	0.9	8.0	15.9	15.5	3.9	1.4	6.5	7.1	25.7	1.8	1.3	2.9	2.1	2.8	2.1	3.3	33.1	33.0	10.3	3.8	0.1	5.0	0.0	0.9	10.8	0.0	1.2	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	5.8	0.0	3.7	0.3	3.1	0.1	5.9	6.5	4.3	6.1	4.3	4.0	4.2	3.9	4.5	3.1
TRIM58	BIA2	ENSG00000162722	"Tripartite motif containing 58"	Q8NG06	1	247857199-247878205	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.8;placenta: 22.4;thyroid gland: 15.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 7.9;HEL: 21.0;K-562: 11.6;PC-3: 20.2;U-2 OS: 16.5;WM-115: 21.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA023637	Uncertain					310000	310000			"HPA023637: AB_1858309"	"unprognostic (3.85e-1)"	"unprognostic (5.24e-3)"	"unprognostic (7.00e-2)"	"unprognostic (6.52e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.14e-5)"	"unprognostic (3.59e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.57e-2)"	0.7	0.8	1.3	1.0	4.4	24.8	0.7	0.3	3.7	0.6	1.3	0.2	0.0	0.3	0.5	0.4	0.5	1.4	0.5	0.8	1.5	3.2	0.5	0.6	3.4	0.4	2.4	1.2	1.1	0.4	0.3	0.7	22.4	6.9	1.7	1.0	1.1	0.5	0.4	0.5	1.2	0.6	0.8	1.3	5.8	0.7	4.9	0.1	0.0	15.2	0.0	0.4	1.9	0.7	3.1	0.6	3.7	0.7	1.7	0.3	1.9	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.0	7.9	0.0	0.0	0.0	0.8	21.0	0.0	0.0	0.0	2.8	1.6	0.0	0.0	0.0	0.0	0.0	11.6	0.1	0.0	0.0	0.0	0.1	1.3	20.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.1	0.0	0.0	16.5	0.0	0.0	3.5	0.0	0.0	0.0	5.9	21.3	2.8	0.7	1.8	0.3	0.5	0.2	3.1	0.2	0.2	0.6	1.0	0.3	0.2	3.7	1.7	0.6	0.6	0.2	1.9	1.3	4.4	0.3	3.7	1.5	3.2	2.4	1.2	6.9	0.1
TRIM61	RNF35	ENSG00000183439	"Tripartite motif containing 61"	Q5EBN2	4	164954446-164977668	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 16.1;thyroid gland: 15.5"	"Cell line enhanced"	"Detected in some"		"HHSteC: 9.9;HSkMC: 6.6;U-266/70: 13.1;U-266/84: 6.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA049109	Uncertain		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"				"Nucleoli fibrillar center, Endoplasmic reticulum"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"HPA049109: AB_2680636"	"unprognostic (2.05e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.92e-1)"	"unprognostic (9.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.32e-2)"	2.4	5.4	1.8	3.0	2.5	3.3	1.6	1.3	2.1	2.6	1.4	1.1	7.2	2.2	2.8	1.9	0.8	3.5	3.1	5.9	2.4	3.0	1.0	1.1	2.1	2.9	2.7	1.3	5.8	0.9	1.5	6.8	1.8	3.8	2.1	1.1	2.9	0.9	1.9	1.2	1.1	1.7	2.1	4.2	4.7	1.5	16.1	1.6	2.7	15.5	0.7	2.8	3.0	5.2	5.5	5.1	3.6	1.3	7.8	4.1	1.5	0.2	0.4	1.0	0.8	0.6	0.6	0.6	2.4	0.8	0.0	0.0	0.3	0.3	0.7	0.2	3.6	0.3	0.6	0.6	0.4	0.4	0.5	0.2	0.5	0.7	9.9	0.5	0.6	6.6	0.5	2.1	0.2	0.2	0.5	1.5	0.3	0.4	0.3	0.8	3.8	0.0	0.5	0.2	1.0	0.3	0.9	0.8	0.5	0.1	0.3	0.4	0.3	0.3	0.7	1.2	0.4	0.1	0.2	13.1	6.6	0.4	0.3	0.2	0.4	3.6	1.3	0.1	3.3	1.1	3.4	3.6	1.6	3.3	1.5	5.5	4.1	4.0	0.5	7.8	0.8	5.1	0.4	1.5	1.8	2.5	1.3	2.1	2.4	3.0	2.7	1.3	3.8	1.6
USP17L11		ENSG00000233136	"Ubiquitin specific peptidase 17-like family member 11"	C9JVI0	4	9215405-9217356	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 1.0;fallopian tube: 1.2;thyroid gland: 1.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.5;NTERA-2: 1.6"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 1.0"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.0"									HPA045642	Uncertain									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.6	0.0	0.0			0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0			1.3		0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0										
USP17L17		ENSG00000249104	"Ubiquitin specific peptidase 17-like family member 17"	D6RBQ6	4	9243879-9245830	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"thyroid gland: 1.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.2;NTERA-2: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.4	0.0			0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.2		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			1.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
UTS2R	GPR14	ENSG00000181408	"Urotensin 2 receptor"	Q9UKP6	17	82374230-82375586	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"testis: 6.2;thyroid gland: 3.8"	"Group enriched"	"Detected in some"	4	"Karpas-707: 7.7;U-266/70: 18.8"	"Group enriched"	"Detected in some"	5	"stomach cancer: 0.7;testis cancer: 2.2;thyroid cancer: 1.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"														"unprognostic (1.55e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.26e-2)"		"unprognostic (2.30e-2)"	"unprognostic (3.98e-1)"	"unprognostic (6.38e-2)"	"unprognostic (4.44e-2)"	"unprognostic (8.73e-2)"		"unprognostic (1.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.84e-2)"		0.0	0.0	0.1	0.5	0.0	0.4	0.2	0.4	1.7	0.0	0.7			1.5	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.1	0.7	0.0	0.1	0.1	0.0		0.0	1.2	0.0	0.0	0.0		0.2	0.0		0.6	0.0	1.1	0.0	0.7	0.0	0.0	0.7	0.7	6.2			3.8		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.0	2.2	0.0	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	18.8	3.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
WARS	"IFI53, IFP53"	ENSG00000140105	"Tryptophanyl-tRNA synthetase"	P23381	14	100333788-100376805	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 142.8;thyroid gland: 157.0"	"Cell line enhanced"	"Detected in all"		"HHSteC: 116.6;SK-MEL-30: 140.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"intermediate monocyte: 131.2;non-classical monocyte: 142.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005573, HPA018944"	Enhanced		Enhanced	Cytosol		53000000	53000000	Cytosol	Cytosol	"HPA005573: AB_2667366, HPA018944: AB_2669986"	"unprognostic (5.36e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.25e-2)"	"prognostic unfavourable (7.88e-4)"	"unprognostic (5.14e-2)"	"unprognostic (4.26e-2)"	"prognostic favourable (1.94e-4)"	"unprognostic (4.84e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.92e-3)"	42.5	23.3	14.5	53.9	20.1	17.0	20.6	10.7	25.4	11.1	19.1	13.3	7.1	12.7	16.5	20.5	17.8	14.5	13.7	32.0	17.8	18.7	24.6	17.9	68.5	35.3	16.9	14.8	12.1	15.6	9.4	23.5	89.6	28.2	16.4	21.0	23.5	15.7	11.7	22.3	9.3	19.8	21.0	15.7	51.6	19.8	23.7	9.4	20.9	157.0	19.2	22.7	24.0	13.8	5.6	27.7	51.8	142.8	3.3	3.4	46.4	10.9	10.4	6.8	39.9	9.9	14.1	11.0	14.1	27.3	30.5	38.4	6.8	9.8	11.9	13.2	33.7	18.6	19.9	16.1	19.6	18.8	5.7	7.6	7.9	8.3	116.6	21.8	12.6	16.0	23.2	17.7	36.8	27.2	24.0	31.5	13.0	20.9	7.5	10.2	6.9	18.9	6.2	10.8	7.6	14.8	9.6	18.4	10.7	8.4	7.3	140.8	18.8	27.6	18.0	3.3	7.3	33.3	7.4	61.5	31.2	22.1	36.7	16.9	29.7	6.1	39.5	51.8	3.4	131.2	3.1	5.6	2.8	3.1	27.7	4.1	2.0	2.4	14.1	3.3	142.8	4.2	3.3	46.4	14.5	20.1	10.7	25.4	17.8	18.7	16.9	14.8	28.2	9.4
WDR72	FLJ38736	ENSG00000166415	"WD repeat domain 72"	Q3MJ13	15	53513741-53762878	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 64.1;thyroid gland: 36.3"	"Cell line enhanced"	"Detected in some"		"A549: 9.3;EFO-21: 6.1;NTERA-2: 5.6;RPMI-8226: 15.8;RPTEC TERT1: 10.3;U-266/70: 7.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048212, HPA057410, HPA059819"	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA048212: AB_2680315, HPA057410: AB_2683430, HPA059819: AB_2684133"	"unprognostic (6.39e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.09e-2)"	"prognostic favourable (3.33e-16)"	"unprognostic (2.83e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.80e-4)"	"unprognostic (7.67e-2)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	2.7	0.2	0.1	3.0	0.8	0.6	4.9	0.3	0.8	4.6	0.2	0.1	0.1	64.1	13.1	0.8	0.1	0.1	0.1	0.5	1.3	1.5	0.9	0.8	0.1	0.2	0.1	0.3	11.2	0.4	0.1	1.1	0.6	0.1	0.1	0.1	0.2	1.1	0.1	0.1	36.3	0.4	0.5	0.6	0.1	0.2	0.0	0.1	0.0	0.2	0.8	0.1	0.0	9.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	3.0	0.1	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.6	0.1	0.0	0.1	15.8	10.3	3.3	1.8	0.0	0.0	0.1	0.0	2.3	0.0	0.1	0.3	0.5	0.0	0.1	7.3	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.5	0.2	0.3	0.5	0.0	0.1	0.3	0.2	0.0	0.2	0.0	0.0	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
WDR86		ENSG00000187260	"WD repeat domain 86"	Q86TI4	7	151375909-151410727	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"thyroid gland: 33.8"	"Cell line enhanced"	"Detected in some"		"HSkMC: 16.6;NTERA-2: 3.1;SCLC-21H: 7.0;SH-SY5Y: 5.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 14.9"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"basal ganglia: 1.5;cerebellum: 1.4;hippocampal formation: 4.4;pons and medulla: 3.6;thalamus: 2.7"	"Low region specificity"	"Detected in many"														"unprognostic (8.93e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.13e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.32e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.84e-6)"	"unprognostic (7.22e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.04e-1)"	7.4	1.7	6.8	0.9	4.2	0.7	5.0	0.6	4.7	11.1	5.6	1.5	15.7	1.8	7.7	8.8	0.9	8.2	2.1	1.1	5.5	1.0	2.3	0.8	1.0	2.1	2.4	2.4	4.5	0.7	21.7	5.0	5.6	3.2	2.9	0.7	14.7	1.9	11.3	1.2	0.7	1.7	1.9	1.3	15.6	2.6	1.9	0.3	0.8	33.8	0.4	0.8	2.3	4.5	0.0	0.0	0.0	0.7	0.7	1.7	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	7.0	5.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.0	1.7	0.9	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	6.8	4.2	0.6	4.7	5.5	1.0	2.4	2.4	3.2	0.3
WSCD2	KIAA0789	ENSG00000075035	"WSC domain containing 2"	Q2TBF2	12	108129471-108250537	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.0;seminal vesicle: 18.2;thyroid gland: 21.8"	"Cell line enriched"	"Detected in some"	21	"RT4: 26.9"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.6"	"Region enhanced"	"Detected in all"		"cerebellum: 44.0"	"Cell type enhanced"	"Detected in single"		"T-reg: 2.5"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013346, HPA048133"	Approved		Uncertain	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA013346: AB_1858865, HPA048133: AB_2797236"	"unprognostic (1.50e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.50e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.43e-3)"	"unprognostic (3.03e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.43e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.62e-3)"	1.4	1.2	6.5	0.5	12.5	0.4	1.0	44.0	15.2	5.4	1.7	1.6	0.0	0.7	6.9	3.0	3.8	2.0	0.5	0.5	10.0	3.0	1.3	0.4	0.8	0.5	1.3	6.0	0.6	2.1	0.4	0.9	0.6	1.9	6.0	0.7	9.9	0.5	18.2	0.5	0.6	0.9	9.2	1.5	0.5	2.0	0.6	2.0	0.0	21.8	0.2	0.5	3.0	0.9	0.8	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	26.9	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	6.5	12.5	44.0	15.2	10.0	3.0	1.3	6.0	1.9	2.0
XKRX	"XKR2, XPLAC"	ENSG00000182489	"XK related, X-linked"	Q6PP77	X	100913445-100929433	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 12.0;placenta: 12.2;skin 1: 12.9;thyroid gland: 11.0"	"Cell line enriched"	"Detected in some"	5	"CACO-2: 13.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"naive B-cell: 5.0;naive CD4 T-cell: 3.7;naive CD8 T-cell: 2.8"	"Group enriched"	"Detected in many"	44	"B-cells: 5.0;T-cells: 3.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"														"unprognostic (3.35e-1)"	"unprognostic (2.38e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.37e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.60e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.60e-1)"	"prognostic favourable (3.52e-4)"	"unprognostic (1.18e-1)"	0.1	1.0	0.2	2.1	0.3	0.1	1.1	0.1	0.1	1.2	7.2	0.2	8.3	0.4	0.2	1.9	3.5	1.1	0.5	0.1	0.2	0.4	0.3	0.1	3.3	2.4	0.2	0.0	0.3	0.2	0.0	12.0	12.2	0.2	0.5	1.3	0.0	1.0	1.8	0.2	12.9	6.8	0.0	0.2	0.6	0.5	0.4	0.0	0.8	11.0	1.9	5.4	0.5	2.4	5.0	0.0	0.0	0.0	0.0	3.7	0.6	0.3	1.0	0.1	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.0	13.0	1.6	1.0	0.1	0.0	0.2	0.0	0.9	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	2.5	0.0	0.0	0.1	0.6	0.1	0.0	0.4	0.0	0.0	0.0	2.5	0.1	2.0	0.3	1.1	0.2	1.1	0.0	0.4	0.0	2.3	0.0	0.3	0.0	0.0	1.9	0.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.1	0.0	0.0	5.0	3.7	2.8	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.1	0.1	0.2	0.4	0.2	0.0	0.2	0.0
ZMAT4	FLJ13842	ENSG00000165061	"Zinc finger matrin-type 4"	Q9H898	8	40530590-40897833	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 11.5;brain: 21.6;thyroid gland: 29.1"	"Group enriched"	"Detected in some"	5	"AF22: 20.6;U-2197: 12.8"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.9"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	115	"NK-cell: 11.5"	"Lineage enriched"	"Detected in single"	115	"NK-cells: 11.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA069813, HPA071585"	Enhanced		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA069813: AB_2686206, HPA071585: AB_2686423"	"unprognostic (1.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.83e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-1)"		"unprognostic (1.07e-1)"		"unprognostic (9.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.46e-4)"	"unprognostic (5.44e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (3.51e-4)"	"unprognostic (4.79e-3)"	0.8	2.0	4.4	0.9	15.3	0.8	0.9	0.6	20.4	3.3	1.0	0.9	0.0	0.7	1.4	1.0	0.7	0.9	1.0	1.5	6.1	4.0	1.2	0.7	0.8	0.9	3.3	7.8	1.6	0.7	0.7	5.3	1.0	21.6	1.6	1.2	1.4	0.8	1.5	0.7	0.7	0.8	0.8	1.0	1.3	1.0	2.9	3.9	0.0	29.1	0.0	0.9	0.8	0.2	0.0	0.0	0.0	0.0	11.5	0.0	0.1	0.0	1.2	20.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.1	0.0	0.0	0.2	0.0	0.0	1.1	0.3	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.6	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.1	4.4	15.3	0.6	20.4	6.1	4.0	3.3	7.8	21.6	3.9
ZNF114	MGC17986	ENSG00000178150	"Zinc finger protein 114"	Q8NC26	19	48270102-48287608	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 11.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 16.7;Hep G2: 19.6;NTERA-2: 10.2;REH: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA025019, HPA029553"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA025019: AB_1859080, HPA029553: AB_10603005"	"unprognostic (1.82e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (3.29e-4)"	"unprognostic (2.67e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.56e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.13e-7)"	"unprognostic (9.74e-2)"	"unprognostic (2.78e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.63e-1)"	1.5	1.0	3.7	2.2	2.7	2.1	1.2	1.2	3.3	2.3	0.6	2.1	1.0	0.9	2.4	2.4	1.3	1.9	1.5	1.7	3.7	4.6	1.6	0.5	1.4	1.9	2.6	0.8	1.2	5.3	4.2	1.6	7.5	2.1	3.1	0.4	2.5	3.7	1.3	3.7	3.7	0.7	1.4	3.5	1.6	0.7	1.6	1.7	1.0	11.5	0.5	1.1	1.3	5.7	2.6	3.5	5.4	0.7	2.0	0.6	0.4	2.7	4.2	5.1	0.5	0.3	0.0	16.7	0.5	0.0	1.5	2.1	1.5	4.3	0.1	4.9	0.3	5.5	7.0	0.3	1.8	0.0	0.4	0.6	1.3	19.6	1.6	2.6	0.5	0.3	0.5	0.8	0.1	0.3	0.7	0.4	0.3	7.9	0.2	8.3	10.2	0.9	10.4	0.0	0.3	0.2	2.3	2.0	2.4	2.7	0.0	2.9	1.1	4.9	0.7	0.8	1.7	1.5	0.5	0.4	0.1	0.1	0.2	1.4	0.8	3.3	0.7	0.9	0.5	0.6	0.3	0.9	0.6	0.4	1.7	2.6	0.5	0.4	5.4	2.0	0.7	3.5	0.2	0.4	3.7	2.7	1.2	3.3	3.7	4.6	2.6	0.8	2.1	1.7
ZNF486	"KRBO2, MGC2396"	ENSG00000256229	"Zinc finger protein 486"	Q96H40	19	20167228-20200490	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 59.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 17.0;HBF TERT88: 16.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.9"	"Low lineage specificity"	"Detected in all"																						"unprognostic (9.94e-3)"	"unprognostic (1.29e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.51e-3)"	"unprognostic (4.14e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.43e-2)"	5.1	2.6	3.5	5.3	4.3	2.2	7.2	9.0	4.1	7.7	2.6	1.6	15.4	0.9	6.2	6.1	3.4	5.1	4.1	2.8	2.7	2.2	9.5	1.4	3.8	6.3	5.2	1.8	7.0	5.6	7.7	3.4	10.2	3.4	7.9	2.5	2.5	3.0	10.1	1.4	4.0	3.2	2.6	4.7	6.0	3.6	2.4	5.3	7.0	59.2	2.1	5.4	13.5	7.0	3.6	1.3	13.9	1.7	1.5	3.2	0.9	0.0	0.0	4.5	0.4	3.4	4.0	0.4	6.4	4.8	11.9	11.6	0.5	2.7	6.0	17.0	5.5	2.7	0.0	0.5	16.8	0.1	2.5	0.1	0.1	1.5	4.1	0.0	0.0	6.5	1.9	7.4	0.6	0.9	2.5	0.0	2.7	0.1	1.2	4.6	7.8	1.7	3.7	6.6	2.2	13.8	4.5	2.7	7.5	0.0	7.5	1.0	3.1	0.1	1.9	1.1	0.4	7.9	5.2	0.6	7.4	5.1	0.1	0.1	2.2	3.1	0.9	1.2	1.4	1.7	1.6	2.6	1.9	2.0	1.2	3.6	2.4	3.2	13.9	1.5	1.2	1.3	2.1	0.9	3.5	4.3	9.0	4.1	2.7	2.2	5.2	1.8	3.4	5.3
ZNF571	HSPC059	ENSG00000180479	"Zinc finger protein 571"	Q7Z3V5	19	37554782-37594790	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 61.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA054762			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA054762: "	"unprognostic (1.16e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.03e-4)"	"unprognostic (5.77e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.71e-4)"	6.5	6.7	8.6	3.2	12.9	6.1	12.5	12.5	12.8	5.9	4.2	9.8	4.4	2.3	6.7	8.7	3.9	6.0	4.5	4.2	10.4	7.2	6.4	4.2	4.1	4.4	15.3	9.4	8.5	3.8	11.5	12.2	4.8	13.4	7.1	3.4	5.1	3.6	4.5	3.5	7.1	3.7	7.7	14.3	4.8	3.5	8.5	15.8	3.7	61.8	3.3	5.0	6.6	5.3	9.4	4.1	4.9	1.3	3.7	8.4	3.2	1.8	1.0	6.3	9.1	4.7	4.7	2.0	2.7	4.4	6.6	8.2	1.9	1.7	9.6	8.6	2.8	2.4	2.0	2.9	11.0	2.1	7.9	5.1	2.7	1.1	5.4	1.9	5.8	2.6	5.2	6.3	5.7	1.3	2.4	0.8	5.3	1.7	9.5	2.1	15.8	3.5	4.8	3.0	5.0	9.0	11.6	13.6	9.5	6.4	2.1	3.2	9.7	1.3	0.8	3.0	3.9	3.2	6.9	7.7	15.8	13.2	0.5	0.8	6.5	1.8	0.8	4.9	6.7	1.3	6.1	8.7	6.3	6.5	2.7	9.4	7.8	8.4	1.5	3.7	1.2	4.1	4.2	3.2	8.6	12.9	12.5	12.8	10.4	7.2	15.3	9.4	13.4	15.8
ZYG11A	ZYG11	ENSG00000203995	"Zyg-11 family member A, cell cycle regulator"	Q6WRX3	1	52842511-52894998	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 21.2;thyroid gland: 8.1"	"Cell line enhanced"	"Detected in many"		"HeLa: 10.5;hTEC/SVTERT24-B: 10.1;K-562: 9.7;SiHa: 10.2"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 11.1"	"Region enhanced"	"Detected in single"		"pons and medulla: 2.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA030378, HPA030379"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA030378: AB_10604159, HPA030379: AB_2673451"	"unprognostic (7.94e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.04e-2)"	"unprognostic (4.06e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.00e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.06e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.15e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.02e-1)"	0.3	0.1	0.2	3.0	0.2	0.4	1.4	0.7	0.1	0.6	0.2	0.1	0.8	0.4	0.1	3.0	1.7	0.1	0.4	0.9	0.1	0.3	6.4	3.1	0.1	1.0	0.1	0.0	0.6	0.3	0.6	0.5	1.0	2.2	1.7	0.2	1.0	0.5	0.0	0.3	0.6	0.3	0.5	1.3	0.3	0.1	21.2	0.0	0.9	8.1	1.3	5.6	0.5	1.1	1.0	0.8	3.1	0.6	0.9	0.7	0.2	0.0	1.9	0.3	0.0	0.0	0.0	4.4	1.2	1.3	5.6	4.6	0.1	0.1	0.0	2.9	1.7	0.1	3.8	0.1	6.7	0.3	7.2	0.0	10.5	0.0	2.7	0.0	0.8	0.0	0.3	10.1	0.1	1.3	9.7	5.4	0.2	5.2	0.0	5.2	1.4	0.9	0.0	1.2	4.6	3.5	0.2	1.4	2.2	10.2	0.5	0.0	5.7	2.9	0.1	0.0	0.1	0.0	0.0	2.7	4.5	0.1	0.0	0.1	0.8	1.8	0.6	0.8	0.5	0.3	0.3	0.7	0.5	0.5	0.1	1.0	0.6	0.7	3.1	0.9	0.3	0.8	0.4	0.2	0.2	0.2	0.7	0.1	0.1	0.3	0.1	0.0	2.2	0.0
